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Abstract
Within the last two decades high-throughput gene expression screening technolo-
gies have led to a rapid accumulation of experimental data. The amounts of infor-
mation available have enabled researchers to contrast and combine multiple exper-
iments by synthesis, one of such approaches is called meta-analysis. In this thesis,
we build a large gene expression data set based on publicly available studies for
further research on T cell subtype discrimination and the reconstruction of T cell
specific gene regulatory events. T cells are immune cells which have the ability to
differentiate into subtypes with distinct functions, initiating and contributing to a
variety of immune processes. To date, an unsolved problem in understanding the
immune system is how T cells obtain a specific subtype differentiation program,
which relates to subtype-specific gene regulatory mechanisms.
We present an assembled expression data set which describes a specific T cell
subset, regulatory T (Treg) cells, which can be further categorized into natural Treg
(nTreg) and induced Treg (iTreg) cells. In our analysis we have addressed specific
challenges in regulatory T cell research: (i) discriminating between different Treg
cell subtypes for characterization and functional analysis, and (ii) reconstructing T
cell subtype specific gene regulatory mechanisms which determine the differences in
subtype-specific roles for the immune system. Our meta-analysis strategy combines
more than one hundred microarray experiments. This data set is applied to a ma-
chine learning based strategy of extracting surface protein markers to enable Treg
cell subtype discrimination. We identified a set of 41 genes which distinguish between
nTregs and iTregs based on gene expression profile only. Evaluation of six of these
genes confirmed their discriminative power which indicates that our approach is
suitable to extract candidates for robust discrimination between experiment classes.
Next, we identify gene regulatory interactions using existing reconstruction algo-
rithms aiming to extend the number of known gene-gene interactions for Treg cells.
We applied eleven GRN reconstruction tools based on expression data only and
compared their performance. Taken together, our results suggest that the available
methods are not yet sufficient to extend the current knowledge by inferring so far
unreported Treg specific interactions. Finally, we present an approach of integrating
multiple data sets based on different high-throughput technologies to reconstruct a
subtype-specific GRN. We constructed a Th2 cell specific gene regulatory network
of 100 genes. While 89 of these are known to be related to Th2 cell differentiation,
we were able to attribute 11 new candidate genes with a function in Th2 cell differ-
entiation. We show that our approach to data integration does, in principle, allow
for the reconstruction of a complex network.
Future availability of more and more consistent data may enable the use of the
concept of GRN reconstruction to improve understanding causes and mechanisms
of cellular differentiation in the immune system and beyond and, ultimately, their
dysfunctions and diseases.
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Zusammenfassung
Die Etablierung von Hochdurchsatz-Technologien zur Durchführung von Gen-
expressionsmessungen führte in den letzten 20 Jahren zu einer stetig wachsende
Menge an verfügbaren Daten. Sie ermöglichen durch Kombination einzelner Experi-
mente neue Vergleichsstudien zu kombinieren oder Experimente aus verschiedenen
Studien zu großen Datensätzen zu vereinen. Dieses Vorgehen wird als Meta-Analyse
bezeichnet und in dieser Arbeit verwendet, um einen großen Genexpressionsdaten-
satz aus öffentlich zugänglichen T-Zell Experimenten zu erstellen. T-Zellen sind Im-
munzellen, die eine Vielzahl von unterschiedlichen Funktionen des Immunsystems
inititiieren und steuern. Sie können in verschiedene Subtypen mit unterschiedlichen
Funktionen differenzieren.
Der mittels Meta-Analyse erstellte Datensatz beinhaltet nur Experimente zu ei-
nem T-Zell-Subtyp, den regulatorischen T-Zellen (Treg) bzw. der beiden Unter-
gruppen, natürliche Treg (nTreg) und induzierte Treg (iTreg) Zellen. Eine bisher
unbeantwortete Frage lautet, welche subtyp-spezifischen gen-regulatorische Mecha-
nismen die T-Zell Differenzierung steuern. Dazu werden in dieser Arbeit zwei spe-
zifische Herausforderungen der Treg Forschung behandelt: (i) die Identifikation von
Zelloberflächenmarkern zur Unterscheidung und Charakterisierung der Subtypen,
sowie (ii) die Rekonstruktion von Treg-Zell-spezifischen gen-regulatorischen Netz-
werken (GRN), die die Differenzierungsmechanismen beschreiben. Die implemen-
tierte Meta-Analyse kombiniert mehr als 150 Microarray-Experimente aus über 30
Studien in einem Datensatz. Dieser wird benutzt, um mittels Machine Learning
Zell-spezifische Oberflächenmarker an Hand ihres Expressionsprofils zu identifizie-
ren. Mit der in dieser Arbeit entwickelten Methode wurden 41 Genen extrahiert, von
denen sechs Oberflächenmarker sind. Zusätzliche Validierungsexperimente zeigten,
dass diese sechs Gene die Experimenten beider T-Zell Subtypen sicher unterscheiden
können.
Zur Rekonstruktion von GRNs vergleichen wir unter Verwendung des erstellten
Datensatzes 11 verschiedene Algorithmen und evaluieren die Ergebnisse mit Infor-
mationen aus Interaktionsdatenbanken. Die Evaluierung zeigt, dass die derzeit ver-
fügbaren Methoden nicht in der Lage sind den Wissensstand Treg-spezifischer, re-
gulatorsicher Mechanismen zu erweitern. Abschließend präsentieren wir eine Daten-
integrationstrategie zur Rekonstruktion von GRN am Beispiel von Th2 Zellen. Aus
Hochdurchsatzexperimenten wird ein Th2-spezifisches GRN bestehend aus 100 Ge-
nen rekonstruiert. Während 89 dieser Gene im Kontext der Th2-Zelldifferenzierung
bekannt sind, wurden 11 neue Kandidatengene ohne bisherige Assoziation zur Th2-
Differenzierung ermittelt. Die Ergebnisse zeigen, dass Datenintegration prinzipiell
die GRN Rekonstruktion ermöglicht.
Mit der Verfügbarkeit von mehr Daten mit besserer Qualität ist zu erwarten,
dass Methoden zur Rekonstruktion maßgeblich zum besseren Verstehen der zellulä-
ren Differenzierung im Immunsystem und darüber hinaus beitragen können und so
letztlich die Ursachenforschung von Dysfunktionen und Krankheiten des Immunsys-
tems ermöglichen werden.
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1. Introduction
Since the beginning of modern natural sciences and especially biology, strategies and
methods to uncover natural phenomena were mainly based on observation and inter-
pretation. Technological inventions like microscopy and x-rays, mass spectrometry and
DNA sequencing opened new and magnitudes deeper views inside objects and organ-
isms. Later simulation and hypotheses testing via models became popular. In the last
century, the availability of computing power and computer-based, so called in silico ex-
periments enabled the construction of complex virtual models. The ongoing development
of technologies and sensing devices increased the amount of experimental data and in
consequence the need for appropriate computational analysis methods.
In biology and related life science fields, computational analysis became relevant in
the second half of the 20th century with the genomic era. Its breakthrough came with
the advent of the so called post-genomic era and the establishment of DNA sequenc-
ing and other high-throughput omics-technologies leading to the rapid accumulation of
experimental data [126, 144]. In contrast to conventional experimental “wet-lab” tech-
niques, more fine grained and deeper insights were achievable with less effort. In this
time, the focus of bioinformatic tools changed from experimental observations and data
collection to results analysis. New methods for comparative analysis of genomic data
became indispensable.
Baldi et al. described in [18] two phases of computational support in biology, termed
computational biology or bioinformatics. The first phase of computational biology was
focused on data analysis like sequencing data. The second phase relates to sophisti-
cated integration of highly diverse kinds of data. Data integration based on a variety
of newly accessible experimental techniques, many of which are capable of data genera-
tion at different levels, i.e. cell, tissue, organ, organism, or even population level. Until
today, the amount of accumulated biological data has increased well beyond petabyte
[218]. Ever since, large amounts of data became publicly available, researchers aimed
to contrast and combine multiple experiments by synthesis so called meta-analysis [48].
Since all experiments are unique in their specific settings and conditions comparing dif-
ferent experiments and results is difficult. Meta-analysis has evolved into an essential
tool to discover candidate biomarkers, understand biological processes or resolve con-
flicting conclusions from different experiments [48, 146]. Meta-analysis rapidly became
an essential tool of exploratory analysis, e.g. during drug response analysis or disease
gene identification [397]. In addition, meta-analysis enables the aggregation of related
experiments to large-scale data sets, required for gene regulatory network (GRN) infer-
ence [236], that aims to uncover the regulatory gene-gene interactions and regulatory
mechanisms between genes.
While the concept of genes and gene regulation was discovered more than 70 years ago
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[84], many questions regarding the specific interactions, so called gene regulations are
still unanswered. Multiple such regulations can be presented as interactions networks or
so called GRNs.
Knowledge about the GRN is crucial to understand the pathogenesis of Mendelian
disorders or systematic dysfunctions of organisms, which can be caused by alterations
and disruptions of the underlying regulatory mechanisms [14, 264]. For instance, some
malfunctions of the immune system can be tracked down to transcription factor (TF)–
initiated and cytokine–initiated gene regulatory events [117]. Alterations of the gene
regulatory program can cause pathological cell development and changes in resulting
autoimmunity with consequences like rheumatoid arthritis or allergies. During the last
30 years, researchers aim to uncover the regulatory mechanism of the immune system,
for example the regulation of T helper cell differentiation [75]. While, it is known, that
T helper cells differentiate into different subtypes that maintain specific function to the
immune system the regulatory mechanism behind are not fully understood and even
unknown for certain subtypes.
In this thesis we aim to contribute to the problem using machine learning algorithms
applied to a large gene expression data set. In particular we study two challenges, that
arose in these years. First, we aim to develop a method that allows for the identifica-
tion of discriminating surface marker for different regulatory T helper cell subtypes. We
implement a machine learning approach to discriminate between induced and natural
regulatory T helper cells. Second, we aim to compare methods for reconstructing T
helper cell specific GRNs from gene expression data to elucidate important gene regu-
latory interactions during regulatory T helper (Treg) cell differentiation by presenting
two general approaches. In Chapter 5, we compare existing algorithms for GRN recon-
struction to extend the number of known Treg cell specific gene regulatory interactions.
In Chapter 6 we present a data integration approach to reconstruct a GRN using re-
sults and data from existing experiments, public databases and literature. We present
a sophisticated data integration strategy to recover and infer gene regulatory interac-
tions between the master transcription factor Stat6 and other transcription factors and
cytokines during Th2 cell differentiation.
1.1. Goals and Contributions
This work is embedded in the context of understanding the role of T helper cell for the
mammalian immune system. We show that the integration of publicly available data
combined with the application of GRN reconstruction algorithms and machine learning
enables a more detailed understanding of the molecular mechanisms in T helper cells
and provides new hypotheses about specific gene regulatory interactions.
The four major topics of this thesis are (i) the application of meta-analysis strategies
on publicly available gene expression data for (ii) the identification of marker genes,
(iii) the inference of gene regulatory networks from gene expression data and (iv) the
reconstruction of gene interactions by integrating experimental data and established
knowledge from different sources.
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The specific contribution of this work are:
• Collect and assemble a set of publicly available T helper cell subtype specific mi-
croarray gene expression experiments. We present different approaches for meta-
analysis and present our own, which is based on the integration of raw data instead
of published results. We briefly describe problems on integrating heterogeneous
data sets and explain how to reduce data set specific bias. Next, we compare
this strategy to “t-test“-based differential expression analysis, and use gene set
annotations to show the meta-analysis’ capability of reducing the differences be-
tween experiments coming from different studies, while preserving the T helper
cell specific expression characteristics of the genes.
• We develop a pipeline for applying feature selection methods to gene expression
profiles to extract candidate genes that code for surface marker proteins. Thereby
we aim to enable the experimental distinction of different Treg cell subtypes and
thus allow for deeper biological function analysis. As a consequence thereof, we
implement an in silico evaluation strategy using Support-Vector-Machines.
• We analyze and compare available methods for GRN reconstruction from gene
expression data. We run a selection of tools without providing additional prior
knowledge to the reconstruction methods. In contrast to other studies, we apply
the methods to noisy, murine expression data. We show that the performance of
tools without additional knowledge and with heterogeneous data quality is rather
poor.
• We demonstrate a gene regulatory network around Stat6 – the master transcrip-
tion factor of Th2 cells. Thereby we demonstrate the power of integration strate-
gies using a variety of RNA- and DNA-sequencing and microarray data, as well
as literature information. Next to a number of known interactions of important
transcription factors and cytokines during Th2 cell differentiation, we extract 11
targets of Stat6 with so far unreported functions in Th cell differentiation.
1.2. Outline of this Thesis
Chapter 2 provides the biological background relevant throughout this work. It outlines
the core structure of the mammalian immune system, and explains the principles
of T helper cell function - the biological context of this thesis. Subsequently, we
introduce the concept of gene expression and gene regulation. We conclude this
chapter by introducing high-throughput detection technologies, like microarray
technology and Next Generation Sequencing for RNA and DNA.
Chapter 3 presents our approach to the aggregation of many publicly available Treg cell
specific gene expression experiments to form a large meta-experiment for further
application. The goal is to compensate the lack of large homogenous data sets
during the application of subsequent data analysis strategies, like machine learning
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for marker detection (Chapter 4) or gene regulatory network reconstruction based
on expression data (Chapter 5). Finally, we perform and evaluate the meta-analysis
of selected Treg cell specific microarray experiments.
Chapter 4 describes a machine learning approach to extract Treg cell specific surface
markers using the assembled meta-expression set. We give an overview about
feature selection methods and their application for gene marker detection, followed
by describing Support Vector Machines (SVMs) a supervised machine learning
algorithm for classification. The SVM classifier is used to test marker qualities of
extracted candidate genes.
Chapter 5 presents the methods for GRN reconstruction. At first, we explain the im-
portance of GRNs to unravel the complex topology of gene-gene interactions with
T-helper cells. Second, we give a broad overview about existing algorithmic ap-
proaches and tools for GRN reconstruction on whole-genome scale from gene ex-
pression data. Third, we present the application of 11 of these tools to the meta-
expression set. We evaluate the inferred networks using public databases and
compare their respective performance.
Chapter 6 describes an alternative approach for reconstructing gene interaction net-
works by data integration for a specific T-helper cell subtype on small scale. Using
the example of Th2 cells we construct a network based on time-series gene expres-
sion data from sequencing and microarrays, TF-binding data from high-throughput
DNA sequencing experiments as well as public database information. The recon-
structed network is specific to Stat6 - the master transcription factor of Th2 cells.
Chapter 7 summarizes this thesis and the main contributions. Finally, it gives an out-
look to future work.
1.3. Own prior work
Some parts of this thesis are based on work which has been published previously in
peer-reviewed publications.
Chapter 3 and 4 are based on a manuscript, in preparation [198]. Parts of the article
are mentioned in this thesis, are the specific experiment selection in Chapter 3 and the
wet-lab experiments in Chapter 4, which all were performed by M. Ventzke and M.
Karl from the German Rheumatism Research Center in Berlin. Other parts, like the
meta-analysis, the concept, design and implementation of the feature selection and in
silico evaluation can be attributed to the author of this thesis. The resulting manuscript
was drafted by all authors. U. Leser additionally supervised the whole project, while R.
Baumgrass supervised the biological experiments.
Chapter 6 presents the contributions of the author to the publication [168]. M. Jar-
gosch and S. Kröger are equally contributing first authors in the referenced literature.
The author contributed the concept and design for the data integration and performed
parts of the data analysis (microarray, RNA-seq, ChIP-seq), partly in collaboration with
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E. Gralinska and U. Klotz. Experiments in this study were selected, conceived and de-
signed by M. Jargosch, R. Baumgrass, Z. Fang and W. Chen. R. Baumgrass, U. Leser, J.
Selbig and D. Groth supervised the project. M. Jargosch, R. Baumgrass and S. Kröger
drafted the manuscript.
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2. From gene expression to regulation in
the immune system
The following chapter presents the biological and technical background regarding meth-
ods and contexts of the subsequent chapters.
First, we describe the immune system and its role in mammalian organisms, followed
by a brief introduction to T cells and specific subtypes as well as the process of T
cell differentiation. We mainly focus on two subtypes: Treg and T helper 2 (Th2)
cells, as these are addressed in Chapters 3, 4 and 5 (Treg cells) and Chapter 6 (Th2
cells). Later we introduce the phenomena of gene expression and gene regulation and
describe transcription factors and their differential roles in T cells development and
fate determination. The fourth section of this chapter elaborates the technical bases
of determining gene expression and gene regulation by microarray and state of the art
sequencing technology.
2.1. The mammalian immune system and immune cells
The general task of immunity as conveyed by the immune system of higher vertebrates is
to combine a set of mechanisms for discrimination between self1 and non-self for defense
against pathogens. The immune system’s major function is to prevent the organism
from intrusion of foreign organisms whilst at the same time controlling its own defensive
response in order to prevent damage to the organism itself.
Higher vertebrates like mammals employ complex immune systems comprised of a
large variety of cells from different origins with differential functions and a large array of
different mechanisms. The immune system can be divided into two general concepts, the
innate and adaptive immune system. Both employ different strategies for the recognition
of pathogen-related patterns (for details about the two concepts, see e.g. [1, 167, 269]).
Cells, like macrophages, granulocytes or natural killer cells make up the innate immune
system. These cells utilize receptors which recognize evolutionary conserved molecular
patterns associated with pathogens. Such receptors, e.g. the Toll-like receptors (TLRs),
the best known and well-studied examples, are genetically encoded and can be employed
by any cell which expresses the gene [211].
B cells and T cells are the cells of the adaptive immune system and can employ a wide
range of molecular mechanisms against the pathogens, i.e., resulting in production of
mediators of inflammation like cytokines. They employ antigen-receptors generated from
randomly selected and combined gene segments. Antigen binding of a receptor activates
1e.g. belonging to and produced by the organism
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B and T cells and leads to the proliferation of antigen-reactive cells. Efficient immune
responses require the proliferation of initially very few antigen-reactive cells, so called
clonal expansion and selection of cells with enhanced antigen-binding capacity. The
antigen-directed (therefore: adaptive) immune responses are much slower than innate
responses (weeks rather than minutes or hours). After driving an adaptive immune
response the pathogens have been cleared from the system, some antigen-responsive
cells are retained as memory cells. The presence of these cells allows for a much faster
response of the adaptive immune system upon a second confrontation with a known
antigen. This property of the adaptive immune system is referred to as immunological
memory and is put to use in vaccination.
Adaptive Immune System
Lymphocytes, the cells of the adaptive immune system, originate from a common pro-
genitor cell in the bone marrow and mature in the bone marrow (B cells) or in the
thymus (T cells), respectively. T cells are divided into cytotoxic and T helper (Th)
cells: Cytotoxic T cells mediate killing of host cells which are infected with intracellular
pathogens whereas Th cells are required for initiation and control of cellular actions of
the immune system, e.g. the B cell response leading to the production of antigen or
cytotoxic T cell action.
Immune Tolerance
One key property of the immune system is the immune tolerance. The term refers
to the immune system’s ability to differentiate between host (so-called: self) antigens
originating from the organism itself, and foreign antigens in such a way that potent
immune responses are only targeting non-self antigens.
The antigen receptors of the adaptive immune system are generated randomly. There-
fore they can, in principle, not only bind foreign but also self-antigens. This situation is
called auto-immunity and is potentially deleterious to an organism. Auto-immunity can
give rise to auto-immune diseases, such as rheumatoid arthritis, diabetes, systemic lupus
erythematosus with varying levels of strength. Auto-immunity is tightly controlled by a
variety of mechanisms such as the deletion of immune cells reactive to self-antigen dur-
ing development and maturation in the bone marrow (B cells) or T cells in the thymus
(central tolerance). To control and confine auto-immunity Th cells can differentiate into
Treg cells in the secondary lymphoid organs (e.g. spleen, lymph nodes, or tonsils) or in
the periphery. Peripheral Treg cells have the potential to inhibit immune responses to
self-antigens by various mechanisms (peripheral tolerance).
2.2. T cells and T cell diversity
T cell development and selection for central tolerance take place in the Thymus where
T cells differentiate into either cytotoxic T cells, generally identified by the expression
of cluster of differentiation 8 (CD8) [382] or into Th cells generally expressing cluster of
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differentiation 4 (CD4). Th cells provide signals which allow for full activation of innate
immune cells, cytotoxic T cells or B cells [344]. CD4 expressing T cells can further
differentiate into several Th cell subsets or into regulatory T cells (for a simplified scheme
see Fig. 2.1).
Th cells express the CD4 co-receptor and have a major role in controlling and regu-
lating the immune system by providing necessary co-stimulatory signals for the action
of other white blood cells [167]. The activation of T cells is mainly driven via T cell
receptor (TCR) stimulus and requires co-stimulation. T cell activation takes place in
lymphatic tissues such as as the spleen or lymph nodes of the periphery and after con-
tact with Antigen-presenting cells (APCs). To prevent inappropriate immune response
to self-antigens (autoimmunity), T cells become anergic and later activation is unlikely.
After activation, T cells change the composition of surface molecules, i.e. molecules which
are involved in their respective functions. This also enables identification of the T cell
subtypes by differences in molecules present on their cell surface (see Chapter 4).
2.2.1. Fate determination and differentiation in T helper cells
The ability of proliferation into different subtypes and functional plasticity of naïve T
(Th0) cells is a prerequisite for T cell immunity. Then acquisition of lineage-specific
T cell effector functions is linked to a proliferative response, suggesting that T cell
activation drives differentiation programs which facilitate effector gene expression [300].
In recent years, much effort has been spent to investigate the plasticity resp. the ability
of re-differentiation of T cells from one to another subtype (for details on plasticity see
e.g. [111, 206, 268, 378, 405]). The differentiation of naïve CD4+ T cells (Th0) into Th
cell subtypes is regulated by specific cytokine milieus and complex TF networks [168].
After activation, Th0 cells are able to differentiate into one of six distinct T cell subsets,
defined by the presence of cytokines and subtype specific TFs [268]. Other subtype
definitions, like Th22, Th9 or Th40 cells [233] are not of interest in this thesis.
2.2.2. T helper cell subtypes
Here, we focus on four of these six subtypes, namely Th1, Th2, Th17 and Treg cells and
the process of T cell fate determination. Furthermore, we briefly describe the role of
each subtype during immune response.
Type 1 T helper (Th1) cells
Th1 cells develop under the presence of interleukin 12 (IL-12) and Interferon γ (IFNγ),
both are the critical cytokines initiating the downstream signaling cascade to develop
Th1 cells. IL-12 is secreted by APCs upon activation. IFNγ is produced by natural killer
cells (NKCs) which in turn are induced by IL-12. The master TF of Th1 cells is the
T-box TF (T-bet). T-bet drives the production of IFNγ, and suppresses Th2 and Th17
programs. Th1 cells host immunity effectors against intracellular bacteria and protozoa
by mediating immune responses by induction of proliferation of cytotoxic CD8+ T cells
and macrophages.
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Figure 2.1.: Development of naïve T (Th0) cells into T helper cell lineages/
subtypes. Process of T cell differentiation is mainly driven by presence
and absence of lineage specific cytokines (written on the arcs) and so called
master TFs (written in the cells). Cytokines at the right side are those,
expressed by the activated cells.
Type 2 T helper (Th2) cells
Naïve T helper cells can differentiate into Th2 cells in the presence of Interleukin-4 (IL-
4) [91, 167]. These cells produce various cytokines (IL-4, IL-5, IL-6, IL-9, IL-13, and
IL-17E (IL-25)) to mediate their functions, which encompasses mainly the activation
and maintenance of the humoral, or antibody-mediated, immune response against ex-
tracellular parasites, bacteria, and toxins. IL-4 itself drives GATA3 expression through
the TF Stat6. GATA3 is the master TF of Th2 cell differentiation (see Fig 2.1). Sub-
sets of immune cells are stimulated and recruited by Th2 cells, such as eosinophil and
basophil granulocytes. The activation of Th2 cells is a major factor for the exacerbation
of Type-1 allergies (immediate hypersensitivity reactions), autoimmune reactions such
as chronic graft-versus-host disease, progressive systemic sclerosis, and systemic lupus
erythematosus [91].
Regulatory T (Treg) cells
The ability of the immune system to balance and regulate immune responses is largely
driven by Foxp3+ regulatory T (Treg) cells as part of the immunological tolerance (see
Fig 2.2). Therefore, Treg cells are not only important objects of study but also targets for
manipulation, as reduced amounts or dysfunction of these cells can lead to autoimmune-
diseases. Over-representation or hyperfunction of Treg cells can lead to cancer [265, 368].
As early as 1995, Sakaguchi et al. showed the importance of CD4+CD25+ Treg cells
for the prevention of autoimmune diseases [304]. A particular important feature of
10
2.2. T cells and T cell diversity
Foxp3+ regulatory T cells is the expression of the master TF Foxp3 [149]. In human,
functional mutations in this TF can result in a loss of Treg cells and development of the
immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX, first
described in [280]).
Foxp3+Treg cells show a certain degree of diversity and different subpopulations have
been identified among the pool of in vivo occurring Foxp3+ Treg cells, also designated as
natural Treg (nTreg) cells [49, 101, 158]. Discriminated by their origin, two important
subtypes are thymus derived Treg (tTreg) and peripherally induced Treg (pTreg) cells,
reviewed in [312, 324]. The differentiation of tTreg cells occurs after positive selection in
response to high affinity TCR signals to self-antigens and is dependent on γc receptor sig-
naling and to some extent also TGF-β [59]. tTreg cells make up a substantial fraction of
the nTreg pool [151, 172]. In contrast, pTreg cells differentiate from conventional CD4+
T cells in response to low-doses of antigen in an anti-inflammatory environment and
dependent on TGF-β, which occurs especially at sites of antigen encounter, i.e., mucosal
tissues like the gastrointestinal tract and the lungs. Regarding functional differences,
tTreg cells are critical for the prevention of autoimmunity whereas pTreg cells are in-
duced to narrow more localized inflammatory responses, esp. against foreign antigens
[76].
Furthermore, naïve CD4+ T cells differentiate in vitro into Foxp3+ iTreg cells after
activation in the presence of TGF-β [60]. However, these so-called iTreg cells do not show
the same features as their natural counterparts, especially in terms of lineage stability
and function. While nTreg cells are in general more efficient in their suppressive function,
iTreg cells are highly efficient in controlling the onset of autoimmunity in a mouse model
of autoimmune gastritis [389]. Additionally, Huang et al. showed that iTregs are more
tolerogenic in an asthma model [156].
For years, Treg cells have been important subjects of medical research due to their
crucial role for the adequate regulation of the immune system. Such research would
benefit greatly from reliable surface markers allowing the effective discrimination of
iTreg and nTreg cells. Being able to perform such discrimination would open the door
for detailed functional studies of both cell subtypes and their respective roles within the
immune system. Results from such studies could have immediate clinical implications
[265, 327]. Also, as described in Chapter 4 a clear definition of nTreg and iTreg cells is
required for cell transfer therapies [256, 350].
Type 17 T helper (Th17) cells
Naïve T helper cells differentiate under the presence of TGF-β and Interleukin 6 (IL-
6) and Interleukin 23 (IL-23) to T helper 17 (Th17) cell [352]. Differentiated cells
express Interleukin 17 (IL-17) which led to their name. The presence of TGF-β during
differentiation relates these cells directly to regulatory T (Treg) cells as the IL-6 inhibits
the differentiation of Treg cells. Th17 cells have been connected to autoimmune and
inflammatory reactions as they react to pathogens and activate neutrophil granulocytes,
which are among the early responding cells in the mammalian immune system [195].
Dysregulation of Th17 cells results in autoimmune disorder and inflammation. The
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Figure 2.2.: Putative mechanisms used by Treg cells. Treg cells have multipe puta-
tive targets as described by Caridade et al. [51]. These include (1) targeting
dendritic cells (DCs) – leading to weak or abrogated signals to naïve/effector
T cells; (2) Metabolic disruption; (3) Competition – for critical cytokines,
such as IL-2, or direct disruption of effector cell engagement with APCs;
(4) Cytolysis – direct cytotoxic effect and consequent apoptosis of effector
T cells or APCs; (5) Production of inhibitory cytokines – including IL-10,
IL-35, and TGF-ß. Figure adapted from [51].
master TF of Th17 cells is STAT-3, which is activated by both IL-23 and IL-6, and, for
example, binds to the IL-17 locus.
2.3. Gene regulation
Genes and the interaction of genes via their products are keys to the functions and
mechanisms of organisms [7]. Gene regulation refers to processes controlling the expres-
sion of a gene. Gene regulation comprises direct mechanisms like gene-gene regulation
and “implicit” mechanism like the circadian clock or the activity of so called enhancer
elements [99, 208, 362]. By current knowledge not all regulatory effects can be fully
explained, as it is assumed that further, so far unknown, factors are involved. Exam-
ples of such known factors influencing gene regulation during T cell differentiation are
the presence of certain cytokines or the specific cytokine repertoire (physical amount),
TF presents or others like Calcium influx during Th1/Th2 cell activation. Methods of
gene expression tracking and comparative gene expression analysis using microarray or
sequencing technology may help to elucidate regulatory mechanisms at transcriptome
level. Thereby it is of importance that such analyses are performed under comparable
physical states and conditions [17, 223].
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2.3.1. Gene expression
Gene expression is the process of transcribing deoxyribonucleic acid (DNA) coding a
gene to ribonucleic acid (RNA), before translation into a functional gene product (see
Fig 2.3). Gene products are proteins or functional RNAs, respectively non-protein coding
genes like transfer RNA (tRNA) or small nuclear RNAs (snRNAs) [7].
As described in Fig 2.3 gene expression consists of mainly four steps. First, DNA is
transcribed into RNA. Second, the RNA is spliced to messenger RNA (mRNA). During
splicing certain coding regions (exons) are kept and non-coding region (introns) are
removed. The remaining exons are spliced together. Third, the spliced elements are
exported into the cytoplasm after preparation . In the last step, the mRNA is translated
into an amino acid sequence making up the protein.
Figure 2.3.: Gene expression of eukaryotic organ is initiated in the cell nucleus.
DNA is transcribed into RNA. Next RNA is spliced and transported from
cell nucleus to the cytoplasm and finally translated to a protein coding amino
acid sequence.
Notably, manipulation and error can act at every step of gene expression, i.e., tran-
scriptional control during transcription of DNA to RNA, control of RNA processing
in splicing (alternative splicing, siRNA), during the transport from the nucleus to the
cytoplasm (tRNA control), via mRNA degradation (miRNA), or translational control
during or before translation into protein [7]. Regulatory effects result from the complex
interplay of multiple mechanisms, not exclusively controlled by TF or miRNA binding.
Nevertheless, in this work we focus on TF as origin of regulatory events as TFs are still
assumed to be one of the most impacting factors during gene regulation.
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2.3.2. Transcription factors and gene regulation
TFs are proteins which regulate the transcription of other genes by binding to a certain
DNA sequence and, thus, activating or repressing the expression of genes in the specific
or flanking genomic regions. TFs can act together with other TFs to block or promote
RNA polymerase , so called co-factorial binding or co-regulation via TF complexes (see
Fig 2.4). In general, TFs are able to turn on or off the expression of other genes by
controlling molecules which enable or disable transcription. Vaquerizas et al. estimated
in 2009 about 1,700–1,900 TF-coding genes in the human genome [366], in mice there are
about 1,700 genes coding for TFs [370]. Additionally, histone modification can influence
binding and regulation by TFs as it allows or inhibits the binding of a TF at a specific
binding site [140].
Figure 2.4.: TF-binding in promoter region initiates gene transcription. Bind-
ing of only one TF may cause a regulatory event, while binding of two can
cause a different regulatory events [122]. The figure illustrates the phe-
nomenon that gene regulation is cause by cooperatively acting of TFs, so
called co-binding.
Transcription factors impact on T cell fate Various TF like TGF-β , TGIF and
cytokines like Interleukin 4 (IL-4), Interleukin 6 (IL6) play a crucial role during Th cell
fate decision as visualized in Fig 2.1. Their presence is necessary to initiate or inhibit the
differentiation into Th cell subtypes. Therefore it is of high interest to uncover regulator
mechanisms which lead to different expression levels of these factors.
2.4. Technologies and tools for sensing gene expression
2.4.1. Microarray technology
Microarrays allow the detection of several thousands of expressed messenger RNAs
(mRNAs) molecules at the same time [310]. Defined genetic sequences (probes) are
placed on small glass or plastic plates (wafers) to detect the expression of complemen-
tary sequences. Each probe is located at a specific location (spot) on these plates and
detects a specific sequence. Probe sequences are either artificially created and standard-
ized for a specific microarray type or individually prepared for so-called custom arrays.
These probes are oligonucleotides (oligos), that are usually 13 to 25-mers (25 bases long
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sequences), that are directly synthesized onto the wafer and refer to a gene or transcript.
Multiple probes represent a single transcript and each probe itself consists of a Perfect-
Match (PM) and a MissMatch (MM) oligo. While the PM has the exact same sequence
as the target transcript, the MM is different by a single base substitution in the middle
of the sequence. MMs enable better background and unspecific hybridization detection
by comparing with the corresponding PMs. During the actual experiments, fluorescent
antibodies are coupled with the sample sequences for optical recognition (scanning) of
the amount of bound sequences for each spot. The measured fluorescence represents
the amount (expression) of the bound sequences. The technology was developed in the
1980s, but real market values was reached first from the mid of the 1990s until today.
For this work the most important types of microarrays are single and two-color-spotted
oligonucleotide microarrays. The standard protocol of performing a microarray expres-
sion experiment is shown in Fig 2.5.
Figure 2.5.: Schema of a microarray experiment from sample purification to
data analysis. The figure illustrates processing steps and their sequential
order during a microarray experiments. (Necessary sample preparation steps
before purification are not shown here.)
1. RNA/ cDNA purification includes extraction of the target cells and the extraction of
RNA (purification). This step is important to avoid false positive signals through
contamination (e.g. by foreign RNA fragments).
2. Reverse transcription is the process of generating complementary DNA (cDNA)
from RNA using the enzyme reverse transcriptase (RT). These cDNA sequences
bound to the specific probes during hybridization (step 4).
3. Coupling is the process of labeling the fragments, typically by fluorescent or radioac-
tive labels. Labeling can be performed directly via specific fluorescent antibodies
or indirectly via antibodies which in turn bind fluorescent antibodies. For two-color
arrays labeling is performed before hybridization, while for single-color arrays the
labeling takes place after hybridization.
4. Hybridization and washing is the actual process, where the cDNA fragments bind to
the oligonuceotide probes on the microarray (hybridization). After hybridization
residual unbound sequences and DNA fragments are removed (washing).
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5. Scanning is the process of detection of emitted light or radiation. High-resolution
pictures of the microarray show the level of gene transcription (gene expression) by
the intensity of the specific light emitted from prior coupled fluorescent antibodies.
The amount of light or radiation emitted is used to calculated raw expression
values. Manufacturers often provide software, which (i) performs microarray type
specific noise reduction and intensity normalization and (ii) translate the signals
into numeric values.
6. Data analysis typically starts with background correction and normalization, which
is mandatory for comparing expression values from different microarrays, like dif-
ferent samples, replicates, etc. Various proprietary and free protocols have been
developed, Figure 2.6 illustrates an example analysis workflow. Until today, Mi-
croarray Analysis Suite 5 (MAS5) and Robust Multi-array Average (RMA) are
two of the most widely used methods [132]. MAS5 performs normalization for
each microarray independently using MM and PM. RMA performs normaliza-
tion over multiple arrays based on PM only. RMA calculates expressions with
corresponding P-values indicating the significance of erroneous [34], where MAS5
also provides flags for absence, minor presence and presence of a ProbeSet for a
given transcript. Other examples of widely used analysis strategies are Gene Set
Enrichment Analysis (GSEA) [343], cluster analysis to extract genome-wide ex-
pression patterns [92, 170, 342], or the application of gene network inference tools
as described in Chapter 5.
Figure 2.6.: Microarray expression analysis workflow. Various workflow variants
similar to the presented (implementing different algorithms) exist.
2.4.2. Next generation sequencing
The first full organism, bacterial phage ΦX174 was sequenced in 1977 by Sanger et
al. [308] it consisted of just 5386 nucleotides encoding 11 genes. The human genome
consists of 3,234.83 nucleotides on 23 chromosome pairs and encodes about 19,000 pro-
tein coding genes [96], which illustrates that high-throughput methods were necessary
to sequence the entire human genome. The task of sequencing is to determine the exact
order of the four bases (adenine, guanine, cytosine, and thymine) in a DNA or RNA
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strand. In the beginning, two-dimensional chromatography was used to determine single
bases in extracted strands, while modern sequencing devices enable automated determi-
nation of the full sequence from a small RNA/DNA sample. The era of high-throughput
sequencing started in the mid 1990s, and the first commercial sequencer (GS20) was
available in 2005[367]. At this time technology was expensive and error-prone. Over the
years, sequencing technology and necessary computation power became cheaper by mag-
nitudes (see Fig 2.7). Some of the most common Next Generation Sequencing (NGS)
technologies are Illumina, 454 pyrosequencing, Solexa, SOLiD, Polonator and HeliScope
sequencing [321]. NGS allows for detecting the dynamics of genome-wide expression
without specific assumptions, like viral genes [50, 287, 313].
Figure 2.7.: The decrease of sequencing costs per human genome over time.
The orange line additionally shows the cost per raw Megabases of DNA se-
quences. Data taken from the NHGRI Genome Sequencing Program (GSP)
[197].
Chromatin immunoprecipitation DNA-sequencing (ChIPseq)
Beside sequencing of complete organisms, DNA sequencing (DNA-seq) can also be used
to analyze specific changes during different states or under various conditions. As
research draw attention to the function of specific regions and DNA sequence in the
genomes, the interest in targeting such was initiated. DNA-seq can shed light on many
DNA alterations and binding effects when combined with Chromatin Immunoprecipi-
tation (ChIP) to measure protein binding to specific DNA regions, called Chromatin
Immunoprecipitation sequencing (ChIP-seq). The detection if a specific protein (TF)
can bind to a gene (TF target) or its surrounding region on the DNA of protein is
the major application of ChIP-seq. Thereby, the TF binding regions are isolated as
DNA fragments (ChIP) and sequenced (seq). Subsequent analysis reveals if the target
gene (or surrounding genomic regions) contain such sequences (binding motifs). The
sequence isolation is performed using specific antibodies that bind the TF or specific
genomic region of interest (see Fig 2.8).
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Figure 2.8.: Illustration of the processing workflow for ChIP-seq experiments.
ChIP-seq procedure consists of i) the isolation of the target samples (here
immune cells), ii) fragmentation of the isolated DNA, followed by iii) the
chromatin immunoprecipitation with the subsequent RNA purification, iv)
adapter ligation and end repair of the isolated sequences, v) library prepa-
ration and vi) clustering the targeted RNAs following by vii) the actual
sequencing and subsequent analysis of detected reads. The figure is adapted
from Kidder et al. [183].
After performing the chromatin-immunoprecipiation and subsequent sequencing of
extracted DNA fragments the sequencing machine generates files that contain the raw
reads. These raw reads are used for the ChIP-seq data analysis. After obligatory quality
control and filtering of low quality, reads are mapped to the reference genome. After-
wards analysis calls for significantly enriched regions (peak calling) and these regions are
mapped to genes (gene locations) in the genome (peak annotation). Figure 2.9 illustrates
the process of ChIP-seq analysis, starting from raw reads up to extract significantly en-
riched genomic regions.
In chapter 6 ChIP-seq data is used to determine TF-binding events that play a crucial
role during T helper cell differentiation. Another use for ChIP-seq data is transcription
factor binding site (TFBS) or Motif discovery in the promotor region of investigated
genes. Retrieved sequences are used to search for known (TFBS) or to identify unknown
(Motif discovery) binding locations for TFs and small RNAs.
RNA sequencing
RNA sequencing (RNA-seq) refers to sequencing technology used to determine mRNA
expression. In contrast to microarray technology, RNA-seq measures known and novel
transcripts in coding and non-coding RNA. Quantification of RNA expression by se-
quencing is based on the number of detected sequences (reads) matching a specific coding
region in the genome. The major advantage of RNA-seq towards microarray technology,
is the ability of detecting so far unknown transcripts (transcripts that do not match any
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Raw read extraction & conversion
into FASTA files
Quality control
Read mapping
Peak calling
Peak annotation
Extraction of associated genes
Trimming & filtering
Figure 2.9.: Chromatin Immunoprecipitation sequencing(ChIP-seq) peak call-
ing analysis workflow. Analysis workflow consist of six steps followed by
an additional annotation step (extraction of associated genes). While step
1-4 are similar to RNA-seq analysis, peak calling and peak annotation are
specific to ChIP-seq analysis.
known sequence). Thereby, sequencing allows to measure “all” expression in contrast
to microarray which only measures mRNA sequences that are presented on the chip.
“All” expressions also includes expected and unexpected changes of the genome, e.g.
mutations, single nucleotide polyphormisms (SNPs), copy number variations (CNVs),
insertion and deletions (InsDels) as well as the identification of new molecular entities
like micro RNA (miRNA), smallRNAs [225].
In principle, RNA-seq allows analysis of all expressed transcripts, with three key goals:
(i) annotating the structures of all transcribed genes including their 5’- and 3’-ends and
all splice junctions, (ii) quantifying expression of each transcript and (iii) measuring
the extent of alternative splicing [212]. A basic workflow of RNA-seq data analysis is
illustrated in Figure 2.10.
In Chapter 6, we will focus on RNA-seq used to determine the expression profiles of
Th2 cells during activation and differentiation from naïve T cell into Th2 cells. Thereby,
we integrate different RNA-seq data sets for certain time points during the process and
enable whole-transcriptome analysis to investigate TF-activity and estimate potential
interactions via detection of co-expression of genes.
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Figure 2.10.: RNA sequencing(RNA-seq) expression analysis workflow.The
steps 1-4 are similar to the ChIP-seq analysis workflow (Figure 2.8), while
step 5-7 are specific to RNA-seq analysis. The general outline of the work-
flow is based on the work of Trapnell et al. [359]
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3. Meta-analysis of large gene expression
experiments from public data
repositories
In this chapter we discuss methods and applications of meta-analysis of gene expression
experiments for aggregating single studies into a large meta experiment. Until today,
high-throughput gene expression experiments are time and money consuming, especially
when large amounts of data are necessary to analyze gene regulatory mechanisms. Meta-
analysis can help to create large assembled experiments to overcome these shortcoming
by using existing data. Furthermore, it has been shown that meta-analysis can increase
statistical power of detecting differential expression [64] and significantly improves re-
producibility when compared with independent studies [146].
The aim of this chapter is to demonstrate a novel meta-analysis approach to aggregate
large data sets of Treg cell experiments for subsequent analysis of expression differences
between Treg cell subtypes, namely iTreg and nTreg cells. We show how data was col-
lected, curated and assembled to create a large gene expression data set. This includes
quality checking and the assessment for batch- and lab-effects between data from dif-
ferent sources and technologies. The final data set is presented as a gene expression
matrix containing over twelve thousand gene expression values retrieved from over 150
microarrays and more than 30 studies.
In the related work section we describe existing methods of meta-analysis for gene
expression data. Afterwards we introduce our strategy of collecting and assembling gene
expression experiments from public repositories (Section 3.4.1-3.4.3). Next, we describe
our approach to process assembled data while focusing on reducing the experiment spe-
cific biases. Thereby we enable subsequent data analysis using established methods
(Section 3.4.5-3.4.6). Finally, our findings are presented in the results and summary
sections. We applied our strategy to Treg subtype specific experiments, as our goal is
the assembly of a large meta expression matrix to enable the identification of distinct
surface marker genes for iTreg and nTreg cells using machine learning, which will be
covered more detailed in the subsequent Chapter 4.
The methods and results of both chapters were originally developed for investigating
surface marker proteins for regulatory T cell subtype distinction, in cooperation with
the German Rheumatism Research Center in Berlin
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3.1. Motivation
The major aim of meta-analysis is to enable analysis of assembled experimental data
from different source. Such assembling helps to overcome restriction regarding lower
data amounts of specific analysis methods. Furthermore it enables the re-use of exper-
imental data by assembling existing experiments instead of (re-)performing them, that
is expensive, time consuming or simply spoken - inefficient, as this experiment data
implicitly already exists. Thereby, meta-analysis must solve several issues, like han-
dling variations (noise) in and between studies, without removing “real” signals, like
differential expression or deciding whether studies are comparable or not.
Since high-throughput methods became more and more popular and the amount of
available experiments increased and still grows, meta-analysis enables the (re-)use of
existing data. Another need for meta-analysis emerged from the fact that up to a certain
point the impact of time or condition changes cannot be avoided during lab-work due
to simple constrains like sequential order or incremental setups of experiments or other
technical limitations. This accounts for other technologies beside microarrays, too, e.g.
RNA- or DNA- sequencing and even for technologies like histopathological images [196].
Two basic classes of meta-analysis methods were established, merging raw data and
combining existing results. While merging raw data allows user full control over methods
of data analysis, combining results releases user from normalizing, correcting and ad-
justing raw data in advance of further context specific analysis. For the field of merging
raw data, two major fields of applications exist. The first is using existing data to create
large data set to further analyze these using methods that have minimal requirements
to the set size. For example some GRN methods that need at least as many experiments
as regulators are requested. And second, the field of clinical applications, where patient
data is permanently added to a cohort, which is analyze as one single experiments. Se-
tups as the second are used for example to extract structural genomic anomalies, disease
specific gene expression pattern, validate drug and changes of their targets [79, 292].
Another reason for the popularity of such approaches is the increasing availability of
large curated, domain-specific data sets and hosting repositories
While the necessity of the first will slowly decrease in the next years, because high-
throughput technology allow for cheaper and larger data generation (Figure 2.7), the
second will keep valid since extraction of patient material and the influence of surround-
ing settings (like even room temperature or chronology of working steps) cannot be
standardized over large periods of time.
3.1.1. Key issues for meta-analysis
As many approaches for meta-analysis with varying quality have been developed in the
last decade (see Section 3.3), Ramasamy et al. stated seven key issues for meta-analysis
[285]:
1. Identify suitable microarray studies,
2. Extract the data from studies,
3. Prepare the individual data sets,
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4. Annotate the individual data sets,
5. Resolve the many-to-many relationship between probes and genes,
6. Combine the study-specific estimates,
7. Analyze, present, and interpret results.
The presented selection and manual curation in this work directly follows the first issue
Ramasamy mentioned. Individual data set retrieval, quality checking, normalization and
individual identifier (Id) mapping reflect the issues two to five. Issue six lead us directly
to using a strategy were raw data is used as we plan to further analyze the data based
on the expression values. Finally, issue seven is the object of Chapter 4 of this work.
3.2. Data source for building meta expression experiments
The basic requirement for the assembly of meta expression experiments is data. Back
in the days, researchers often only published results without attaching the raw data
that was generated and analyzed to achieve these. But, in the last 10-15 years more
and more scientific journals and open access initiatives started to demand to publish
the raw data that corresponded to scientific publications. A major intention was to
increase traceability and reproducibility of scientific experiments and results. Neverthe-
less, this development also enabled the re-use of published data for meta-analysis, as the
amount of available raw data of experiments increased permanently. Especially because
detailed information about the experimental context and technical descriptions are of-
ten provided. The tremendous amount of published raw data strengthen the demand
for central instances that enable access to the data. Consequently scientific online data
repositories emerged.
3.2.1. Online data repository
Data retrieved from high-throughput gene expression experiments, mainly using mi-
croarrays, tremendously increased over the last 15 years and thus the potential for
meta-analysis. In these years data repositories emerged to tackle and overcome the
problem of data scarcity and permit the demand for researcher to publish their raw
data. Multiple online accessible data repositories ease the acquisition of publicly avail-
able experimental data. NCBI’s Gene Expression Omnibus data repository (GEO) and
EMBL-EBI’s ArrayExpress are the most popular and largest repositories for gene ex-
pression data. Up to date both platforms contain about 60-70 thousand experiments
from array or sequencing experiments. Already in 2011 Barret at al. assessed the size
and growth of data for the GEO repository over the last ten years exemplarily [22]. Two
years later, the same authors described the tremendous amount of uploaded sample and
the continuous exponential growth of the database [23]. Figure 3.1 illustrates the growth
of the database between 2000 and 2016. Another advantage of GEO and ArrayExpress
is that third-party libraries for scripting languages allow remote access and automatic
retrieval of data and meta-information via Application programmer interfaces (APIs).
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Figure 3.1.: GEO Gene Omnibus platform growth over the last 15 years. Plot
illustrates the orders of magnitudes of platform, studies and samples sub-
mitted to the GEO database each year since inception. Until January 2016
about 1,669 million samples from 64,816 series (studies) perform on 15,358
were submitted to the GEO database. (Numbers were take from the web-
site (https://www.ncbi.nlm.nih.gov/geo/summary/?type=history, on-
line on 2016/01/10)
Over the years other, more organism, or tissue specific repositories emerge, but also
disappeared, as for example The Arabidopsis Information Resource (TAIR) [154] or the
Stanford Microarray Database (SMD) [116]. Finally both were integrated into GEO and
ArrayExpress.
The advantage of many of these such “specialized” repositories or databases (e.g.
M2DB [62]) is, that many of these perform manual data curation, which means, that
additional steps of quality control and meta-information annotation is applied before
integrating data sets into the repository. Thereby, next to automated quality control,
experts and scientists evaluate the data sets before integrating them into the repositories.
Furthermore, data is enriched by additional information [8]. Although, many of these are
commercially driven, they often grant access to researcher and academia, like Oncomine
- an compendium of cancer transcriptome profiles that features additional analysis tools
[291] or BloodSpot [16] a repository for cancer studies, that hosts data for normal and
aberrant blood formation studies.
In the field of biological sciences various repositories covering different scope and
aspects emerged. A number of repositories evolved that focus on hosting sequencing data.
The limitation to sequencing data is caused by multiple reasons, one is the establishment
NGS technology and the second the huge requirements on computational power and
storage to host and analyze such data [282, 337]. Some of the most popular repositories
are:
• DNA DataBank of Japan (DDBJ) [189]
• EMBL Nucleotide Sequence Database (ENA) [177, 339]
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• GenBank [26]
• dbSNP [323]
• dbVar [262]
• EBI Metagenomics [159]
• NCBI Trace Archive [70]
• NCBI Sequence Read Archive (SRA) [70]
• IGSR: The International Genome Sample Resource (The 1000 genomes project)
[67]
• The ENCODE (ENCyclopedia of DNA elements) project [69]
• RNASeqMetaDB [123]
The Immunological Genome Project [320] is an repository that aims to provide ge-
nomic data regarding the immune system of mice. As all integrated data is generated
by the project members itself, analysis and tools for further investigation are provided.
But, to this point the repository is rather small (816 arrays of 249 cell types, from 27
tissues in 2012) [320]. Other immuno-related repositories were not further maintained
or integrated in others, like Macrophage Expression Atlas (GPX) [121] or Resource of
Asian Primary Immunodeficiency Diseases (RAPID) [181]. Unfortunately, today only
very few repository focusing on immune cells exist, the most popular project is the Im-
munological Genome Project and systems immunology (ImmGen). ImmGen focuses on
genes and their networks in the immune system, while it aims to construct regulatory
computational models to identify known and novel regulatory interactions [320]. While
ImmGen is an online platform to analyze and annotate data it also uses Gene Expression
Omnibus (GEO) as data hosting platform. The access to preprocessed or normalized
and categorized data is restricted. Therefore, we make use of search and filter functions
of the GEO that contains many appropriate experiments as described in Section 3.4.
Nevertheless, additional manual data curation is absolutely necessary to ensure that se-
lected experiments meet specific requirements to assemble a data set that enables valid
comparison between Treg cell subtypes and further analysis.
3.2.2. Data curation
When merging or assembling data from different sources one aspect of quality control
is to assess the comparability. As we suggest to use large data repositories, that cover
various kind of data unspecific to a certain field of research it is necessary to check wether
selected data does in fact contain experiments, that meet the study aim. Therefore,
manual curation is an additional preprocessing step that ensures this aspect of data
quality. In 2001 Brazma et al. presented Minimum Information About a Microarray
Experiment (MIAME) a standard that describes which minimal information must be
provided to a microarray experiment [39]. This minimum of information should ensure
the interpretation and the verifiability of experiments. Brazma et al. defined six section
of MIAME that describe a microarray experiment:
1. Experimental design: the set of hybridization experiments as a whole
2. Array design: each array used and each element (spot, feature) on the array
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3. Samples: samples used, extract preparation and labeling
4. Hybridizations: procedures and parameters
5. Measurements: images, quantification and specifications
6. Normalization controls: types, values and specifications
These features support the integration of new experiments into repositories and pro-
vide important information for reproducibility of experiments or for latter re-use, as for
example for meta-analysis.
3.3. Related work
Up to date, various methods of using existing data to create new artificial data sets
from microarray expression data exist. Already in 2002, Rhodes et al. aimed for stable
cancer markers over different individuals, with varying experimental setting, conditions
and patient states. They proposed meta-analysis of different patient studies to overcome
the problem of data sparsity. Furthermore, Rhodes et al. assumed that meta-analysis
produces more stable markers with increasing amount of data from different studies
[290].
As early as 1999, Lander [200] reviewed the application and the resulting opportuni-
ties for microarrays and the advantages of combining multiple studies to enable global
expression and genome analysis. As one of the first, Choi et al. analyzed batch effects
as an issue of systematical differences between studies [64]. This work was a follow-up
study to the meta-analysis study of Rhodes et al., who aimed to identify prostate can-
cer related genes from multiple microarray studies [290]. In the following years various
methods to reduce the batch-effect were presented [10, 25]. But, as Johnson et al. wrote
in [171] many of these methods required large amounts of data to work properly and
to not diminish biological signal. Various methods have been developed in the last 15
years using different approaches, e.g. single values decomposition [10] or empirical Bayes
methods [171, 207, 251].
3.3.1. Comparison of methods for meta-analysis of gene expression data
In 2007 Cahan et al. [47] distinguished between two basic classes of microarray meta-
analysis. The first class depicts merging raw data from different studies and considering
the merged data as one experiment in subsequent analysis. In the second class exper-
iments that are selected for a meta-analysis are provided as individual lists of differ-
entially expressed (differentially expressed) genes or list of summarized gene expression
changes. It is important to note, that thereby individual studies were not necessarily an-
alyzed using same or even compatible methods. The first approach is widely used when
patient data from different studies is aggregated [226, 375, 387]. An example of the
second class is the integration results from multiple studies to develop gene interaction
networks from different experiments and even from different technologies (microarray,
RNAseq, DNAseq) as described in [168]. Both classes exhibit certain advantages (+)
and disadvantages (-) regarding different aspect as these are:
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Merging raw data
- High computational and technical re-
quirements
+ Fine-grained selection of experiments
(parts of studies)
+ High comparability of results
+ Reproducibility of complete analysis
pipeline
- High effort on integration of different
techniques and platforms
+ Quality control of raw data
+ Batch- /lab-effect estimation
+ Re-computation using different (new)
methods
+ Freedom of choosing methods for sub-
sequent expression analysis
+ Flexible ID mapping, e.g. using dif-
ferent reference genomes
Combining result lists
+ Low computational and technical re-
quirements, no raw data processing
+ Integration of multiple technologies,
e.g. microarray, RNAseq
+ Integration of heterogeneous source
and formats
+ No preprocessing effort
+ Extensibility by additional data,
without reprocessing data
- No quality control of raw data
- Compatibility of processing methods
required
- Ambiguity of mapping – compatibil-
ity required, e.g. ProbeSets to tran-
script to gene
- Comparability of results restricted to
applied processing and analysis meth-
ods in original experiments
An example for the concept of comparing results is used by GEO Gene Omnibus online
portal, that does provide web features such as, search and on demand visualization of
individual gene expression data.
Along with the individual advantages come distinct fields of application of both classes.
On the one hand biologist tend to compare results from different publications, where
on the other hand bioinformaticians or statisticians often prefer raw data to apply their
favorite methods, existing frameworks or scientific workflows. Thereby, biologist do not
need specific skills for data processing and can focus on results from different studies as
these may also include varying technologies for gene expression detection, like RNA-seq
and microarray experiments. Furthermore required computational power to process and
analyze large amounts of raw data prior integration into a meta set must be available.
Another reason to perform meta-analysis by merging raw data is to overcome batch
effects, where data/material for different samples is processed time and even location
(lab) independently [295]. In 2012 Tseng et al. prepared an overview on existing methods
of meta-analysis for gene expression experiments [361].
3.3.2. Types of meta-analysis
Choosing a particular type of meta-analysis method is mainly driven by the overall goal
of a study. Beside differential expression analysis, also gene function prediction, target
gene detection, and gene cluster detection demand for different analysis strategies. For
instance, differential expression analysis compares gene expression of two samples from
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different batches, where a conceivable aim of a gene cluster analysis is the identification
of homogeneously expressed genes, which does not require a direct comparison between
samples or states and therefore batch effects are negligible. In consequence, choosing
appropriate strategies of meta-analysis depends on the available input data and the aim
of the subsequent analysis.
Before presenting implementations in detail, we give an overview of meta-analysis
methods. Five of the most relevant methods of meta-analysis are the following (based
on [361]):
P-value combination allows for integration of results from different studies and belongs
to the second class. For example Rhodes et al. suggest to combine P-values by
summing up minus log-transformed P-values for a gene over all studies. The re-
ceived score indicates the strength of differential expression [290]. Next to other
transformation methods, some approaches calculate min or max P-values over all
and use these as test statistics to estimate significance of differential expression
[217]. Obviously, only studies sharing the identical or very similar aim should be
combined.
Combining effect size is based on the idea that each gene expression profile for each
study is the combination of the true effect size (real gene expression changes) and a
study- or batch-specific error. The method belongs to the first class as it combines
raw data. Different authors approach to model the effect using fixed effect models
(FEM) or random effect models (REM) between studies. FEM assume the effect
size to be identical for all integrated studies [37, 311] where REM try to cover
heterogeneity of studies caused by sample or processing differences, which is much
more realistic [64].
Combining ranks denote the use of ranking results (e.g. differentially expressed genes),
which are combined using robust rank statistics [214, 409]. Outliers are a constant
problem of such methods, when rank aggregation is performed using mean or
similar statistics [361]. Approaches like RankProd try to overcome such problems
by calculating the product of ranks of fold changes (fold changes) instead of P-
values in each inter-pair group of samples [147]. As the fold changes are not re-
calculated, combining ranks is part of the first class methods.
Directly merging raw data is the class of methods that combine raw data as a single
study before performing further analysis like normalization. As such methods do
not involve inter-study effects (also called effect-size) handling, additional effort is
necessary to account for batch-effects or errors [326]. Direct merge of raw data is
often applied when studies use identical microarray technologies or even identical
microarray types [205]. In recent years, several methods and R packages have
been developed to enable direct merging of raw data with subsequent batch-effect
handling as e.g. BMC [25], COMBAT [171], GENENORM, and XPN [317, 347].
Latent variable approach describes a probabilistic model to integrate studies. The basic
idea is to use a latent variable to model quantities of gene expression that can be
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combined over studies. For example, Choi et al. used latent variables to estimate
an index – the probability of expression (POE), that is used to compare two groups
of a meta data set [63]. This approach is part of the class of methods that merge
raw data.
3.3.3. Existing meta-analysis approaches and implementations
A major issue on meta-analysis is the problem of removing signals, that occurs dur-
ing each adaption, transformation or shift of expression values up to a certain amount,
regardless of the used method. The better the method estimates differences based on
batch- or lab specificity the lower the loss of “real” differences. Several authors dis-
cussed this problem coming along with meta-analysis starting from study selection up
to mapping strategies between different platforms [48, 266, 285].
As early as 2002, Rhodes et al. [290] applied a meta-analysis strategy on different
prostate cancer microarray experiments with the idea of identifying recurring gene ex-
pression pattern across different studies and technologies. They found a set of genes
that was consistently and significantly dysregulated across all experiments. Rhodes et
al. did not account for inter-study effects as they disregarded the actual strength of dys-
regulation but considered shared differentially expressed genes between different data
sets.
In 2003, Choi et al. [64] extended the idea of combining data sets with a systematic
approach to handle inter-study differences. The approach summarizes the individual
bias of an experiment, the so called effect size. The effect size implements a statistical
framework for combining different results by comparing intra- and inter-study differences
of expression levels for single genes under consideration of the inter-study effect, that
is measured by comparing the average measure of differential expression across all data
sets for each gene. The effect size was estimated via a fixed effect model (for limited
number of experiments performed under accountable conditions), a random effect model
(for published experiments from different origins ) and by an Bayesian approach, that
offers more flexibility and robustness for varying inter-study differences.
Sirbu et al. [346] proposed a method for meta-analysis in preparation of gene regula-
tory network reconstruction from public data. They focus on integration of single- and
multi-channel arrays and compare their method against Johnson’s ComBat method [171]
and the XPN method published by Shabalin et al. [317]. Before normalization a prepro-
cessing step is performed, where values were estimated with a mixed method of Loess
normalization [330] (for Affymetrix single-channel arrays) and PM-only normalization
(for dual channel arrays) [332]. Sirbu et al. normalized cross-platform via expression
values transformation to values between 0 and 1 after preprocessing each data set by
subtracting sample mean and division by sampled standard deviation of the sample. The
transformation was done by subtracting the overall smallest expression values from all
values and subsequent division by the greatest values in the data set [346].
Johnson et al. [171] implemented an empirical Bayes approach (ComBat), which con-
sists of (i) standardizing expression values per gene to similar means and variances, (ii)
batch effect parameter estimation using parametric empirical priors and (iii) the adjust-
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ment of the data to the batch effect. The authors note that before estimating the batch
effect all genes that were “absent” in at least 80% of the measurements were removed to
eliminate noise.
XPN (cross platform normalization) method [317] enables normalization of studies
from different array types. After pre-processing the data and reducing the experiments to
a common gene/probe set each experiment is represented as a matrix and then combined
into one combined matrix. Via multiple k-means clustering XPN identifies homogenous
groups of genes and samples in combined data. For each block the specific values are
shifted to its mean plus noise. To achieve robustness and minimize effect of initial cluster
centroid selection the results of multiple clustering iterations are averaged and assigned.
Frozen robust multiarray analysis (fRMA) by McCall et al. [251] approaches the chal-
lenge of removing batch effects, where a batch is defined as a number of microarrays that
are processed at same time and lab, while an experiment consists of multiple batches
that use the same technology (array type). fRMA is very similar to the RMA method
for single experiments but does account for differences for the batches by calculating
a reference distribution from a database of publicly available expression data. After
background correction all single arrays are (quantile) normalized regarding the reference
distribution. Finally expression values are summarized by correcting the expression value
by the calculated batch effect.
Conlon et al. compare two Bayesian approaches [68] that belong to the class of latent-
variable approaches. One that combines standardized gene expression measures across
studies, while the second combines probabilities of differential expression. Later ap-
proaches like GeneMeta [239] and its extension MetaArray [114] focus on comparing
expression profiles and extracting differentially expressed genes between different data
sets that were processed on identical microarray platforms (GeneMeta). Therefore a user
must i) perform a gene-id mapping before applying MetaArray if different platforms are
used, and ii) assess the comparability between different experiments.
Campain et al. extended Yangs Differential Expression via Distance Synthesis (DEDS)
[392] to enable meta-analysis (mDEDS) [48]. It makes use of multiple statistical mea-
sures to obtain a list of differentially expressed genes. In contrast to other methods like
MetaArray, differentially expressed genes are detected regardless of used platform types.
Similar to RankProd, mDEDS assumes that relevant genes can be detected between
multiple experiments by rank combination. As the introduced method performs the
actual aggregation after detecting differential expression it belongs to the class of rank
combining methods.
MergeMaid by Cope et al. [71] provides function to merge different expression sets into
a single one. MergeMaid enables visual comparison of specific samples or probes (e.g.
genes) between different studies, but requires user-supplied mappings. MergeMaid alone
does not provide mechanism to handle or overcome differences between array types, or
batch effects. Therefore the subsequent application of a batch effect reduction method
is necessary.
Another field is the problem of mapping identifier from different platforms. Anova
Sibling Consolidation by Li et al. [216] is a method to test comparability between exper-
iments from different microarray platforms. They utilize Anova test statistic to check
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whether expression profiles of two probes mapping to the same gene are similar expressed
and thus can be merged or not. This approach can be adapted to check same expression
for two probes from different experiments or even different microarray platforms as long
as a mapping between them is available.
Comparison of methods Evaluation of different methods (not identical to prior pre-
sented) revealed that there is no overall best working method, rather then different
methods have perform better regarding certain criteria. To shed some light onto this,
Chang et al. reviewed and compare 12 meta-analysis methods [56]. They formulated
four criteria, namely (i) detection capability, (ii) biological association, (iii) stability and
(iv) robustness.
Detection capability is an approach to assess how many differentially expressed genes
are detected under the same assumptions regarding significance for all methods.
Biological association denotes the results of pathway enrichment analysis and the rela-
tion to the targeted disease, which is implied by the underlying data set.
Stability is detected by splitting data sets into subsets and compare results of meta-
analysis methods regarding overlapping differentially expressed genes.
Robustness of methods is determined by adding outlying studies to the data sets and
measuring their influence towards the prior detected set of differentially expressed
genes and the relative difference.
An important conclusion of Chang et al. was, that the most appropriate method
depends on study goal and the underlying data set, as robustness and stability might be
better covered by methods that did not performed best over all criteria.
3.4. Assembling gene expression experiments for meta-analysis
As mentioned in the motivation our approach is guided by the key issues for meta-analysis
by Ramasamy et al. [285]. Figure 3.2 outlines our strategy starting from data collection
until extracting the final meta expression matrix. Here, we perform meta-analysis by
assembling a large curated Treg cell gene expression compendium from public data. W
e describe each step in detail, followed by the results presentation in Section 3.5.
3.4.1. Data collection
To collect data we used NCBI’s GEO web portal (http://www.ncbi.nlm.nih.gov/geo)
and the query T regulatory cell AND mus musculus. We obtained a list of 1500 arrays.
GEO organizes microarray and other high-throughput experiments by four different
categories: GEO platform identifier (GPL), GEO sample record (GSM), GEO series
record (GSE), and GEO dataset record (GDS) [363]. The GPL specifies a concrete
technology the experiment is based on, e.g. the specific microarray chip or sequencing
31
3. Meta-analysis of large gene expression experiments from public data repositories
Querying studies via NCBI's Gene Onmisbus portal 1. Data collection - querying NCBI's Gene Onmisbus portal 
Selection, filtering and curation of retrieved experiment descriptions2. Retrieving meta information & curating selected experiments
Microarray normalization (RMA) 4. Normalizing selected microarray experiment (RMA) 
Mapping individual ProbeSet IDs to Ensembl Genes IDs5. Mapping ProbeSet identifier to Ensembl Genes
Meta expression set assembling & renormalization6. Assembling & re-normalizing the meta expression set
Retrieving raw data and performing quality control3. Retrieving raw data, quality control and filtering
Figure 3.2.: Schema illustrates the steps of meta-analysis starting from re-
questing online repositories up to assembling the meta expression
matrix. Sections 3.4.1 - 3.4.6 describe the pipeline in detail.
technology that was used to perform the experiment. GPLs are unique up to the manu-
facturers version of a technology like different versions of a specific microarray chip. The
GSM identifies the specific microarrays record and its output files. Each GSM is unqiue
over the complete set of all experiments in the GEO repository. A GSE can specify all
experiments that were processed in one study or, more abstract, all experiments that
share a common context, not necessarily processed together in a single study. Exper-
iments (GSMs) can be associated to more than one study and each study can inherit
experiments from others. Thus, meta studies can be modeled as it is presented in this
work.
3.4.2. Retrieving meta information
The list of extracted experiment Ids was filtered for study type Expression profiling
by array using GEO webportal filter tools. In the next step meta information and
description for each experiment were retrieved using R package GEOmetadb [408]. All
information about the GEO experiments are stored in a SQLite database, which can be
accessed locally using structured query language (SQL). Thus it is possible to access
the information via introduced identifers like GPL, GSM or GSE.
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We created a list containing title, organism, GSE, GSM, GPL and the description
of all filtered experiments to enable immunologist to manually identify and remove ex-
periments that do not satisfy a defined set of minimal requirements. Next to organism
information immunologist focused on the cell type mentioned in the description, the stim-
ulus, and experimental details like viral treatments, knock-out (KO) or knock-in (KI)
information. Table 3.1 contains a detailed list of the major criteria used to include or
reject experiments to our collection.
Table 3.1.: Listing of criteria for inclusion or rejection of experiments while
manual curation by immunologist.
Include criteria: Exclude criteria:
• In-vitro and in-vivo induced iTreg cells
with activation period longer than 3 days
• In-vitro and in-vivo iTreg cells induced
for short-time only (3 days or shorter)
• Fresh ex-vivo and activated nTreg cells
from wild-type mice, Balbc mice (lab mice),
• Genetically modified mice with deficient
Treg cell master transcription factor Foxp3
C57BL/6J (lab mice), NOD mice, • Cell mix of iTreg and nTreg cells
TCR-HA transgenic mice, • Scurfy mice
Foxp3 reporter mice • Genetically modified mice with deficiency in
Il-2 pathway
Furthermore time information was added if mentioned in the specific experiment or
study to ease the subsequent manual categorization into nTreg or iTreg cell experiments.
This is necessary as the stated aim of the resulting meta expression set is to identify
distinct surface marker gene for both Treg cell subtypes. The process of manual curation
resulted in a set of 300 microarray experiments assigned to 74 different studies (GSE),
where 48 were initially classified as nTreg cell and 26 as iTreg cell related studies. Due to
constraints of our normalization and aggregation pipeline the data set was further limited
to experiments performed using Affymetrix gene chip technology (see Figure 3.3). Table
3.2 summarizes the initial amounts of experiments returned by GEO Omnibus web portal
upon request and the finally selected set of 154 microarrays.
3.4.3. Retrieving raw data
In the next step the raw data, here Affymetrix CEL files (containing the data extracted
from an Affymetrix GeneChip) were retrieved using R-package GEOquery [80]. GEO-
query enables the automated download of data by GSM/GSE accession numbers from
the GEO repository.
Studies or single experiments were deselected if either no experimental raw data were
available or if the data did not pass a quality check using arrayQualityMetrics [180], i.e.
were detected as outlier in three or more tests. This criteria led to the exclusion of five
experiments. It is important to mention that quality control tests were applied to each
study (GSE) in isolation to prevent outlier-detection coming from differences between
studies (see Section 3.4.6).
All these selection and filtering steps led to a final set of 154 arrays from 36 studies,
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Table 3.2.: Table shows the size of the collected data set for each step of the
pipeline. The column “matched GEO-query” contains the numbers of el-
ements as retrieved from GEO, while “selected” contains those, included in
the meta expression data set after filtering and quality control.
matched GEO-query selected
Arrays 604 154
Data sets 238 36
Treatments - 15
Platforms 51 6
Species 1 1
Cell types >4 2
Figure 3.3.: Fractions of platform types in the final meta expression set. 154
arrays (29 iTreg and 125 nTreg) from 36 GEO series were selected. This
set contained six different Affymetrix GeneChip R⃝technologies. Numbers
below the platform type indicate the corresponding amount of integrated
microarrays.
where 29 arrays originated from iTreg cells and 125 arrays from nTreg cells (see Figure
3.3). Appendix A, Table A.1 contains all selected microarray experiments that were
integrated in the meta expression set.
3.4.4. Meta expression set
After collecting the data as described in the previous steps, data must be preprocessed
to allow for a joined analysis. Due to the heterogeneity of the experimental settings
under which the data was obtained, a proper normalization of expression values is of
highest importance. Such a normalization must take intra-study and inter-study variety
into account. While intra-study variety relates to the general problem of normalizing
measured expression intensities between microarrays [332], across-study variety refers to
multiple effects and systematic differences between experiments that were not part of
34
3.4. Assembling gene expression experiments for meta-analysis
the same study [47, 311]. To overcome the problems of intra- and inter-study effects a
two-step algorithm was implemented resulting in comparable expression values over the
complete set of selected studies.
In the first step, all measurements within the same study were normalized using RMA
(robust multi-array average) published in 2003 by Irizarry et al. [163] and provided by
different R-packages like the Affy package [110, 283]. Required study-specific information
about replicates, groups of arrays, temporal or circadian information, so called phenodata
were taken from previously retrieved meta data. The phenodata of a study basically
includes the description of each array and its association to a specific subgroup that
share a certain property, e.g. cell type, stimulation, stimulation time, treatment and
tissue. In the second step, we reassigned the selected microarrays in either the group of
iTreg cell or in the group of nTreg cell experiments. Disregarding small differences in
sample preparation or similar we consider such differences as biological variance. The
resulting set of experiments from different studies, assigned to one of both groups was
necessary to enable subsequent assembly of a large expression set. The next step was
the definition of a common set of gene Ids over all studies to enable meta set assembly.
3.4.5. Identifier mapping
Next, we built a single meta expression matrix across all studies including the inter-
secting of ProbeSet Ids of all experiments. Thereby we mapped original ProbeSet Ids
to Ensembl Mouse Gene Identifiers (ENSMUSGs) using biomaRt [89]. In detail we re-
trieved all ProbeSet Ids to ENSMUSG mappings for each of the six used microarray types
(Tab. 3.3). As multiple ProbeSets on a standard Affymetrix microarray are related to
transcripts (to cover different exons and transcripts of genes) and thus can be part of
the same gene. To solve this problem a surjective mapping from multiple ProbeSet Ids
to one ENSMUSG is required.
Table 3.3.: Overview of integrated gene expression arrays. All microarrays are in
situ oligonucleotide arrays manufactured by Affymetrix.
GEO Accession Title
GPL339 Affymetrix Mouse Expression 430A Array [MOE430A]
GPL8321 Affymetrix Mouse Genome 430A 2.0 Array [Mouse430A_2]
GPL1261 Affymetrix Mouse Genome 430 2.0 Array [Mouse430_2]
GPL7546 Affymetrix GeneChip Mouse Genome 430 2.0 Array [CDF: Mm_ENTREZG_10]
GPL6246 Affymetrix Mouse Gene 1.0 ST Array [MoGene-1_0-st] [transcript (gene) version]
GPL11180 Affymetrix HT MG-430 PM Array Plate [HT_MG-430_PM]
As Affymetrix provides microarray platform specific annotations by chip definition files
(CDFs) to handle transcript mapping, these annotations do not prevent the described
mapping problem. A CDF specifies which genomic region is represented by one or more
probes and which probes of a microarray form a ProbeSet. Here, we applied chip type
specific CDF environments provided by Bioconductor platform for R [354]. Afterwards,
biomaRt service [88, 89] was used to retrieved corresponding ENSMUSGs.
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Over the years different strategies were published to handle multi-referenced genes,
like [216, 237, 333]. Next to trivial approaches like “first come first serve”, where the
first matched Id and the corresponding gene expression profile are matched, more com-
prehensive methods like Anova Sibling Consolidation (ASC) [216] came up. Thereby,
statistical metrics are used to determine if the expression profile of multiple ProbeSets
with the same target gene can be combined or not. ASC does not suggest how to perform
mapping if expression profile do not match [216]. Other meta-analysis methods hand-
over this problem to the user or, like frozenRMA [251], restrict the type of platforms to
ensure common Id sets as workaround. Since the selection of experiments in this work
contains experiments from different platforms, we did not apply such method (for more
details see discussion in Section 3.4.5).
ProbeSet 1 (fold change = 2) Transcript t1 Gene_g1
ProbeSet 2 (fold change = 0.3) Transcript t2 Gene_g1
ProbeSet 3 (fold change = 10) Transcript t3 Gene_g1
ProbeSet 4 (fold change = 2.5) Transcript t1 Gene_g1
Gene_g1 (fold change = 10)
Figure 3.4.: Different ProbeSet Ids link to the same Ensembl Mouse Gene
Identifier This problem is solved by assigning the expression values of
the ProbeSet with the highest fold change between measured experimen-
tal states,(e.g. stimulation, cell type, treatment or time point) to the gene.
To solve the consolidation problem of assigning multiple expression values to a sin-
gle ENSMUSG we implemented a simple straight forward way of mapping, where the
ProbesSet with the highest intra-study expression change is selected and its expression
values are mapped to the corresponding ENSMUSG (illustrated by Figure 3.4).
The mapping was performed for all 36 retrieved and normalized studies. After map-
ping all studies to a common set of ENSMUSGs expression data from all studies can be
represented in one matrix (ENSMUSGs as rows and microarrays as columns).
3.4.6. Renormalization of assembled meta experiment
Now, we focus on the reduction of experiment specific expression pattern, so called batch
and lab effects (also called effect-size or inter-study effect), that occur when experiments
are performed under different conditions, e.g. different protocols, different laboratories
or using samples from different individuals that are considered as similar. To reduce
such effects several methods have been developed, like differential expression analysis or
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Gene Wide Association Studies (GWASs). In the following, we describe our strategy to
overcome such problems, using the prior introduced data set.
Lab-/batch effect
The batch effect on the assembled data set is visualized in Figure 3.5 and 3.6. To
illustrate the effect we clustered the assembled data set for groups regarding the global
expression profile over all genes (Figure 3.5). The average Euclidean distance between
arrays of the same experiment over all experiments is 125.595, where the average pairwise
distance between all arrays is 211.041. Figure 3.5 shows the hierarchical clustering of all
arrays in the data set by expression values.
Figure 3.5.: Hierarchical clustering of assembled meta expression matrix. Most
of the microarrays from the same experiment (GSE) cluster together, which
illustrate the lab-/batch effect, as their expression profile is more similar
among studies than towards other experiments.
Re-normalization strategy
The assembled meta expression matrix contains expression values of 12825 ENSMUSGs
(rows) coming to 154 microarrays (columns) from 36 different experiments. The matrix
reveals high variance for each gene. We performed an additional re-normalization step
using quantile normalization to adjust expression values for inter-study effects. The
quantile normalization transforms expression values for all single microarrays in the as-
sembled data set to a value range fixed for all integrated experiments (see Figure 3.6).
The idea is that the rank-based re-assignment of expression values as quantile transfor-
mation does not change the ranking of genes by expression values within an experiment,
while it enables the direct comparison between studies. Such rank-based transformation
allows for identification of expression change for a single gene by comparing its ranks for
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different groups of arrays, independently of the specific value distribution of the single
arrays or studies.
Table 3.4.: Table illustrates expression value adjustment via re-normalization
to improve comparability between data from different studies. Table
shows the means of all variances obtained for all genes in the complete data
set and in the specific subsets (columns). The first row shows the varying
distribution of expression values between assembled, but not re-normalized
studies (GSEs). The second row shows the variances based on re-normalized
expression values.
Mean of variances
within studies (GSEs)
Mean of expression variances
within assembled meta experiment
all cell types all cell types nTreg iTreg
not adjusted 0.1221 1.8510 1.8710 1.3990
adjusted 0.1142 1.3030 1.2800 1.0840
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Figure 3.6.: Upper boxplots show expression distribution of non-adjusted ex-
pression values after meta experiment assembly. Varying expression
values are clearly visible for both cell types (nTreg - red, iTreg - blue) and
for all included studies. Lower boxplots show expression distribution af-
ter applying quantile re-normalization. Mean expression as well as minimal
and maximal expression are adjusted to common levels, to enable subsequent
expression analysis.
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3.5. Results
In the following section we describe the results of data set retrieval, assembly, and
re-normalization. Furthermore, we use differential expression analysis to evaluate the
presented approach by detecting differentially expressed genes.
3.5.1. Data set assembly and re-normalization
After creating a large meta expression data set containing 154 nTreg and iTreg cell mi-
croarrays from 36 different studies, the data was preprocessed (quality control, Id map-
ping), normalized, and re-normalized for further analysis. The resulting meta-expression
matrix consists of 12825 genes and 154 measurements.
Renormalization was performed to adopt for batch-effects between microarrays from
different studies and reduced inter-study differences between the expression profiles.
Also, re-normalization led to identical expression values for genes with the same ranks
in different experiments and thus to identical value distributions, as shown in Figure
3.6. Table 3.4 illustrates this effect using mean variance and mean expression measures.
While the variance of genes within an experiment does only decrease slightly, the inter-
study differences of expression means decreased by about 20-30%.
Figure 3.7 illustrates the effect for four pairs of experiments. We randomly selected
200 genes out of 12825 to show the effect of re-normalization. The reduction of the gene
set is necessary for better visualization. The microarrays used for one-to-one comparison
in the Figure 3.7 were not part of the same study. The quantile-quantile-plots (QQplots)
illustrate distribution shifts of these 200 randomly selected genes, where individual ex-
pression differences between genes in both experiments remain.
3.5.2. Differential expression analysis
One advantage of creating meta-expression experiments based on raw values is the op-
portunity to apply typical gene expression analysis methods, like differential expression
analysis using t-test, GWAS or GSEA. Here, we present the results from differential ex-
pression analysis using t-test between iTreg and nTreg cell. Differential expression was
calculated using R-package limma [297]. Genes were detected as differentially expressed
when their absolute fold change was above 1 and the corresponding Benjamini-Hochberg
corrected P-value below 0.05. We detected 877 genes to be lower expressed in iTreg cells
and 260 genes to be higher expressed than in nTreg cells. Figure 3.8 shows expression dif-
ferences for all differentially expressed genes between iTreg and nTreg. Out of the set of
12825 genes, 1137 genes were detected as differentially expressed before re-normalization
and 891 of these were also detected as differentially expressed after re-normalization. En-
richment analysis of the non-overlapping genes of both data set states (before and after
re-normalization) using DAVID [155] did not reveal any significant genes groups regard-
ing Gene Ontology (GO) terms or pathways associated to Treg differentiation or Treg
subtype fate. The set of 246 genes exclusively detected as differentially expressed prior
re-normalization contains T cell specific genes. Additional, we analyzed the subset of
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Figure 3.7.: QQplots illustrate difference before and after re-normalization.
First row of figures shows qqplots of non-adjusted data, where second
row of figures shows re-normalized data. By comparing upper and lower
figures it becomes clear that expression values became more homogeneous,
which illustrates the reduction of the inter-study effect (the shift onto the
diagonal), at the same time the profile of expression differences between sin-
gle genes are widely kept (compressions and stretches in line profiles). 200
randomly selected genes were used to plot four comparisons of expression
profiles from two independent microarrays (origin from different studies)
each time.
iTreg
nTreg
Figure 3.8.: Genes differentially expressed between iTreg and nTreg cells.
Heatmap shows the mean gene expression extracted from the assembled
and re-normalized meta expression set. Color key indicates expression val-
ues. Upper band of the heatmap represents expression in iTreg cells, where
lower band represents expression in nTreg cells.
TFs from differentially expressed genes (Table 3.5) based on a published list of TFs by
Wei et al.[378]. Except for Ikaros, non of these is known to be specific for nTreg or iTreg
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cell, while some are Th cell related. For example Jund, Il2 and Tcf7 are known to be
important during T cell fate decision [252, 301].
Table 3.5.: Listing of differentially expressed TFs before re-normalization but
not differentially expressed afterwards. Except for Ikarus (italic writ-
ten), all listed TFs are unknown to have a subtype specific gene expression
profile.
Ensembl gene identifier MGI gene symbol Gene name
ENSMUSG00000014603 Alx3 aristaless-like homeobox 3
ENSMUSG00000035277 Arx aristaless related homeobox
ENSMUSG00000039910 Cited2 Cbp/p300-interacting transactivator,with Glu/Asp-rich carboxy-terminal domain, 2
ENSMUSG00000026436 Elk4 ELK4, member of ETS oncogene family
ENSMUSG00000022101 Fgf17 fibroblast growth factor 17
ENSMUSG00000015627 Gata5 GATA binding protein 5
ENSMUSG00000002578 Ikzf4 IKAROS family zinc finger 4; similar to helios
ENSMUSG00000027720 Il2 IL2 (interleukin 2; T-cell growth factor)
ENSMUSG00000027947 Il6ra interleukin 6 receptor, alpha
ENSMUSG00000071076 Jund Jun proto-oncogene related gene d
ENSMUSG00000027985 Lef1 lymphoid enhancer binding factor 1
ENSMUSG00000038909 Myst2 MYST histone acetyltransferase 2
ENSMUSG00000029832 Nfe2l3 nuclear factor, erythroid derived 2, like 3
ENSMUSG00000028019 Pdgfc platelet-derived growth factor, C polypeptide
ENSMUSG00000045302 Preb prolactin regulatory element binding
ENSMUSG00000000782 Tcf7 transcription factor 7, T-cell specific
ENSMUSG00000022015 Tnfsf11 tumor necrosis factor (ligand) superfamily, member 11
ENSMUSG00000020923 Ubtf upstream binding transcription factor,RNA polymerase I
ENSMUSG00000021514 Zfp369 zinc finger protein 369
Further gene set enrichment of the 891 differentially expressed genes using GO terms
high ranks several T cell and differentiation related terms. In Table 3.6 we focus on
terms that are highly specific for Lymphocytes and T cells, where terms that are related
to general differentiation processes were left out.
The results from differential expression analysis and GO term enrichment analysis
indicate, that re-normalization did not tremendously change the set of signals. The re-
normalized meta expression includes 77% of the differentially expressed genes detected
before re-normalization. This set also features Treg cell specific TFs (shown in Table 3.5).
Furthermore, changes in the set of differentially expressed genes did not influence results
from GO enrichment analysis, indicating that the overall expression characteristics were
kept, while inter-study effects could be reduced (Figure 3.6 and 3.7).
3.6. Summary
In this chapter we described our approach of collecting and assembling gene expression
microarray data to analyze Treg subtype specifics. Therefore, we constructed a large
meta expression set based on data from public online repositories. We focused on data
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Table 3.6.: GO enrichment analysis of differentially expressed genes. Using the
enrichment online tool DAVID [155] (online,12/2015). 16 T cell related GO
terms where identified as significantly overrepresented in the gene set. Terms
are sorted from lowest to highest P-value.
GO ID GO term P-value
GO:0046649 lymphocyte activation 8.66 ∗ 10−6
GO:0046651 lymphocyte proliferation 1.36 ∗ 10−4
GO:0042110 T cell activation 1.64 ∗ 10−4
GO:0045596 negative regulation of cell differentiation 2.03 ∗ 10−4
GO:0002520 immune system development 3.56 ∗ 10−4
GO:0042098 T cell proliferation 0.0010154699
GO:0050670 regulation of lymphocyte proliferation 0.0026163637
GO:0030098 lymphocyte differentiation 0.0030818036
GO:0045597 positive regulation of cell differentiation 0.0038178296
GO:0050863 regulation of T cell activation 0.0047773595
GO:0042129 regulation of T cell proliferation 0.0077358778
GO:0048538 thymus development 0.0083282627
GO:0050671 positive regulation of lymphocyte proliferation 0.0088422211
GO:0051249 regulation of lymphocyte activation 0.0117505093
GO:0050868 negative regulation of T cell activation 0.0367450441
GO:0002711 positive regulation of T cell mediated immunity 0.0384057351
processed using Affymetrix GeneChip technology and studies that deal with regulatory
Treg cells. To analyze Treg subtype specifics we searched and retrieved experiments that
either performed expression analysis on induced regulatory T cells or natural derived
regulatory T cells from mice. We applied quality control and did manual curation
regarding cell extraction methods, treatments and stimulation.
After revising the list of experiments, we performed a two-step normalization to ac-
count for differences coming from heterogeneous condition experiments. The two-step
re-normalization based on quantile normalization realigned the values distribution be-
tween the different studies and thus improved comparability.
Together, we extracted a gene expression set of 12825 genes and 154 experiments that
allow gene expression analysis of iTreg and nTreg cells. Validity of our approach was
assessed using GO term enrichment analysis and extraction and association analysis
of 1137 differentially expressed genes. We examined the list of genes regarding known
transcription factor involved in activation and differentiation of T cells.
At this point, the extracted and validated meta-expression set can applied to further
analysis regarding the extraction of Treg subtype specific surface marker genes (Chapter
4) or the application of GRN reconstruction methods (Chapter 5).
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Table 3.7.: Enriched GO terms from categories Biological Process
(BP) and Molecular Function (MF) for the comparison of
differentially expressed genes detected before and after re-
normalization. Enrichment was performed using DAVID Tool [155] (online
12/2015). The set of significantly enriched terms (P-value < 0.05) does not
include T cell or lymphocyte specific terms. Terms below the line are not
significantly enriched, but enriched
GO ID GO Term P-value
GO:0022403 (BP) cell cycle phase 8.07*10-7
GO:0000279 (BP) M phase 4.78*10-6
GO:0022402 (BP) cell cycle process 1.15*10-5
GO:0000278 (BP) mitotic cell cycle 6.32*10-5
GO:0007049 (BP) cell cycle 7.47*10-5
GO:0007067 (BP) mitosis 2.18*10-4
GO:0048285 (BP) organelle fission 2.18*10-4
GO:0000280 (BP) nuclear division 2.18*10-4
GO:0000087 (BP) M phase of mitotic cell cycle 2.18*10-4
GO:0005524 (MF) ATP binding 6.87*10-4
GO:0051301 (BP) cell division 0.0010345834
GO:0032559 (MF) adenyl ribonucleotide binding 0.0019198435
GO:0030554 (MF) adenyl nucleotide binding 0.0036673415
GO:0001883 (MF) purine nucleoside binding 0.0044644562
GO:0001882 (MF) nucleoside binding 0.0044644562
GO:0000166 (MF) nucleotide binding 0.0056049633
GO:0022900 (BP) electron transport chain 0.008686148
GO:0051726 (BP) regulation of cell cycle 0.009773237
GO:0051276 (BP) chromosome organization 0.0125079349
GO:0004674 (MF) protein serine/threonine kinase activity 0.029825514
GO:0003723 (MF) RNA binding 0.0300973949
GO:0032555 (MF) purine ribonucleotide binding 0.0308970401
GO:0032553 (MF) ribonucleotide binding 0.0308970401
GO:0050867 (BP) positive regulation of cell activation 0.0322112683
GO:0051251 (BP) positive regulation of lymphocyte activation 0.0322112683
GO:0002696 (BP) positive regulation of leukocyte activation 0.0322112683
GO:0017076 (MF) purine nucleotide binding 0.0427998494
GO:0050671 (BP) positive regulation of lymphocyte proliferation 0.0745291764
GO:0032946 (BP) positive regulation of mononuclear cell proliferation 0.0745291764
GO:0070665 (BP) positive regulation of leukocyte proliferation 0.0745291764
GO:0002684 (BP) positive regulation of immune system process 0.0746925142
GO:0006091 (BP) generation of precursor metabolites and energy 0.0777034487
GO:0006412 (BP) translation 0.0793245375
GO:0006605 (BP) protein targeting 0.0885839432
GO:0044265 (BP) cellular macromolecule catabolic process 0,0904737852
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4. Ensemble feature selection for Treg cell
subtype marker identification
This chapter describes the application of ensemble feature selection algorithms to identify
Treg cell subtype markers from gene expression data. Our aim is to identify robust
surface marker genes based on the meta expression set of Chapter 3 to discriminate
between Foxp3+ Treg cell subtypes. Such marker would enable the sorting of specific
cell types for further research as these cell types are under suspicion to have different
functions in the immune system, and are in principle, potential targets for therapeutic
interventions.
The design and implementation of the presented feature selection strategy and the val-
idation using classification was developed in cooperation with immunologists from the
German Rheumatism Research Center in Berlin, who designed and performed wet-lab ex-
periments. Furthermore, the collaborators contributed with immunological expertise for
presenting the biological background, curating the data sets and discussing the results.
4.1. Motivation
For years, Treg cells have been important subjects of medical research due to their
crucial role for the adequate regulation of the immune system. Such research would
benefit from reliable surface markers allowing the effective discrimination of iTreg and
nTreg cells. Being able to perform such discrimination would open the door for detailed
functional studies of both cell subtypes and their respective roles within the immune
system. Results from such studies could have immediate clinical implications [265, 327].
One prerequisite for clinical applications, like cell transfer therapies, is a clear definition
of nTreg and iTreg cells [256, 350].
Up to date, differential expression analysis of Treg specific gene expression data did
not reveal stable marker genes to discriminate cell subtypes. There are several studies
that have compared the transcriptional profiles of Treg cells to distinguish subsets, but
until today only two markers for discriminating nTreg and iTreg cells, Helios [101, 298]
and Neuropilin-1 [42, 388] arose. Unfortunately both have been reported to be only
partially suitable as markers for nTeg and iTreg cell discrimination [6, 278, 380, 388].
Other strategies to distinct between subtypes were shown to be insufficient, too. For
instance Foxp3, the master TF of Treg cell cannot function as a surface marker protein,
as it is an intracellular marker and requires cell permeabilization for staining [198].
Another so far common strategy is the depletion of CD8+ cells followed by a positive
selection of CD25+ cells. These cells are Treg enriched but not a pure fraction [355].
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We applied an ensemble of feature selection algorithms to identify yet unknown marker
genes that enable the distinction of Treg subtypes. Our approach is adaptable and
generalizable to similar problems in related or other fields of cell biology or immunology
(see Chapter 2).
4.2. Feature selection
With increasing amounts of data unsupervised machine learning methods became pop-
ular such as unsupervised clustering, e.g. k-means [133], SOM [192], unsupervised clas-
sification, e.g. SVM [338] or Bayesian reasoning [18]. While unsupervised methods try
to infer structures and patterns from unlabeled data, supervised machine learning use
labeled data to train a model. One of the most common unsupervised methods is hierar-
chical clustering, for example to infer structure heatmaps and generate dendograms (see
Figure 3.8 as example). Unsupervised methods are used when underlying data structure
is unknown and no gold standard or training data is available. Dimension reduction like
clustering or principle component analysis (PCA) is a common task for unsupervised
methods. Supervised methods use class labels to fit a model based on such labeled data
(training set) to separate classes or reduce features necessary to classify unlabeled data
(test set).
Here, we aim to identify a small but relevant set of features (genes) for Treg subtype
discrimination in the set of expression profiles of thousands of genes while the set of
available experiments is limited to a few hundred. Kohavi and John formulated the
feature (subset) selection problem as a learning problem of selecting a relevant subset
of features, while ignoring the rest [191]. So, the general goal of feature selection is to
minimize the set of features to describe a structure [185, 191], which for our problem
means to identify single genes or sets of genes whose expression profiles separate two cell
sub-populations.
For long, feature subset selection has been a research area within statistics, especially
in pattern recognition and machine learning. It is not surprising that feature selection
is as much of an issue for machine learning as it is for pattern recognition, as both fields
share the common task of classification [130].
Classification aims to infer class labels for unlabeled instances using a generalized
model. Identifying a small set of genes that enables such a classification of experiments
is goal of our feature selection strategy.
Meanwhile, machine learning was applied in the field of analyzing gene expression
data, too. With the establishment of microarray technology, researcher start to apply
machine learning techniques to recognize patterns of expression or identify gene groups
that describe differences in gene expression.
4.2.1. Methods for feature selection
In contrast to dimension reduction or more general complexity reduction methods, fea-
ture selection does not alter the variables and values, but aims to find a subset that best
exemplifies the original data [134], while it also aims to offer interpretability to the user.
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But, along with the variety of existing methods, related specific secondary objectives
exist. Saeys et al. [302] state that the most important ones are:
• avoid overfitting and improve model performance,
• provide fast and effective models,
• gain insides into the underlying processes that generated the data.
Table 4.1.: Overview of feature selection categories and their major properties.
In column four we list exemplary implementations. The table was inspired
and adapted from [143, 302].
Category Advantages Disadvantages Implementations / algorithms
Univariate - Fast and low complexity - No feature dependencies Information Gain [391]
- No classifier restriction - No classifier interaction χ2 [391]
Fi
lte
r - Computational efficient
Multivariate - Model feature dependencies- No classifier restriction
- Less scalable to univariate methods
- No classifier interaction
Correlation-based feature
selection (CFS) [130]
- Still low complexity Minimum Redundancy MaximumRelevence (mRMR) [275]
Deterministic - Models feature dependencies - Overfitting Sequential forward selection [166, 187]
- Interaction with classifier - Classifier influences final feature set Sequential backward elimination [166, 187]
W
ra
pp
er - Simple combination ofFS and classifier - Problem of local optima (greedy)
Gradient-based-leave-one-out
gene selection (GLGS) [229]
Randomized - Less prone to local optima - Overfitting Genetic algorithms [191]
- Interaction with classifier - Classifier influences final feature set Simulated annealing [224]
- Models feature dependencies - Computational intensive Randomized Hill climbing [391]
Em
be
dd
ed - Interaction with classifier - Classifier influences final feature set Decision trees [191]
- Less computational intensive
than wrapper methods
Weighted Naive Bayes [128]
SVM by using the weight vector [124]
- Models feature dependencies
Basically, feature selection methods can be divided into the following three categories,
(i) filter methods, (ii) wrapper methods and (iii) embedded methods. Table 4.1 sum-
marizes the advantages and disadvantages for the three categories, that we describe in
detail in the following subsections.
Filter methods
Filter methods evaluate the relevance of each single feature by regarding the intrinsic
properties of the data. Subsequently, features are ranked and those with the lowest
relevance are removed [302]. The main difference to the other methods is, that the rele-
vance of single features rather than feature subsets is calculated. Therefore, computation
complexity is lower than for methods evaluating subsets. Additionally, the absence of a
classifier for evaluating distinction power of the resulting feature set makes the approach
suitable for a large feature set, as computation effort does only increase linear. Two
subcategories of filter methods exists, namely univariate and multivariate ones. While
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univariate methods do not assess relationships or dependencies between features, multi-
variate methods like Minimal Redundancy Maximal Relevance (MRMR) try to extract
minimal feature subsets by reducing the number of identical similar features. As follows
we describe four popular filter methods (two univariate and two multivariate):
Information Gain (IG) a univariate method that approximates the conditional proba-
bility distribution P (C|F ), where C is the class label and F is the feature vector.
Thus IG ranks the features regarding their descriptive power to describe the class
differences.
Chi2 statistic (χ2) evaluates features based on their χ2 statistics with respect to the
class labels [129]. Afterwards, features are ranked, while highest ranked features
are potentially best for discriminating the classes.
Minimal Redundancy Maximal Relevance (MRMR) aims to maximize the relevancy
for a feature regarding the classes by minimizing the redundancy for each class.
As this method considers feature interactions it extracts the best subset of genes
describing the classes. The interaction between features is estimated using mutual
information (MI) for discrete variable or F-statistics like ANOVA or regression
analysis for continuous variables (as present in gene expression data). MI calcu-
lates the shared information content of two variables by estimating the amount of
information one variable provides about the other. Thus MI is able to asses the
redundancy of the subset. For continuous variable the F-statistic estimates the rel-
evance of a gene regarding a class, while correlation measures for gene expression
profiles give information about the redundancy of two genes.
Correlation-based feature selection (CFS) aims to find a descriptive set of features
by estimating the degree of redundancy among them using correlation. Highly
correlated features are removed except for a “representative”. In contrast to other
methods CFS provides a “heuristic merit” for complete feature subsets. Thus CFS
is able to alter the current feature subset based on its current relevance [143].
Wrapper methods
Wrapper methods combine two components into one algorithm, namely a model hypoth-
esis search within the feature subset search. This means that such methods evaluate
extracted subsets by dividing data into training and test set and apply classification
[130]. Heuristic search algorithms are used to define feature subsets. To this end deter-
ministic and randomized search approaches can been applied. Deterministic approaches
offer lower computational complexity, whereas randomization has a lower likelihood of
ending up in local optima [143]. As classification is part of wrapper methods, complex-
ity of calculation and the extracted “optimal” feature set relies on the chosen classifier.
Examples are:
Sequential forward selection (SFS) also know as Sequential Forward Floating Selection
(SFFS), is an incremental method that adds the most descriptive feature to a subset
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while removing the least descriptive ones from the complete set. Starting with an
empty set, the method consists of roughly three steps. First, the inclusion step,
the most descriptive feature among all yet unselected feature is selected. Second,
the exclusion step identifies the least significant features among currently selected
ones, except for the feature selected in step 1 and removes it. In the third step,
again the least significant feature is removed if i) the feature subset consist of at
least two features and ii) the feature set evaluation result is worse as of the best
other subset so far. If i) and ii) are satisfied a new iteration starts with the first
step until no more feature are available.
Sequential backward elimination (SBE) uses the same principle as SFS. In contrast to
SFE, SBE is starting with the full set of features and iteratively reduces the set
by the least descriptive ones.
Embedded methods
Embedded methods ‘learn” the optimal subset by evaluating classification output of fea-
ture subsets. In detail such methods aim to derive optimal feature sets using a classifier.
In contrast to wrapper methods, the specific classification method (classifier component)
is fixed for each embedded method. On one side, this implies that calculated feature
subsets highly depend on the applied classifier [143]. On the other side computation is
much more efficient than for wrapper methods. Examples are:
Random forest describe a collection of decision trees applied to different data subsets.
Results are used to reduce the set of features iteratively by removing those with
the lowest average importance in the forest. The smallest forest with the lowest
error is finally selected [86].
Support vector machines-recursive feature elimination (SVM-RFE) starts by using all
features to separate classes. Gradually all no discriminative features are removed.
Discrimination power of a feature is represented by its weight, that is calculated
by training an SVM with the current feature set and evaluating its classification
performance [143]. Cross-validation is used to avoid local optima caused by data
set splitting (into training and test set) [228, 351]
4.2.2. Feature selection for gene marker detection
The application of feature selection methods to gene expression data is a common strat-
egy for several years [302]. The major aim is to distinguish cohorts or groups of experi-
ments in a study using single genes or small groups of genes [32]. Many studies focused
on separation of healthy and disease samples, as for examples for cancer [5, 228, 286, 393].
Other fields of application are the detection of drug-targets or disease-diagnosis [386].
Saeys et al. summarized the major categories and feature selection methods in the
microarray domain [302]. The authors also stated the advantage of univariate filter
methods to be fast and final rankings are intuitive and easy to understand. Another
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advantage is, that ranking reflects the discriminative ability of each feature, as this is of
high interest when identification of single biomarkers are in the focus of interest.
Ensemble feature selection for increasing robustness
Next to the application of a particular feature selection method, ensembles of methods
have been successfully tested to extract and evaluate feature subsets [356]. It has been
shown for gene expression and mass spectrometry data, that averaging results from mul-
tiple methods increases robustness of results [2, 213, 392]. Furthermore, ensembles can
lead to multiple equally well discriminating subsets [393]. Also aggregation of results, or
model combination, e.g. boosting, have been tested and shown to improve the robustness
and stability of feature selection [302].
Such ensembles of feature selection methods often improve classification results, but
increase computation cost. Since large computation resources became available, the
impact of computation cost became less important. The subsequent approach combines
two filter methods to extract relevant features.
4.3. Feature set evaluation using linear SVM classifier
To evaluate the performance of extracted feature subsets, classification can be used to
infer class labels from the exact set of extracted features.
Several classifier methods exist and are suitable to evaluate feature sets, e.g. K-nearest
neighbors [277], decision tree or Naïve Bayes [164]. In this work we focus on SVM
classifier as these enable robust classification [2]. SVMs are linear classifiers that belong
to the general category of kernel methods and are widely used in bioinformatics. Several
studies showed their high accuracy on gene expression data (described and reviewed by
[24, 136, 338]).
Here, we focused on binary classification, as our aim was to classify experiments from
two classes (iTreg, nTreg). The feature vector used for classification was constructed
based on the expression values of the genes that were identified as discriminating features.
To show the validity of the extracted features we trained a classifier on the extracted
feature set and a training set of experiments. Ideally, the classifier is able to infer the
correct class of an experiment from a test set using the learned model.
As all feature vectors have the same length, they can easily be projected in the same
multidimensional space. Thus, the SVM calculates a hyperplane in this multidimensional
space that separates all features of one class from the ones of the other class. Those
features, that are used to define the hyperplane from the training data are called support
vectors and define the decision boundaries between both classes. The optimal decision
is the hyperplane, that maximizes the distances between both classes. An example
separation of two classes by a SVM is shown in Figure 4.1.
For details on SVMs see [136, 338], for the specific field of multi-class SVM see [152]
and the documentation of LibSVM – on of the most popular libraries implementing
SVMs [55].
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Figure 4.1.: Support Vector Machines (SVM) aim to find the “best” hyper-
plane (line a) that separates two classes. Blue and yellow dots repre-
sent entities of two classes, that are separated by a line (a), that maximized
decision boundaries (arrow-line d). Two dimension can be separated by a
line, like illustrated here, while for higher-dimensional problems a hyper-
plane separates the classes. A small number of support vectors define the
decision function. The support vectors line c1 and c2 determine the decision
boundaries. Line b is one “not optimal” example of a separating hyperplane.
4.3.1. Classification of imbalanced data sets
A ubiquitous problem of classification is the imbalance of class instances, which means
that the majority of instances belongs to one class, where only a small fraction belongs
to the other. In such settings most classifier tend to predict the majority class more
often then the other [58]. To overcome the class imbalance problem solutions on data
and algorithmic level were proposed. On the data level it was proposed to sample
data, i.e. down-sampling to achieve class balance or oversampling like bootstrapping
[232]. On the algorithmic level various approaches have been developed, e.g. class-
specific cost variation or instance-weighted support vector machines [58, 371]. A clear
advantage of tackling the problem on algorithmic level is that the classifiers keep their
general applicability towards imbalanced data sets. This is of importance as for some
classification problems the smaller class is typically of higher interest as the other, e.g.
in text mining (entity recognition, relationship extraction from text) [357]. In contrast
to that, creating test sets/test data with equal class distribution reduces the impact of
the imbalance when evaluating extracted feature subsets.
4.4. Detecting robust markers by ensemble feature selection
In this section, we describe our strategy to find a small set of marker genes, that is able
to classify unknown cells based on their gene expression profiles. Specifically, we applied
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Figure 4.2.: Data preparation and feature selection pipeline. Green arrows and
braces represent data flows. We performed two data split steps to ensure that
all samples from identical studies were not shared between data sets. Feature
selection depicts the strongest attributes; here the genes that describe Treg
cell subtype class best. GSE is accession number prefix of GEO series, that
identifies a specific study.
feature selection to determine marker genes for the distinction between iTreg and nTreg
cells based on labeled gene expression data. The meta expression data set from Chapter
3 serves as input. For each experiment in the set, we know whether it is derived from
iTreg or nTreg cells.
The basic idea of our approach is to extract those genes, that allow for discrimina-
tion between the cell types based on their expression profile. Subsequently, candidates
were filtered for those that represent surface marker proteins and therefore enable cell
detection by biotechnologies like flow cytometry. The discrimination power of remaining
candidates was evaluated using SVM classification. Finally, experimental validation of
gene and proteins expressions of the candidates was performed by immunologist using
qRT-PCR and Immunoblotting.
The general pipeline of our approach is illustrated in Figure 4.2. The basic steps are:
1. Data preparation & preprocessing, which mainly refers to the meta expression
analysis in Chapter 3,
2. Generating overlapping subsets and splitting of these subsets into training and test
data for subsequent feature evaluation,
3. Application of feature selection methods and aggregation of results,
4. Evaluation using SVM classification.
The subsequent wet-lab validation (Section 4.4.5) is not part of the feature selection
pipeline.
52
4.4. Detecting robust markers by ensemble feature selection
4.4.1. Data preparation & preprocessing
Many feature selection methods require discretization of continuous variables [130].
While some methods can handle continuous features, data has to be normalized or
transformed to enable comparability between features. As described we used publicly
available microarray data from 36 studies. The data was curated and labeled regarding
T cell subtype (see Chapter 3, p.34ff).
4.4.2. Data partitioning and splitting into training and test sets
Basic idea of data set partitioning was to generate training and test sets, extracted from
independent studies. Thereby, we aim to reduce overfitting of feature selection to our
specific data set. The resulting data sets vary in size and balance of nTreg and iTreg
experiments.
We performed a two-step splitting of the data set as shown in Figure 4.2 (center part)
to achieve two goals:
• increasing robustness of feature selection,
• enabling evaluation of candidate genes using classification on hold-back test data.
First, we performed the data splitting considering study association of the experiments
to ensure that feature evaluation is not biased. This was done because expression profiles
of experiments (over all genes) from identical studies are often highly correlated or very
similar, (e.g. for replicates). As shown in Section 3.4.6 this applies for the presented data
set, too. In consequence all experiments from the same studies were assigned to either
the training or the corresponding test sets prior the second split. Therefore, we created
36 copies of the meta expression set X. In each copy X ′i all experiments belonging to a
certain study i (where i = 1, ..., 36) were removed.
Second, each of these 36 subsets was split again, for ten-fold cross-validation. We split
each subsetX ′i into ten overlapping, but not identical subsets, where each subset included
experiments from both classes. For all ten subsets we performed feature selection and
aggregated the results to detect those features with highest average discrimination ability
and robustness. Overall, we prepared 360 overlapping but not identical subsets for
feature selection and 36 independent test sets for latter evaluation using SVMs.
4.4.3. Feature selection methods application and candidate merge
We performed feature selection using an ensemble of two methods, namely Chi2 and
Information Gain (IG). Both are filter methods that calculate the individual weight of a
feature independent from other features. As described in Section 4.2.1, the Chi2 method
evaluates features based on their χ2 statistics with respect to the class labels [129]. The
IG based approach uses as selection criterion the information gain for all pairs of genes
[391].
We used the implementations provided by the Weka 3: Data Mining Software (Weka)
[129] with default settings. Both methods were applied separately to all 360 subsets.
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Figure 4.3.: Frequency of simultaneously selected features (genes) by both
methods on different subsets. We extracted those genes as candidates
that were selected as features in more than 50% (here: 18 of 36) of the
subset analyses. This cut-off led to 41 candidate genes.
Each method produced a list of genes ranked by discriminative power, which we cut off
after 100 genes. This gave rise to 36 times 10 sets of 100 genes for each method.
For extraction of candidates, the calculated gene sets were combined as follows. First,
for each of the 36 subsets the intersection of both feature selection methods was calcu-
lated for each of the 10 sets. Next, genes were ranked by the number of occurrence in
these 10 sets, and only those were kept that occurred in the majority of the selected sets,
i.e. six times. Combining the resulting 36 gene sets, we considered those candidates that
are present in at least 50% of the subset evaluations (i.e. 18 times, as shown in Figure
4.3).
Table 4.2 shows the list of the 41 most top-ranked genes from feature selection and ag-
gregation. To enable the application as cell type markers we investigated their biological
characteristics. Central point of additional manual analysis was to check whether the
candidates represent cell surface markers, as only these could be utilized for cell sorting.
We identified six genes that were detected to have strong discriminating power and code
for surface proteins, namely Cd79b, Cd97, Ctla-2b, Emp1, Gabrr2 and Tnfrsf13b.
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Figure 4.4.: First phase of evaluation: Classification of experiments based on
potential marker genes. The complete meta expression set was used for
leave-one-out cross validation, but samples from the same study are not
shared between training and test sets.
4.4.4. Subset evaluation using SVM classifier
The set of candidate genes were further validated computationally. As we used two filter
methods for feature selection, we now aim to evaluate the discrimination power of the
extracted candidates using a SVM classifier. For computational evaluation, we used all
six candidates as features for a support vector machine classifier [73] to discern iTreg
from nTreg cell samples. Evaluation was performed in a leave-one-out manner (Figure
4.4), and average results across all folds are reported. As SVM implementation we used
the sequential minimal optimization algorithm (SMO) [279] implemented in Weka.
In Table 4.3 we report average results for all metrics across all folds following the
described evaluation in Figure 4.4. We evaluated using metrics, precision, recall, sensi-
tivity, specificity, accuracy and F-measure. The metrics for binary classification as it is
used here, are described as follows:
True positive (TP) depicts the number of correctly predicted class 1 labels.
False positive (FP) depicts the number of falsely predicted class 1 labels.
True negative (TN) depicts the number of correctly predicted class 2 labels
False negative (FN) depicts the number falsely class 2 predicted labels
Precision is the proportion of correctly predicted class 1 labels to all existing class 1
labels.
Precision = TP
TP + FP
Sensitivity / Recall is the proportion of correctly predicted class 1 labels among all
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Table 4.3.: Performance metrics of validation using SMO classification results
for each cell types over all folds. Metrics were calculated for both candi-
date sets, six selected marker genes and full set of 41 candidates. Specificity
and sensitivity for both classes are “diagonal identical”, as a correctly positive
inferred instance of one class (true positive) is a correctly negative inferred
instance (true negative) in the other class.
6 candidate genes 41 feature selection genes
iTreg nTreg iTreg nTreg
Precision 0.8750 0.9746 0.8571 0.9504
Sensitivity/Recall 0.8750 0.9746 0.75 0.9746
Specificity 0.9746 0.8750 0.9746 0.75
Accuracy 0.9577 0.9577 0.9366 0.9366
F-measure 0.8750 0.9746 0.8 0.9055
predicted class 1 labels.
Sensitivity = TP
TP + FN
Specificity is the proportion of correct predicted class 2 labels among all class 2 labels.
Specificity = TN
TN + FP
Accuracy is the proportion of the sum of correctly class 1 predicted inferred interactions
(true positives) plus correctly predicted class 2 labels.
Accuracy = TP + TN
TP + TN + FP + FN
F-measure is the harmonic mean of precision and recall.
F1 =
2 · Precision ·Recall
Precision+Recall
Furthermore, weighted metrics are visualized in Figure 4.5. In contrast to Table 4.3,
metrics shown in Figure 4.5 were calculated regarding the specific class balance of the
test sets to illustrate variance of measures between test sets. Additionally, we evaluated
the performance of the complete extracted set of 41 candidates to show validity of the
feature selection.
4.4.5. Experimental validation of detected Treg subtype marker gene
candidates
For wet-lab validation of extracted subtype marker, murine Treg cells were used, because
in silico analysis was also carried out with mice transcriptome data. Also, performing the
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a) 6 manually selected candidate genes b) 41 genes from feature selection
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Figure 4.5.: Weighted performance metrics of SVM-based SMO classification.
Leave-one-out cross validation was performed. Features were restricted to
a) 6 manually selected genes out of b) 41 genes as found by feature selection.
For each test set the weighted mean was used to balance metrics derived for
both Treg subtype classes. In contrast to Table 4.3, metrics were calculated
for each test set classification separately to illustrate variances between the
sets.
validation in mice has the advantages of inbreed consistency and the far greater number
of available data sets, which is very important for our strategy to increase robustness of
predictions by grounding in a large set of heterogeneous experiments. However, we are
aware that direct transfer of our results to humans is not possible, because not all genes
in mice have a homologous gene in human.
Validation of data set derived expression differences between cells types on RNA
level
To verify gene expression intensities of the six candidate genes in an independent ex-
periment via qRT-PCR nTreg cells were sorted from Foxp3-IRES-EGFP mice and iTreg
cells were generated in vitro by cultivating naïve T cells with IL-2 and TGF-β. There is
a remarkable consistency of the results conclusions from the microarray analysis (Fig-
ure 4.6). qRT-PCR indicates even higher significance of changes between iTreg and
nTreg cells for the selected genes than our microarray analysis (Figure 4.6b). The genes
Ctla2b, Emp1 and Tnfrsf13b had a higher expression in iTreg cells compared to nTreg
cells, whereas Gabrr2, Cd97 and Cd79b had a higher expression level in nTreg (Figure
4.6a). Thus, successful validation using qRT-PCR shows that extracted gene expression
profiles of the candidates enables the discrimination between the Treg cell subtypes,
if cells are treated similarly to those in the microarray experiments used for feature
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selection.
(a) Relative mRNA expressions (b) Fold changes
Figure 4.6.: a) Relative mRNA expression of candidate genes was analyzed
by qRT-PCR. mRNA was extracted from cultured iTreg and ex vivo
nTreg cells of Foxp3-IRES-GFP mice and normalized to RPS-18 expres-
sion (n=6). The results show high consistency for predicted markers be-
tween meta-analysis and validation experiments; validation and original ex-
periments were performed under similar conditions (non-cultivated nTreg
cells). b) Comparison of fold changes for candidates derived from
meta-analysis and qRT-PCR experiments. Rough-hatched bars show
log2 fold changes calculated from meta-analysis. Fine-hatched bars depict
fold changes calculated from qRT-PCR between cultured iTreg and ex vivo
nTreg cell.
Validation of candidates on protein level using Immunoblotting
To analyze protein expression of the candidate genes, we performed immunoblot ex-
periments with available antibodies. Unfortunately, only for Cd97 and CD79b working
antibodies were available. EMP1 showed a slightly increased expression in nTreg cells
compared to iTreg cells (Figure 4.7), whereas the receptor GABRR2 showed a clear
difference in protein expression between both subtypes. The results show that protein
expression levels obtained from immunoblot analysis of EMP1 and GABRR2 are able
to distinct in vitro Treg and ex vivo nTreg cells as predicted by own in silico analysis.
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iTreg nTreg
EMP1
Lamin B
GABRR2
LaminB
iTreg nTreg
Figure 4.7.: Immunoblot analysis of EMP1 and GABRR2. Analysis revealed sta-
bility of differences in protein expression between cell subtypes for both
candidates. Expressions of both proteins where subtracted by background
signal and normalized to LaminB expression.
Implication from wet-lab validations
We identified six candidate genes encoding surface proteins, namely Cd79b, Cd97, Ctla-
2b, Emp1, Gabrr2, Tnfrsf13b. For these genes we confirmed the expression profiles from
microarray meta-analysis via qRT-PCR (Figure 4.6), while using comparable conditions
as in the baseline microarray experiments.
Unfortunately, it is not easy to infer applicability of the markers for discrimination of
these cell types as the conditions which where used by the majority of the experiments
in the meta data set do not or poorly reflect nature. A major problem is, that the
iTreg cell were induced and harvested under certain cultivation conditions which were
not applied to the ex vivo nTreg cells. Thus, validation experiments did indeed validate
the presented machine learning strategy to find differences between cell types and also
showed the validity of the extracted marker candidates.
Further wet-lab experiments revealed that observed differences are likely to be origi-
nated from cultivation differences between cells (data not shown here). Nevertheless, it
was shown (see Figure 4.8), that three of the extracted marker (Cd79b, Ctla-2b, Gabrr2 )
have potential marker quality. Because they were also differentially expressed when ex-
periments were performed under identical conditions (with additionally cultured ex vivo
nTreg and in vitro iTreg).
4.4.6. Discussion
In contrasts to differential expression analysis the presented feature selection approach
of marker gene identification is not based on fold change height, rather than ability to
discriminate between cell types. In fact, the chosen strategy of using top ranked genes
from ensemble feature selection uses an arbitrarily set up threshold, which is a common
issue on ranking methods [86]. But in contrast to differential expression analysis using
arbitrarily chosen minimal fold changes, the threshold is set after assessing genes specific
marker quality.
Another feature selection based strategy is to reduce the gene set in advance by those
genes that do not code for surface marker. That refers to the first point of the “feature
selection checklist” by Guyon et al. [124].
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Figure 4.8.: Gene expression log2 fold changes including cultured ex vivo nTreg
cells. Non-hatched bars show fold changes calculated from Bioinformat-
ics meta-analysis. Rough-hatched bars depict fold changes calculated from
qRT-PCR between iTreg and not cultured nTreg cell. Fine-hatched bars
depict fold changes from qRT-PCR between iTreg and five days cultured
nTreg cells.
But first, as we did not obtain a gold standard for all surface marker proteins, such set
reduction could have led to exclusion of marker genes by false annotation. Second, next
to identifying marker candidates, other, more general goal of this work was to shed more
light on the differences between both cell subtypes, as this includes more differences as
the expression of certain genes. The full list of retrieved features could also be used for
further investigation.
Another drawback is information leakage, i.e. that training and test set data for valida-
tion was extracted from the same set of experiments (shown in Chapter 3). Nevertheless
excluding complete experiments from feature selection would have substantially reduce
the amount of input data and thus the robustness of our methods. Figure 4.9 shows
the size of the included experiments to illustrate the frequency of small experiments.
Excluding small studies would have resulted in inefficient training and test set size for
classification, while excluding large experiments would have effected feature learning.
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Figure 4.9.: Number of microarray experiments per study. The majority (72%)
of integrated studies/ study parts are rather small, containing less than five
microarrays.
4.5. Summary
We reported on a machine learning approach to identify potential surface markers for
separating in vitro differentiated iTreg cells from ex vivo nTreg cells [198]. Different
feature selection methods were analyzed and compared. We applied two methods to the
previously described meta-expression set (in Chapter 3). We hypothesized that markers
which are statistically discriminative under a wide variety of experimental conditions
should be more robust than those from a single experiment only. Using statistical learn-
ing algorithms, we identified 41 candidate genes, which are highly discriminative between
nTreg and iTreg cells. Among these 41, six genes encode for surface proteins and could
thus be potentially applied as sorting markers in cell. To verify our machine learning
results we first validated these candidates using classification by SVMs and secondly per-
formed wet-lab experiments (qRT-PCR on mRNA level and Western Blotting on protein
level) with murine in vitro generated iTreg and ex vivo isolated nTreg cells. However,
since the vast majority of the nTreg data was generated using uncultivated nTreg cells,
observed differences could be an artifact of the experimental procedures and not of the
underlying biology.
Nevertheless, our approach successfully identified genes for discrimination between
cell types. Furthermore the approach is easily extendable to other biological context
and thus offers an alternative to existing methods like differential expression analysis.
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In this chapter we focus on methods for reconstruction of gene regulatory networks
(GRNs). As described in Chapter 2, current knowledge on gene regulation of Treg cells
is insufficient to explain all regulatory effects. While various methods for reconstructing
GRNs were published in the last decade, their performance varies strongly between
different data sets [137, 246]. Since we are interested in Treg cell specific gene regulatory
interactions, we aim to evaluate the performance of different reconstruction methods
applied to a Treg cell specific dataset. Knowledge on T cell subtype specific GRNs
may elucidate the differences and can lead to a novel approach for understanding and
controlling the differentiation (described in Chapter 2).
The chapter is organized as follows: First we introduce the general concept of GRNs.
Second, we provide an overview of available methods and tools for the reconstruction
based on gene expression data. Third, we infer networks from steady state expression
data by applying a subset of the presented tools to the Treg cell specific meta-expression
data introduced in Chapter 3. Finally, we evaluate and compare tool performances using
two public interaction databases and examine the most commonly inferred interactions.
5.1. Motivation
Research on networks and especially network visualization has a strong history in biol-
ogy [7]. Since, the knowledge about genes, proteins and their interactions grew rapidly
over the last decades, it has become imperative to find proper forms of presentation.
As in other fields, networks aim to visualize the coherence of biological entities. When
the networks became larger and more dense, network analysis was needed and adopted
from other fields, e.g. social network analysis (SNA) [376]. In these early days, the
applied methods and metrics were topology-based [21, 87, 94, 169, 288]. Later, quanti-
tative measures like correlation and co-expression were focused. Over the last 15 years,
gene co-expression networks, protein-protein interaction networks and cell-cell interac-
tion networks became the most important types of biological networks [402].
Today, GRNs are an important type of biological networks as they aim to explain
the regulatory mechanisms (edges) between genes (nodes). The term and concept gene
regulation is under permanent progression and actors and mechanisms are continuously
added. Understanding regulatory mechanisms on large scale is one of the most important
goals in systems biology. Gene regulation describes the mechanisms influencing gene
expression, i.e. binding, transcription and translation.
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The translation from genes to proteins is based on gene regulatory mechanisms and
essentially influenced by specific elements. Via DNA binding, cis-regulatory elements
like TFs control the transcriptional events of target genes. Such elements can bind
directly to the DNA or indirectly influence transcription via co-factorial binding or as
part of compounds [242] and thus influence the expression of genes. The identification of
such regulatory mechanisms is the aim of GRN reconstruction. GRNs enable the flexible
representation of gene regulation. They are extendable by additional concepts (edges
and nodes) like different types of edges representing different kinds regulatory influence
or linking nodes, beside genes, to integrate different biological levels, e.g. miRNAs or
proteins.
In this work, the terms reconstruction and inference describe the process of uncovering
direct and indirect interactions between regulatory elements, such as activation, inhibi-
tion or binding. The edges between genes in GRNs are often termed gene regulation,
regulatory event, regulatory dependency or more general interaction or relation. Here,
we focus on the transcriptome level, where gene expression analysis is used to detect
state changes of genes or can be used to calculate correlations between gene expressions.
Although, GRN reconstruction is not a new topic in the field of computational biology,
still a number of problems remain unsolved until today:
• The quality and performance of GRN reconstruction depends on the amount of
available input data. Producing large data sets for higher organism, like human or
mouse experiments are time, and money consuming.
• The “small m large p problem”, still accounts and requires pre-selection and reduc-
tion of the target gene set prior to the actual reconstruction. This rule says, that
the number of queried regulators (e.g. genes) is limited by the number of input ex-
periments (m) used to determine regulatory effects [30]. To overcome the problem
heuristics are required or the set of potential target genes must be reduced, as it
is the case for ODE-based approaches [31].
• The evaluation of inferred GRNs is an open problem, as each newly inferred reg-
ulatory relation must be experimentally validated. High fractions of incorrectly
inferred regulatory relations increase cost and reduce efficiency. No gold standards
for evaluation of networks of higher organisms like mammals exist and reliable
estimations about size and density of the true networks are unavailable. Simulated
data sets and validated data sets are used for comparative studies and evaluation
of GRN reconstruction methods to overcome this shortage. A popular platform
providing such data is the DREAM challenge - an annual, public competition that
focuses on comparing submitted algorithms and tools based on predefined question
and provided data [247].
Different methods, approaches and implementation have been published over the years
and since the first DREAM challenge - annual challenges of biological interaction and
network inference called for submissions in 2006, more than 70 paper were published1.
1List of publications, available here: http://dreamchallenges.org/publications/
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During the first years of the challenge (up to DREAM4 in 2009), biological data was
mainly simulated (in silico) and only partially “real” experimental expression data from
simple organism like E.coli [246] was applied.
Since this time, various authors published algorithms and tools for GRN reconstruc-
tion. In the following section we describe different methods and compare their basic
characteristics (Table 5.4, p.80)
5.2. Methods for GRN reconstruction
In this section, different methods of network inference will be presented. The methods
are explained regarding their application towards biological data and the reconstruction
of gene regulatory networks.
GRNs methods can be categorized into those who deal with steady state data and
those with handle time-series data, often referred as dynamic data. Another important
distinction is the ability of handling priors, e.g. known interactions. Such priors are
used by many methods to set up an initial network structure as baseline for subsequent
reconstruction.
5.2.1. Formal definition of GRNs
A GRN is a graph G = (V,E), of nodes V , that represent genes, and edges E, that
represent regulatory interactions between genes. An edge e ∈ E is defined by two
adjacent vertices v1, v2 ∈ V .
GRNs can either be undirected or directed (Figure 5.1) to indicate the actor of a
regulation and its target gene. TFs or other cis-regulatory elements are connected to
their target genes, while they can be targets of other regulators, simultaneously. This
includes them-self in case of loops. Loops are frequent structures in GRNs for example
the IL2 cytokine loop during T cell differentiation [44].
v1
e1 v2
v3
e2
Figure 5.1.: Directed GRN with three nodes v1, v2, v3 and two edges e1, e2.
Node v1 is the source of e1and target of e2, v2 is targeted by a regulatory
event initiated by v1. v1 might represent a TF that is target of another TF,
here v3. Regulatory strength can be represented as edge weights assigned
to e1 and e2.
GRN can also be weighted graphs to provide quantitative measure to a regulatory
interaction. Weighted graphs are defined as: G = (E, V,w) where w : E → W is a
mapping function of edges to discrete or continuous values (weights).
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Table 5.1.: Comparison of steady state data and time-series data
Steady-state data Time-series data
• Data measured at a fixed • Collection of experiments/
time point or process state measurements over time
• Used to compare states, • Adds a temporal dimension
e.g. drug-response, different of signal capturing,e.g.
cell-type, tissue samples to cover different temporal
states during a biological process
Steady-state and time-series data
In this study, we focused on GRN reconstruction from steady state data, as large time-
series data for T cells (especially Treg cells) is not publicly available. However, it is
important to mention, that using time series data is more straight forward than steady
state data [315], because it allows for capturing the dynamics of gene regulatory processes
and is able to reveal directional interactions to indicate the cause-and-effect relationships
among genes [373]. For a short comparison of GRN reconstruction based on steady state
and time-series data see Table 5.1.
5.2.2. Co-expression or correlation networks
In 1998, Eisen et al. described co-expression as similarity in pattern of gene expression
[92]. The authors used hierarchical clustering to structure expression pattern of genes
and visualized co-expression using heatmaps (e.g. Figure 3.8), a still often used repre-
sentation of expression profiles, until today. A few years later, researchers started to
extract GRNs from gene expression data by detecting co-expression and visualize the
correlation between genes as networks [52, 90, 341]. Gene expression studies were typi-
cally performed to compare the expression level of genes between healthy and diseased
tissue [81]. Later it became also popular to compare gene expression levels at different
time points. However, the basic idea is to test whether genes share common expression
profiles over different measurements (e.g. states or time-points). The similarity of gene
expression profiles is assessed by testing for significance of expression changes between
state. Major challenge on inferring co-expression networks is to define a threshold as
lower bound for assuming two genes as biological meaningful connected, i.e. the trans-
lation into the binary relation “connected/unconnected” [402]. A common approach
to define the set of connected genes is calculating the pairwise correlation between all
genes and using a correlation threshold (above 0.5) to decide whether two genes are
connected or not. If no threshold is defined the network is fully connected, i.e. all genes
are connected to all other genes.
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Weighted co-expression networks
Weighted co-expression networks are an extension of the general co-expression network
concept by edge weights. Thereby, the value representing the relevance of the co-
expression is assigned to each edge in the network. Already in 2000, Butte and Kohane
suggested to use the significance of the correlation as edge weight [46]. They stated that
the binary correlation values do not give any information about the biological meaning
of the interaction which hampers the comparison between different studies. In contrast
to that, values depicting the significance of a co-expression allow for inter-study compar-
ison [52]. Zhang and Horvath described different approaches to construct co-expression
networks [402]. First, unweighted co-expression networks, wherein hard-thresholding is
used to remove edges not exceeding the minimal co-expression criteria. Such networks
can be represented as a binary adjacency matrix. Second, weighted networks, that are
based on soft-thresholding, i.e. all edges with values above a certain minimum are in-
cluded and the corresponding co-expression measure is assigned as edge weight. It was
also suggested to use only those function parameters for soft-thresholding, that lead to
scale-free network topologies. They justified this by several studies, that revealed that
the majority of various kinds of biological networks (e.g. pathway or metabolic networks)
are scale-free.
Measures of co-expression
A common method to quantify co-expression between entities is to apply by correlation
measures between their expression profiles. Correlation metrics like Pearson Correlation
Coefficient (PCC) or Spearman’s rank Correlation Coefficient (SCC) are calculated for
each pair of genes. Additionally, estimation of statistical significance of correlation or
simple sorting of correlation values can be used to reduce the networks by removing
edges representing low correlations.
The PCC is a linear correlation coefficient that returns a correlation measure p between
−1 and 1 , where −1 represent full anti-correlation, 1 identity, and 0 no correlation. PCC
uses the covariance (cov) of the gene expressions (x, y) to quantify the strength of co-
expression:
px,y =
cov(x, y)
σxσy
, where σx is the standard deviation of x. (5.1)
The SCC describes the correlation between two variables as monotonic function.
SCC is defined as the PCC for ranked variables, as this means:
rS = prx,ry =
cov(rx, ry)
σrxσry
(5.2)
where rx and ry are the ranks of x and y. All SCC values rS are −1 ≤ rS ≤ 1, where −1
denotes anti-correlated, 1 full correlated and 0 non-correlated entities, as for the PCC.
Table 5.2 shows criteria for choosing either PCC or SCC as correlation measure.
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Table 5.2.: Properties of correlation metrics, PCC and SCC [95].
Pearson Correlation Coefficient Spearman’s rank Correlation Coefficient
• Continuous values • Interval or ratio level or ordinal values
• Entities are linearly related • No assumptions on distribution
• Values are bivariate normally • Based on the ranked
distributed values rather raw data
Construction of co-expression networks
Co-expression networks are constructed based on correlation metrics. Correlation mea-
sures are calculated for all pairs of genes based on methods such as the presented Pearson
or Spearman correlation measures. Calculating all pairwise correlations results in a sym-
metric adjacency matrix of all genes (nodes). The unique (upper or lower) triangle of
the matrix represents a network with n nodes and e = n2n−1 edges.
Different approaches have been developed to reduce the amount of edges. For example,
• remove edges with a correlation values below a (prior defined) threshold,
• include only edges that represent statistically significant correlation values (lower
bound for p-values),
• forbid triangles (three fully connected nodes), by removing the weakest edge,
• use additional criteria independent of correlation.
5.2.3. Bayesian networks
Another common approach to estimate the regulatory relationships between genes is
learning Bayesian network (BN) from steady state high-throughput expression data [105].
In general, BNs model the qualitative properties of GRNs by using a combination of
probability estimation and graph theory [53]. The objective of network inference using
BNs is to find the network that “best describes” the probability distribution over the set
of variables [104]. Thereby, each gene is treated as a random variable and the network
graph represents the joint probability distribution over the set of variables.
Definition
A BN represents the informational or causal dependencies among the variable (nodes)
of the network (see Figure 5.2). The dependencies are quantified by conditional proba-
bilities of each node given its parents in the network. A BN is defined as
BN = (G,P ), (5.3)
where G = (V,E) is a directed acyclic graph (DAG) and P is a set probability distribu-
tion. Each node Vi in the BN is described by the entirety of its concrete set of ancestors
ΠVi , represented as a set of random variables. For GRNs, this means that the expression
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profile of gene v1 is explained by its incident genes ΠV1 = v11 ...v1n , so called parents.
[263]
v1
v4v3
v2
v5
Figure 5.2.: A Bayesian network representing conditional probabilities among
variables. The graph illustrates a simple BN, where the v1...v5 represent
genes and the causal relationship amongst them. In this example the expres-
sion of v3 and v4 depends on v1 and v2 respectively, where the expression
of v5 depends on the common expression of v3 and v4. Despite no direct
relation between v1 and v5, it is clear, that v5 depends on the expression of
v1 and this relation is mediated by v3.
This is known as the Markov property defining the assumption, that it is sufficient to
know the current state of a stochastic process (and not its past history) to predict its
futures state [95]. This enables the representation of the joint probabilities distribution
P (G) of the random variables as a product of conditional probability distributions:
P (G) =
p
i=1
PGi(Gi|ΠGi)), (5.4)
where ΠGi is the product of the set of parents of i [273]. BNs have three fundamental
structures, converging connection, serial connection and diverging connection to repre-
sent all possible configurations of three nodes and their possible relationships in a DAG
[263]. Based on Markov chain rule the probability distributions P for the structures are
defined as:
converging connection: P (A,B,C) = P (C|A,B) · P (A) · P (B) (5.5)
serial connection: P (A,B,C) = P (B|C) · P (C|A) · P (A) (5.6)
diverging connection: P (A,B,C) = P (A|C) · P (B|C) · P (C) (5.7)
Construction of Bayesian networks
To find the “best describing BN” two steps are applied to construct the networks: struc-
ture learning and parameter learning [263].
Structure learning denotes finding the “highest scoring” structure of a BN. Because
this problem is NP-hard for networks, where each node has no more then K par-
ents (K > 1) [203] heuristics based on prior knowledge or random selection of
interactions are as used to setup an initial structure. Nagarajan et al. propose
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three categories to classify the algorithms for structure learning: constraint-based,
scored-based, and hybrid [263].
• Constraint-based structure learning is based on pruning the network using
the Induction Causation Algorithm as framework for learning/inferring the
structures.
• Scored-based structure learning follows the idea of assigning a score to the
current network and the aim of maximizing the score by altering network
structure using Greedy Search, Simulated Annealing, genetic algorithm or
similar as long as the network score can be maximized.
• Hybrid structure learning defines the combination of both (constraint-based
and score-based learning) algorithms.
Parameter learning aims to improve the network structure by altering edges or edge
weights after it has been learned. The process is simplified by the Markov property
of the networks (each variable is independent of its non-descendants), thus only
a limited parental space has to be considered for each node. This is important,
because (biological) networks from high-throughput data often have a high number
of potential nodes and a small number of observations, which makes parameter
estimation complex.
Another approach to reduce complexity is the discretization of the parameters.
For parameter discretization, Nagarajan et al. proposed three methods [263]:
• applying of prior knowledge to interpret and assign discrete values directly,
• using heuristics to perform binning of continuous values prior to structure
learning,
• testing different intervals and boundaries and choose the best in terms of
accuracy and information loss.
To sore the resulting networks and identify the best, the Bayes rule can be applied.
P (G/D) = P (G/D) · P (G)
P (D) , (5.8)
In equation (5.8) P (G) represents the prior knowledge or any constant non-informative
prior. P (G/D) is a function, to be chosen by the algorithm that evaluates the probability
that the data D has been generated by the graph G [19]. Popular scores that account for
overfitting are the Bayesian Information Criteria (BIC) [194] and the Bayesian Dirichlet
Equivalence (BDE) [138].
Dynamic Bayesian networks
One major drawback of BNs is the incapability of modeling loops, although loops are
a basic and common structure element of biological networks, (e.g. feedback loops). In
2000, Friedman et al. proposed Dynamic Bayesian Networks (DBNs) to overcome this
shortcoming [105]. Figure 5.3 illustrates how circles are modeled by DBNs using time-
series expression data. A DAG is generated for each time-point as described for BNs,
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while the fusion of these graphs can model circles or loops and results in a graph not
required to be a DAG.
v1
v3
v5
v1
v3
v5
v1
v3
v5
BN in time point t BN in time point t+1
GDBN GBN1 GBN2
DBN
Figure 5.3.: The left network GDBN represents the Dynamic Bayesian Network
(DBN) over two time points of a time-series. The transitions v1 →
v3 → v5 → v1 represent a circle transition over two time points. Right side
BN illustrate the DBN on the left GDBN = GBN1 ∪GBN2 , while split into
two networks, one for each time-point. The mentioned circle is distributed
over both subnetworks (GBN1, GBN2), as the only parent of v1 ∈ GBN2 is
v5 ∈ GBN1
Alternative approaches proposed to preserve the DAG topology by time-sliced BNs
[127, 188]. The basic idea is to prevent circles emerging over time by reducing the network
to those variables Xt from a specific time point t and with parents from Xt−1 only.
After merging the networks from different time points to one, identical nodes (genes)
v1in different networks are represented as independent nodes (v1t , v1t+1), referenced by
the time-point information.
v1 ∈ {BNt, BNt+1} → v1t , v1t+1 ∈ BNts, (5.9)
where t and t + 1 represent two time points, ts the time series, and BNts is the DBN
representing both time points. In DBNs, it is required differentiation between, so called
intra-slice and inter-slice connections [53]. For example in Figure 5.3, edges v1, v3 and
v3, v5 in graph GDBN , are intra-slice connections, while edge v5, v1 is an inter-slice con-
nection, i.e. it connects nodes from different time points t, t+ 1.
5.2.4. Information theory approaches
Information theory networks, relevance networks or mutual information networks are
different terms for one class of network reconstruction algorithms. In 1999, Butte and
Kohane first mentioned relevance networks to estimate the relation between laboratory
tests [45]. In 2000, the same authors adopted this approach to infer relations between
genes in expression experiments, as alternative to state-of-the-art correlation analysis
[46]. Basic idea is that a high MI of two genes is non-random, rather expressing a
biological relation.
To compute the entropy and subsequently the MI, Butte and Kohane suggest dis-
cretization of the continuous expression values. As with BNs, the major issue of dis-
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cretization is to be sensitive towards signals, since any discretization process implies loss
of information [107]. For MI networks, Butte and Kohane suggested a binning approach,
where the range of all values is binned using hierarchical clustering and continuous val-
ues are mapped to representatives of the specific bins, e.g. bin mean. Meyer et al. [253]
propose partitioning all continuous variables V in i bins, where each bin contains/ repre-
sents the same number of variables. After discretization, the entropy H for each variable
is calculated by:
H(Vi) = −
n
i=1
p(vi)log2(p(vi)), (5.10)
where p(vi) is the marginal probability distribution of Vi
Subsequently, the pair-wise MI is calculated and used to infer the GRN. The MI for
all pairs of n genes are noted in the so called mutual information matrix (MIM). This
square matrix, contains the MI values mimij for each pair of genes Vi, Vj .
mimij =MI(Vi, Vj) (5.11)
The MI is now calculated by
MI(Vi, Vj) = H(Vi)−H(Vi|Vj) (5.12)
= H(Vi) +H(Vj)−H(Vi, Vj), (5.13)
where an MIji > 0 means that the two genes are not randomly associated. Where
MIji = 0 means that both genes together do not contain more information than one
separately.
This results in:
MI(Vi, Vj) =

vi∈Vi,vjinVj
p(vi, vj)log2
p(vi, vj)
p(vi)p(vj)
), (5.14)
where p(vi, vj) is the probability distribution of Vi and Vj .
As gene expression data is known to follow a Gaussian distribution [259], the equation
5.14 is modified to:
MI(Vi, Vj) =
1
2 log2
|C(Vi)| · |C(Vj)|
|C(Vi, Vj)| , (5.15)
where C is the covariance matrix of the variables and | · | denotes the determinant of C.
5.2.5. Boolean networks
Boolean networks (BoolNs) are one of the simplest approaches to define GRNs. BoolNs
are suitable to model interactions and causal relations between nodes. The basic idea is
that variable value space is strictly limited to be boolean, i.e. variables in BoolNs can only
assume two states, commonly 0 and 1 resp. false and true. The nodes (genes) in BoolNs
are connected by either active or inactive connections (edges). An edge represents logical
operator or function that connects two nodes. Thus, a BoolN G(V, F ) is defined as a set
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of binary variables V (genes) and a set of n boolean functions F (edges between genes).
Hence the current state S of the network V (t) and the function fi|F defines the state of
V (t+ 1), where t1...m are time points or states.
Such networks can illustrate dynamics and kinetics of networks, even without prior
knowledge and based on relatively small amounts of input data. Major drawback of
the simple and straight forward concept are that BoolNs cannot capture quantities or
complex behaviors of real world systems like decreases and increases of gene expression
or noise. Required mapping to binary value space makes BoolNs vulnerable for noisy
data. Nevertheless, such networks enable time-discrete and synchronous updates and
was shown to work well for simulating GRNs [53].
Probabilistic Boolean networks
In 2002, Shmulevich et al. introduced Probabilistic Boolean Networks (pBoolNs) an
extension of BoolNs that enables the representation of probabilistic relationships between
variables (genes) [325]. The basic idea is to extend BoolNs by assigning a set of function
to each node vi instead of only one.
Fi = {f (i)j }j=1,...,l(i), (5.16)
where f (i)j is a possible function that determines the value of gene vi and l(i) is the
number of possible function for xi.
5.2.6. Ordinary Differential Equations
Ordinary differential equations (ODEs) are used to reconstruct GRNs by describing the
expression profiles of each gene by a differential equation over all other genes in the
network [19]. The function is defined by:
V˙i = fi(V1, ...Vn, Y,Θ), (5.17)
where Vi = {v1, ..., vm} is the vector of expression of the gene vi and over all states/times
(s1, ..., sm), with state-derivates V˙i = {dv1/ds, ..., dxM/ds}. Y represents external per-
turbations influencing the system and Θ is the vector of model parameters [274]. The
simplest ODE model describes that each expression change of each gene depends on the
changes of all other genes:
V˙i =
N
j=1
aijVj , (5.18)
where aij denotes the influence of gene vj towards vi. If aij is positive vj promotes
expression of vi, where negative values of aij indicate inhibition. Parameter (pre-)setting
of a can be utilized to integrate prior knowledge or fixing the model towards further
alterations. Popular extension of the models can be achieved by additional parameter
that for example simulate external processes like mRNA degradation.
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A major problem on applying ODEs for GRN reconstruction is that for the most of
the cases, the number of genes is much larger than the number of experiments (small
m large p problem). To solve such a differential equation the number of genes must
be smaller than the number of experiments [30]. To overcome this problem different
approaches were developed, e.g. Gardner et al. [109] assumed that GRNs are unlikely to
be fully connected. Therefore, some of the potentially regulating genes p can be set to
zero, which reduces the problem. By choosing a k < n the equation can be solved. The k
genes that fit the expression data with the smallest error are selected as approximation.
5.2.7. Adaptions of reconstruction algorithms
Over the last years, several extension and combinations of reconstruction algorithms
have been developed. For example, classification based approaches like ADANET [328]
have been developed to infer relations between genes based on the binary classifica-
tion. As such, ADANET applies the ensemble classifier AdaBoost [103] to infer GRNs.
Huynh-Thu et al. developed Genie3 – an approach that decomposes the problem of
reconstruction into regression problems, that are solved by Random Forests or Extra-
Trees ensemble methods [160]. Alterations of ODE based methods use approximation
(FastNCA [54]) or regression (NIR [109], TSNI [19]) to speed up algorithms and reduce
computational cost. Another trend is to combine different reconstruction methods, as
for example DELDBN [220]. Thereby, after setting up an initial network structure using
DBNs, the GRN is refined by solving the ODE system.
For sake of clarification, it is important to mention that some of the described meth-
ods and extension integrate prior knowledge. In practice this has become an effective
approach to improve in silico network inference methods.
5.2.8. Integration of prior knowledge to GRN reconstruction
Nowadays, the variety of available additional biological information on genomic, epige-
nomic, transcriptomic, proteomic and metabolomic level is heavily used to assess rel-
evance and influence of regulatory interactions [161, 374]. One of the major aims for
using prior knowledge is to reduce complexity, e.g. overcoming the “small m large p
problem” by shrinking the number of potential regulators or by assigning parameters
like probabilities of potential connections or even precluding specific regulatory interac-
tions [30, 219, 336].
In particular, it is a common strategy to divide the gene set into those, that can reg-
ulate others (regulators), like TFs and those, that receive the signal (targets). Defining
whether a gene can act either as target or as regulator of an interaction prior network
inference helps to reduce complexity and computation effort. For instance, regarding
ODEs such information helps to define initial parameter sets. For directed networks like
BNs or DBNs such priors reduce the number of allowed interactions [113].
Another common approach is to define an initial network structure. For instance,
Zhu et al. applied TFBS and protein-protein interaction (PPI) data to improve network
inference using BNs [407].
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Prior knowledge can be retrieved from different kinds of sources. High-throughput
technologies, genome-wide data sets and the increasing amount of large-scale, multidi-
mensional, and context-specific structured information gives access to biological insides
that can be applied to network inference as prior of gene associations [219] or can be
used for evaluation of inferred networks. Within this particular study we used additional
information and knowledge from databases for the evaluation of the GRN networks (Sec-
tion 5.5.1). Despite performing experiments by hand, different sources for information
and knowledge retrieval have been described and applied for network reconstruction, as
for example:
(Online) databases Several databases contain gene regulatory interactions. As there is
no common definition for the term regulatory interaction the databases vary in the type
of information (e.g. binding, sharing biological context, co-expression, sharing pathways
or signaling cascades, experimentally validated physical interaction), size and quality.
Many are separated into curated or (experimentally) validated interactions and auto-
matically retrieved or inferred. While for the first group information is often very reliable,
the second group lacks on reliability. Important interaction databases are STRING-DB
containing experimentally verified and inferred interaction [345], the 5Database of Inter-
acting Proteins (DIP) containing experimentally verified interactions [385] or the Human
Protein Reference Database (HPRD) containing manually extracted interactions from
the literature [276]. Others contain gene and protein meta information, like the GO
[13] or Kyoto Encyclopedia of Genes and Genomes (KEGG) [176], or Pathway data
only, like REACTOME [173] or Panther [255]. Databases like Transfac [139] or JAS-
PAR [307] contain information regarding TFs and their target genes, as well as detailed
information on the specific binding sites.
DNA sequence analysis Sequence analysis is used to identify TFBS, that indicates
potential binding and thus potential regulatory interaction [377] (for details see Section
2.3.2). ChIP-seq experiments are one option to obtain sequences for binding analysis,
motif discovery and analysis of co-factorial binding. DNA sequence analysis experiments
can be performed or existing experiments can be retrieved from public sequence data
repositories, e.g. the European Nucleotide Archive (ENA) [209] or the Sequence Read
Archive (SRA) [210].
Literature search In recent years literature search has become popular to search in
unstructured data (publications) for co-occurrence of genes. The idea is that two genes
potentially interact if they frequently occur in a common context (sentence or para-
graph). Some relation extraction methods also aim to estimate from the text, which
type of interaction is intended by the text [309, 358, 411].
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5.3. Tools implementing GRN reconstruction
Here, we introduce available implementations that could be successfully evaluated using
the steady state expression data sets from Chapter 3. 14 out of 26 tools from Table 5.4
could not be tested and evaluated.
Table 5.3 summarizes problems and unmet requirements that led to the individual
exclusion. Successfully applied tools are described in the subsequent paragraphs.
Table 5.3.: Overview of the tools that were discarded from GRN reconstruc-
tion comparison. 11 tools were discarded, because they require time-series
data or additional information. Furthermore, no working implementation
was found for five tools, while the available implementation of RegnANN is
incompatible to required third-party libraries.
Tool Prior knowledge
required
Data
requirements
Working
implementation
birta yes TF-network and miRNA data yes
BNT no time-series data yes
BoolNet no time-series data yes
deal required – yes
FusGP no time-series data not available
Inferrelator required – yes
MNI yes additional expression data yes
NCA required – yes
REVEAL no – not available
RegnANN no – no, incompatible
SEBINI no – not available
ScanBMA no time-series data not available
TDARACNE no time-series data yes
TSNI no time-series data yes
Weighted correlation network analysis (WGCNA)
Weighted Gene Co-expression Network Analysis (WGCNA) is an implementation of
co-expression networks. WGCNA identifies highly correlated (co-expressed) clusters of
genes and summarizes these using the module eigengene or an intramodule hubgene.
Eigengenes or hubgenes are used for comparison and for calculating membership mea-
sures [201]. WGCNA is implemented as R-package and calculates an co-expression
matrix for all input genes. The resulting fully connected network can be reduced using
thresholds for minimal correlation measures as requirements for establishing an edge.
Here, we specified, that two genes are connected by an edge, if their correlation value is
greater than the following lower bound. Here, it is implemented as a dynamic threshold
for each network:
cormin = mean(Cx) + 2 · sd(Cx) (5.19)
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where Cx is the correlation matrix of input data matrix X. So, an edge is inferred
between two genes, if their corresponding correlation values ci,j > cormin.
Banjo
Banjo implements static and dynamic Bayesian networks to analyze large data sets.
While the Banjo implementation of DNB is intended to infer networks from time-series
data, we use the static version as we apply steady state expression data. Furthermore,
Banjo offers to integrate known TFs activities and initial network structure for parameter
learning. It is important to mention, that Banjo has a number of requirements to the
input data. For instance, it is required to discretize the input expression values into
intervals x = 1 ≤ i ≤ 7, where i ∈ N Banjo comes with two routines (i) binning and
(ii) quantile discretization. We applied interval based (binning) discretization using five
intervals. As structure learning algorithm we chose simulated annealing. Additionally,
the maximum number of parents for a node in the inferred network was set to five. As
Banjo extracts a set of potential network with a corresponding score, only the highest
scoring network was extracted and evaluated. Furthermore, we removed all self-loop
interaction before evaluation.
BNLearn
BNLearn is a R-package that contains six ways of learning Bayesian networks from genes
expression data [248]. The six different option/ algorithmic approaches are Grow-Shrink
(GS), the Incremental Association Markov Blanket (IAMB), the Fast Incremental As-
sociation Markov Blanket (Fast-IAMB), the Interleaved Incremental Association (Inter-
IAMB), the Max-Min Parents and Children (MMPC) or the Semi-Interleaved HITON-
PC, constraint-based algorithms. Here, we selected IAMB to learn the DAG structure.
Thereby the Markov Blanket (MB) for each gene (node) is determined by first identify-
ing all variables that potentially belong to the MB of the current nodes (incl. potential
false positives) using mutual information. In the second step, each variable in the MB
is tested whether it is independent regarding the other variable of the MB [360]. After
performing the structure learning loops were removed.
BC3NET
The R-package BC3NET [83] is an extension of the mutual information (MI) based
C3NET algorithm by Altay and Streib [9]. Basic idea of both is to identify the “conser-
vative causal core”, i.e. the statistical significance MI network of all pairs of genes. In
detail, two genes are connected if their shared MI is maximal for at least one of both with
respect to all other genes. The C3NET algorithm calculates the MI for all pairs of genes
before the edges that do not satisfy the mentioned constraint are iteratively removed
. BC3NET extends the general principle of C3NET by bootstrap aggregation called
“bagging” to create an ensemble of data subsets before for applying C3NET to each of
the subsets [82]. Finally, the resulting networks from all subsets are aggregated using
statistical hypotheses testing to determine a threshold parameter for the aggregation.
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C3mtc
C3mtc is another extension of the C3NET algorithm (see BC3NET) that aims to imple-
ment a more efficient strategy of edge selection and adds a final step of multiple testing
correction to account for the type one error [83]. While step one is similar to C3NET
(calculating MI for all gene pairs), the second step is an extremal selection strategy,
allowing only one outgoing edge per gene, to reduce the amount of interaction to be
tested. Finally, in the third step multiple testing correction is performed to obtain the
relevance for the interactions.
NIR
Network Identification by multiple Regression (NIR) belongs to the category of ODE-
based methods and estimates regulatory interactions based on multiple linear regression
[109]. The aim is to create a model from RNA expression changes by using a set of
steady state transcriptional perturbations. The method was originally developed to
estimate the gene regulatory effects during treatments. It follows the assumption, that
changes in steady state data are mainly influenced by the treatment, rather then by
cell-development or other time-depended effects. Here, we circumvent this assumption
by considering the different cell type (iTreg/ nTreg cells) as treatment differences and
trying to estimate regulatory interactions between both. Additionally, we grouped the
microarrays regarding their original study correspondence to calculate the individual
standard error for each study, which is used to estimate the significance of gene expression
changes.
ARACNE
Since in 2006, Margolin et al. presented the “Algorithm for the Reconstruction of Ac-
curate Cellular Networks” ARACNE [249], it has become one of the most popular and
most often adapted GRN inference tools. ARACNE uses MI to determine the most
statistical significant relation between two genes that can not be explained by errors, ar-
tifact of other statistical dependencies in the network. It assumes, that such irreducible
statistical dependencies is likely to identify direct regulatory interactions. The algorithm
calculates the MI between all pairs of genes as well as the information-theoretic measure
of relatedness. A major drawback of that approach is, that it is not sensitive to mediated
relations, i.e. genes separated by one or more intermediaries may be highly co-regulated
without implying an irreducible interaction. Thus ARACNE infers a direct interaction
between two genes, if there are connected via intermediates. To overcome this, the Data
Processing Inequality (DPI) is used to remove such false positive indirect interactions.
The DPI states that in a clique of three genes (g1, g2, g3) where two genes (g1, g3) interact
only through the third gene g2, then MI(g1, g3) ≤ min[MI(g1, g2);MI(g2, g3)]. Thus
the least of the three MIs can come from indirect interactions only and is removed.
Here, we applied two extension of ARACNE implemented by the R-package “parmi-
gene” [305]. ARACNE.a implements an adaptive model, while ARACNE.m implements
a multiplicative model to estimate the significance of the MI.
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MRNET
MRNET is a “Maximum Relevance Minimum Redundancy” (mRMR) based network
inference approach belongs to the class of information theory approaches [275]. It calcu-
lates the MI for all gene pairs and uses the feature selection approach mRMR to identify
the “relevant” interactions in the network, while discarding the rest.
CLR
Context Likelihood of Relatedness (CLR) is another machine learning approach that uses
the concept of information theory networks [97]. After calculating the MI information
for each pair of genes, CLR applies a correction step to eliminate false correlation and
indirect influences (see ARACNE) by calculating the statistical likelyhood of the pair-
specific MI in the context of the “background” distribution. Background distribution of
MI denotes the distribution of MI over all pairwise interaction partners. Only those MI
that are significantly higher, than the “background” are considered.
Genie3
A regression tree-based approach of decomposing the problem of network inference is
implemented by Genie3 [160]. Thereby, the problem of network inference for n genes
is decomposed into n regression problems, where the aim is to predict the expression
profile of one gene by all others. The regulatory importance of a gene towards a target
gene is collected over all sub-problems and ranked to create a general regulatory network
for the data sets. More general the approach of Genie3 is to perform tree-based feature
selection to select those genes that have highest descriptive power towards the expression
pattern of the other genes. Genie3 is implemented as a R-Script.
5.4. Overview of selected GRN reconstruction methods and
tools
Table 5.4 gives an overview about the advantages and disadvantages of the described
methods and lists for each method a set of available implementation. To the best of
our knowledge, there are no implementations using artificial neural networks (ANNs)
currently available. Therefore this class of network reconstruction algorithms was not
described and considered in this work.
Various authors compared and summarized algorithmic approaches for GRN inference
before, e.g. [53, 125, 234, 296]. As in this work too, many reviews and comparisons are
focused on GRN inference from either steady state or time-series data only. Chai et
al. [53] or Hempel et al. [141] focused on methods for inference based on time-series
data. Others analyzed and compared approaches without focusing on temporal aspects,
like in [19, 108, 137, 247, 296]. Hecker et al. [137] formulated two important questions
for benchmarking reconstruction algorithms: (i) Does the model correctly predict the
behaviors of the GRN? (ii) Does the model represent the true structure of the system?.
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Table 5.4.: Methods and Tools for GRN inference. For each method/class of meth-
ods (upright written in most left column) we list a number of tools. Under-
lined tools are used for network inference in Section 5.5.3. Tools marked with
an asterisks are not longer supported or not available.
Advantages Disadvantages Tools
C
oe
xp
re
ss
io
n/
cl
us
te
rin
g
ne
tw
or
ks
- Computational low complexity - Infer undirected connections WGCNA [201]
- Scale for large networks - No noise handling Hierarchical
- Infer cyclic networks - Handle continuous values Clustering [92]
- Infer complete networks or
require threshold setting
Ba
ye
sia
n
ne
tw
or
ks
- Handle noise and uncertainties - Infer undirected connections Banjo [398]
- Able to work on the logically interacting
components with small number of variables
- Do not scale for large network
(large number of nodes)
BNLearn [316]
SEBINI* [353]
- Integrate the prior knowledge to strengthen
the causal relationship
- Cannot consider temporal
information from time-series data
birta [401]
deal [38]
- Infer the structure of network statistically - Do not support (feedback-) loops
D
yn
am
ic
Ba
ye
sia
n
ne
tw
or
ks
- Model (feedback-) loops - Computationally slow BNT [260]
- Handle perturbation and structural
modification of the network
- Do not scale for large network
(large number of nodes)
ScanBMA [396]
FusGP [258]
- Model direct and indirect causal relations - Sensitive to missing values Banjo [398]
- Consider temporal flow of time-series data REVEAL* [221]
Bo
ol
ea
n
ne
tw
or
ks - Scale for large networks - Computationally slow
- Only binary variables simplify simulation - Sensitive to missing values BoolNet [261]
- Easy to interpret - Require data discretization
O
D
E
ne
tw
or
ks - Handle steady state and time-series data - Require |genes| ≤ |experiments|) NCA [222]
- Easy to change/ adapt
- Infer directed, signed networks
- Computationally
intense
TSNI [19]
NIR [109]
- Return quantative measure of effect - Parameter search requires priors MNI [85]
Inferelator2 [243]
N
eu
ra
l
ne
tw
or
ks
- Handle steady state & time-series data - Computationally complex (slow) RegnANN* [120]
- Can infer “any” functional relationship
incl. loops, cyclic graphs, etc.
- To avoid over-fitting training is
required on different data sets
- Infer directed and undirected networks
(specific method dependent)
- Only for small networks due to
computation cost
- Robust regarding noise
In
fo
rm
at
io
n
T
he
or
y
ba
se
d
ne
tw
or
ks
- Easy integration of prior knowledge
- Capture non-linear interactions
- Threshold estimation necessary
to avoid complete networks
ARACNE [249]
TDARACNE [410]
- Fast computation - Require data discretization C3NET [9]
Genie3 [160]
MRNET [254]
CLR [97]
The first question refers to the (model) output of the inference and its accordance with
the actual observed outcome from wet-lab experiments. The second question depicts
the specific gene interactions of the model, i.e. the truth or correctness of each inferred
interactions is of importance. To answer the second question detailed knowledge of the
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organism and the true regulatory interactions, as it is the case for model organisms like
E. coli or S. cerevisiae is required.
As mentioned, the most popular benchmarking setup for GRN reconstruction based
on gene expression data was developed in 2010 as part of the DREAM5 network in-
ference challenge [247]. Thereby, the reconstructed GRNs were evaluated using binary
classification using standard performance metrics from machine learning (precision vs.
recall (PR) and receiver operating characteristic (ROC) curves). Marbach et al. also
evaluated the power of combining different algorithms to asses more robust networks, by
stacking the approaches [247]. Thereby, they observed, that no single method performs
very well over all datasets, while the combination of tools achieved better and more
robust results.
5.5. Application of reconstruction tools to infer a Treg cell
specific GRN
In this section we applied a subset of the described tools to the prior described Treg cell
meta expression set (Chapter 3). Thereby, we aim to compare the performance of dif-
ferent GRN reconstruction approaches. Tools from only four out of the seven categories
(listed in Table 5.4) were tested. Before we describe the setup of the evaluation strategy,
we introduce the public data repositories that we used as evaluation databases. After
applying the selected reconstruction tools, we report and compare their performances.
5.5.1. Evaluation databases (silver standards)
To evaluate whether the inferred edges are known gene-gene interactions or not, we
compare them to the set of approved interaction from two major interaction databases,
namely ConsensusPathDB (CPDB) [175] and STRING-DB [102]. Both databases do
not claim to contain the complete set of existing interactions. In addition, both focus
on integrating different source and assign confidence levels (e.g. predicted, mined from
literature, experimentally validated) to the interactions. It is important to mention, that
we use domain independent databases for evaluation, because no T cell or immune cell
specific interaction databases or repositories were not freely and publicly available or as
in the case of InnateDB are part of CPDB or STRING-DB.
ConsensusPathDB (http://consensuspathdb.org) is an integrated database that
combines information like protein interactions, signaling reactions, metabolic reactions,
gene regulations, genetic interactions, drug-target interactions and biochemical pathways
from 30 public resources databases into a single schema and thus grants access to more
than 150,000 unique physical entities and 500,00 interactions, including about 17,000
gene regulatory interactions. For the presented evaluation strategy we downloaded and
prepared the murine protein-protein interaction set and pathway set from CPDB that
contains manually added interactions as well as interactions from the following sources:
81
5. Reconstruction of gene regulatory networks
BIND The Biomolecular Interaction Network Database contains protein function infor-
mation, interaction and pathway data [15],
Biogrid Biological General Repository for Interaction Datasets is a interaction reposi-
tory with data compiled from comprehensive manual curation [334],
PDB The Protein Data Bank mainly focuses on information about the 3D folding struc-
tures of proteins [28],
IntAct IntAct Molecular Interaction Database provides interaction from literature cu-
ration and manual submission [182],
MINT The Molecular INTeraction database contains structured information about gene
and protein interactions [267],
DIP Database of Interacting Proteins is a database of experimentally validated protein
interactions [306],
InnateDB is a systems biology data repository for interactions and pathways related to
the innate immune response [40],
MatrixDB a curated database of experimentally established protein data [57],
MIPS-MPPI the MIPS Mammalian Protein-Protein Database is a collection of manu-
ally curated high-quality PPI data collected from the scientific literature by expert
curators [271].
ConsensusPathDB data integration and mapping was performed using UniProt and En-
trez gene identifiers.
For the evaluation we used two subsets of the full CPDB, (i) all protein-protein in-
teractions (CPDB.ppi) and (ii) pathway information for mouse (CPDB.pw). For (i) we
used the provided identifier mapping files to translate interactions from UniProt ids to
ensembl mouse gene ids, while for the second CPDB provides a list containing ensembl
mouse gene ids. (i) contains 17,089 PPIs of mouse proteins and (ii) lists 2,141 pathways.
STRING-DB database (http://string-db.org) is one of the largest public interac-
tion databases, today. It contains roughly one billion interactions for more than 2,000
organisms annotated with confidence levels. A confidence score assigned to each in-
teraction is used to indicate and verify the level of validation. STRING distinguishes
five main sources of interactions: (i) genomic context predictions, (ii) high-throughput
lab experiments (iii) (conserved) co-expression, (iv) automated textmining, (v) previous
knowledge in databases [102]. In 2012, STRING-DB contained about two million PPIs
for mouse. A confidence score is assigned to each interaction, that corresponds to the
probability of finding the linked proteins within the same KEGG pathway [369]. As many
of the included PPIs have a very low confidence score, we use two subsets for evaluation,
(i), only those interactions with are confidence score of at least 400 (STRING.400) and
(ii) the set of experimentally validated interactions, only (STRING.exp).
Using information from CPDB and STRING-DB we obtained four evaluation sets.
Additionally, we created a set by integrating all sets into one, which is indicated as
“combined”.
Regarding the subsequent application, an edge is considered as existing (true), when
it is either listed as an interaction in STRING.exp, STRING.400, CPDB.ppi, combined,
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or both genes share a common pathway from CPDB.pw or combined.
5.5.2. Tool testing strategy
The selected GRN reconstruction tools are applied to the test strategy (Figure 5.4),
which consists of six steps, described as follows: As input data for testing the strategy
we used the steady state Treg cell gene expression data set, which was presented in
Chapter 3.
1. Preprocessing: The microarray experiments from the selected expression data
set are formatted and transformed regarding to the tool specific requirements (see
tool descriptions in the following Subsection 5.3). Because some tools do not allow
continuous expression values, these must be discretized or binned. Others require
special input formats like matrix representation.
2. Inference: This step depicts the actual inference of the applied tools. Inference
is performed on ten gene sets. Each tool is tested ten times while each gene set
constitutes an initial expression set. The sets are incrementally built on each other,
i.e. the set of 20 genes contains the set of 10 genes, and so on and so forth.
3. Edge extraction: The tools specific output format are translated into an adja-
cency list format for subsequent performance estimation.
4. Evaluation: Evaluation depicts the validation whether the inferred edges are
present in the selected evaluation sets or not. During evaluation we apply the two
gene-interactions databases and four filter sets. For each tools we extract the num-
ber of true positively, true negatively, false positively, and false negatively inferred
interactions. The direction of interactions was not considered during evaluation.
5. Performance estimation: Performance measures (accuracy, specificity, preci-
sion, recall and F-measure) are calculated for each method based on the results
from evaluation step.
6. Ranking: In this step tools are ranked regarding their performance measures.
5.5.3. Results – Performance of GRN reconstruction tools on Treg cell
expression data
Here, we describe the results of the network inference by the reconstruction tools towards
the earlier presented Treg-subtype specific data set generated from meta-analysis. After
data preprocessing, inferrence and result formatting we obtained an adjacency list of
inferred interactions for each tools and each gene set.
In Table 5.5 we present the number of inferred interactions per tools based on the
supplied gene set and additionally the number of known interactions in evaluation data
sets based on the gene sets. The numbers illustrate the differences in the size of the
inferred networks, which in the end also results from the individual thresholds applied
for the tools. For example the exclusion of loops/ties tremendously reduced the number
of inferred interactions for Banjo and WCGNA. Furthermore, lower bounds for edge
weights, like significance levels had to be applied to the tools WGCNA, BC3NET, C3mtc,
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inferred edges
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Consensus
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Figure 5.4.: Tool testing strategy. The six layers (1-6) illustrate the main steps of the
pipeline in processing order.
ARACNCE.m, ARACNE.a to prevent inferring complete networks, while a large fraction
of the interactions have very low predicted regulatory influence. Since the number of
inferred interactions depends on individual thresholds we do not interpret the size of
the inferred networks, rather than testing how many of the inferred interactions can be
found in one of the five evaluation data sets.
After applying the presented test strategy we assessed individual tool performances
using the following metrics:
True positive (TP) depicts the number of correctly inferred edges.
False positive (FP) depicts the number of inferred edges that do not exists in the true
network.
True negative (TN) depicts the number of correctly not inferred edges.
False negative (FN) depicts the number of edges that exists in the true network but
were not inferred.
Accuracy is the proportion of correctly inferred interactions (true positives) plus the
correctly not inferred interactions (true negatives) to all interactions.
Accuracy = TP + TN
TP + TN + FP + FN
Specificity/True negative rate is the proportion of correctly not inferred interactions
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Table 5.5.: Number of interactions inferred by the presented tools (rows)
tested on ten gene sets (columns). The table header (bold) shows ten
genes sets, the column names indicate the number of genes each set contains.
The table is horizontally divided into two parts the upper part lists for each
applied tool (rows) the total number of inferred edges per gene set. The
lower horizontal part “Evaluation data sets” shows for each evaluation set
the number of existing edges based on the given gene set.
Gene set size 10 20 30 40 50 60 70 80 90 100
To
ol
s
ARACNE.a 17 36 62 94 136 187 230 268 329 374
ARACNE.m 19 59 103 147 212 274 366 443 541 619
Banjo 7 16 25 36 48 58 87 89 106 127
BC3NET 11 26 48 63 80 100 124 158 183 224
BNLearn 14 32 38 53 55 69 61 60 75 71
C3mtc 9 18 25 32 40 49 59 67 75 86
CLR 34 130 280 489 766 1107 1525 1980 2507 3099
Genie3 17 27 45 60 62 76 116 133 76 78
MRNET 28 110 263 473 745 1079 1499 1940 2452 3037
NIR 30 60 90 120 150 180 210 240 270 300
WGCNA 2 7 15 26 36 55 72 91 125 154
E
va
lu
at
io
n
da
ta
se
ts
STRING.exp 4 22 58 102 138 162 172 212 272 340
STRING.400 10 52 112 184 246 316 380 458 578 716
CPDB.ppi 5 10 19 23 30 34 41 45 48 50
CPDB.pw 29 124 260 476 610 869 1017 1290 1915 2622
combined 34 137 293 520 670 942 1120 1413 2059 2777
among all truly not existing interactions.
Specificity = TN
TN + FP
Precision is the proportion of correctly inferred interactions out of the full set of inferred
interactions.
Precision = TP
TP + FP
Sensitivity/Recall/True positive rate is the proportion of correctly inferred interac-
tions to all interactions.
Sensitivity = TP
TP + FN
F-measure / F1 is the harmonic mean of precision and recall.
F1 =
2 · Precision ·Recall
Precision+Recall
Table 5.6 shows the results for all applied tools (rows) on the different evaluation data
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sets (columns).
Based on meta expression data set from Chapter 3 we created ten increasing subsets
containing 10 to 100 genes. The gene sets composed as follows: first, we filtered for all
genes for TFs and Cytokines which have been defined as relevant for T cell regulation
by Wei et al. [378]. Second, the resulting genes were tested for significant differential
expression and ranked regarding their fold changes (between iTreg and nTreg cell experi-
ments). The ten genes with the highest fold changes were assigned to the first evaluation
set, the 20 genes with the highest fold change to the second and so on and so forth. In
consequence, the smaller sets are part of the large ones.
To provide an overview about the average performance of the tools we calculated the
mean over all data set sizes (10 to 100 top genes) Table 5.6 illustrates, that almost all
tools do not infer “known” interactions indicated by the low sensitivity rates (TPR) of
lower 1pp. Nevertheless, the majority of inferred interactions is correct for nine of 11
tools, as accuracy values above 0.5 indicate for all evaluation data sets. Those metrics
in Table 5.6, that are marked with an asterics must be considered very carefully, as the
corresponding tools (Banjo and Genie3) were not able to infer any correct interaction
except for self-loops (that were removed prior evaluation). Their sensitivity value of 0
corrupts all other metrics for these tools. But, accuracy values mainly result from high
specificity, which is high because of the low number of inferred interactions for all tools
(see Table 5.5). Because not inferred interactions count as negative and the inferred
networks are rather small specificity (true negative rate) is high. This is illustrated in
Table 5.5 by the number of inferred interactions per tool and the number of known inter-
actions for each evaluation data sets. The number of theoretically allowed interactions
(n2 − n for directed and n ∗ (n− 1)/2 for undirected networks) is very large in contrast
to the number of proven interactions included in the databases. Furthermore, also the
number of inferred interaction heavily varies between the tools.
Comparing sensitivities illustrates that the tools are not able to infer large fractions of
existing interactions. While specificity is high due to the high number of true negative
(TN) inferred edges, as this is high by chance as the most possible edges are negative
in the evaluation networks, too. To account for this effect we also calculate specificity
values for all tools and gene sets (illustrated in Figure 5.5) as well as an average F-
measure and accuracy illustration over all gene sets in Figure 5.6. Both illustrate the
drawback of inferring large numbers of interactions, as specificity drops if many false
positive (not existing interactions) are inferred.
In detail, CLR und MRNET, two machine learning based information theory ap-
proaches show highest F-measures, while their specificity and accuracy is the worst
among the tested tools (see Figure 5.5). This relies on the fact, that both methodw infer
by far the most edges, which in turn reduces the amount of correctly inferred negative
interactions (specificity). NIR performed best in terms of accuracy, which is mainly
founded by the high specificity.
Finally, results show, that none of the presented tools is able to infer a relevant set
of known interactions. The results are insufficient for further analysis as the fraction of
false positives among the very low number of correctly inferred interactions is high. So
far we can not estimate, whether a significant number of the inferred interactions is true
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Table 5.6.: Performance of GRN reconstruction tools tested using five evalua-
tion set. The table is vertically divided into four parts, each for one metric,
namely sensitivity, specificity, accuracy and F-measure. Tools are shown in
the rows of each part, while the columns present the evaluation data set. Best
performing tool per metric is highlighted in bold. Numbers marked with an
asterics(*) must be interpreted carefully, see text.
STRING.exp STRING.400 CPDB.ppi CPDB.pw combined
Sensitivity (TPR)
ARACNE.a 0,020 0,067 0 0,128 0,146
ARACNE.m 0,024 0,079 0 0,196 0,215
Banjo 0 0 0 0 0
BC3NET 0,010 0,023 0 0,094 0,098
BNLearn 0,009 0,020 0 0,073 0,076
C3mtc 0,004 0,014 0 0,059 0,060
CLR 0,072 0,201 0,001 0,517 0,586
Genie3 0 0 0 0 0
MRNET 0,071 0,190 0,001 0,495 0,554
NIR 0,018 0,024 0,001 0,069 0,072
WGCNA 0,006 0,012 0 0,045 0,047
Specificity (TNR)
ARACNE.a 0,805 0,827 0,796 0,855 0,863
ARACNE.m 0,712 0,738 0,701 0,791 0,800
Banjo 1* 1* 1* 1* 1*
BC3NET 0,873 0,878 0,868 0,914 0,916
BNLearn 0,883 0,888 0,879 0,916 0,917
C3mtc 0,921 0,925 0,919 0,949 0,949
CLR 0,104 0,162 0,075 0,295 0,326
Genie3 1* 1* 1* 1* 1*
MRNET 0,162 0,214 0,133 0,342 0,367
NIR 0,929 0,930 0,926 0,939 0,940
WGCNA 0,955 0,957 0,953 0,972 0,972
Accuracy
ARACNE.a 0,580 0,609 0,567 0,647 0,659
ARACNE.m 0,517 0,552 0,502 0,624 0,636
Banjo 0,853* 0,853* 0,853* 0,853* 0,853*
BC3NET 0,623 0,631 0,617 0,678 0,680
BNLearn 0,632 0,639 0,626 0,675 0,677
C3mtc 0,655 0,661 0,652 0,691 0,692
CLR 0,100 0,178 0,059 0,364 0,406
Genie3 0,853* 0,853* 0,853* 0,853* 0,853*
MRNET 0,138 0,209 0,097 0,387 0,422
NIR 0,797 0,799 0,791 0,814 0,815
WGCNA 0,677 0,680 0,673 0,700 0,700
F-measure (F1)
ARACNE.a 0,029 0,089 0 0,172 0,196
ARACNE.m 0,029 0,093 0 0,230 0,253
Banjo 0 0 0 0 0
BC3NET 0,016 0,036 0 0,140 0,147
BNLearn 0,015 0,032 0 0,106 0,110
C3mtc 0,008 0,024 0 0,095 0,097
CLR 0,045 0,126 0 0,321 0,365
Genie3 0 0 0 0 0
MRNET 0,045 0,124 0,001 0,320 0,358
NIR 0,025 0,034 0,001 0,093 0,097
WGCNA 0,012 0,022 0 0,082 0,084
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Figure 5.5.: The line plots illustrate the tool specific characteristics of the per-
formance metrics (y-axis) for increasing gene set sizes (x-axis).
From upper left to lower right the figures show F-measure, sensitivity, ac-
curacy and specificity. Labels on the x-axis depict the gene set size. The
measures were calculated based on the “combined” evaluation corpus. The
lines for Banjo are plotted before the lines of Genie3 and thus fully or almost
invisible.
but missing in the evaluation databases, or not.
Nevertheless, comparing the top three most often inferred interactions over all gene
sets revealed three edges: Ccla4-Lta, Lta-Il2, Il2-Foxp3. Ccla4 is a chemokine which
is known to be functionally different in different T lymphocyte subsets and specific for
CD8 lymphocytes [227]. The protein family associated to the cytokine Lta regulates Treg
suppressor function in vivo but not in vitro [41], which is interesting as our data compares
iTreg with nTreg cells. Il2 and Foxp3 are two well known key regulators for T cell. While
Il2 is the most important cytokine during Th2 cell induction it is also important for the
signaling during the development and function of regulatory T cells [244]. Foxp3 is the
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Figure 5.6.: Boxplots of F-measure and accuracy aggregated for each tool over
all gene sets to illustrate variance. Comparison shows that no tool
is able to outperform all others in terms of F-measure and accuracy. Even
more we observed that higher number of correctly inferred interactions come
along with a higher number of false positives.
master transcription factor for Treg cells (see Chapter 2). Furthermore it is known that
a reduction in Il2 transcription results in impaired FoxP3+ CD4+ Treg-cell recruitment
and function [318].
5.5.4. Discussion of the results from GRN reconstruction
The presented application of GRN reconstruction methods using the expression data
set derived from meta-analysis did not reconstruct large fractions of known interactions
and thus encouraging results for further research. Table 5.5 shows that the number
of known interactions (interactions found in evaluation sets) is rather small, compared
to the theoretically possible number of interactions. Even worse, it is impossible to
estimate the number of truly not existing interactions, since a gold standard is missing.
We illustrate this inadequacy for the chosen evaluation sets in Table 5.7. The table
shows the number of theoretically possible edges and the number of corresponding edges
for each evaluation sets.
The comparison of the inferred interactions between the tools also revealed, that only
a small fraction of interactions is commonly inferred by multiple tools. Table 5.8 indi-
cate the low overlap of interactions. Marbach et al. state in [247] that a high overlap
between different tools increases the reliability of the inferred interactions. In this study
we could not identify large overlaps of inferred networks. Table 5.8 shows that the over-
lap of identically inferred edges by six or more tools is very low. Moreover, tools based
on a similar or common theoretical approach tend to infer more identical edges, e.g.
MRNET, CLR, and both ARACNE implementations. The low amount of overlapping
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Table 5.7.: Estimation of potential edges per network. Here, we compare the max-
imal possible number of edges per network (“full, directed, without loops”)
with the number of corresponding edges in evaluation sets.
Gene set size 10 20 30 40 50 60 70 80 90 100
full, directed net 90 380 870 1560 2450 3540 4830 6320 8010 9900
STRING.exp 4 22 58 102 138 162 172 212 272 340
STRING.400 10 52 112 184 246 316 380 458 578 716
CPDB.ppi 5 10 19 23 30 34 41 45 48 50
CPDB.pw 29 124 260 476 610 869 1017 1290 1915 2622
combined 34 137 293 520 670 942 1120 1413 2059 2777
inferred edges give reason to disregard further ensembled analysis using majority voting,
i.e. constructing a network based on those edges inferred by the majority of tools. Fur-
thermore, applying and testing the union of the inferred networks as additional approach
was neglected, because of the high false positive rates (FPRs) and the low overlap of
inferred interactions.
Table 5.8.: Overlap of inferred edges per gene set. The rows represent the genes
sets (10 to 100), while the columns represent the frequency of inference. The
column “in total” contains the number of inferred unique edges. For example
the column 2× depicts the number of overlapping edges that were inferred by
exactly two tools, where 11 indicates how many unique edges were inferred
by all applied tools.
Unique interactions inferred
in total 1× 2× 3× 4× 5× 6× 7× 8× 9× 10× 11×
G
en
e
se
t
siz
e
10 71 29 13 7 9 5 5 3 0 0 0 0
20 208 68 56 37 23 15 5 1 2 0 1 0
30 417 131 139 63 45 29 5 2 1 1 1 0
40 679 185 278 90 84 22 12 4 1 2 1 0
50 994 228 470 126 109 39 11 5 3 2 1 0
60 1388 289 720 151 154 43 11 11 4 4 1 0
70 1880 352 1031 211 202 43 21 12 3 5 0 0
80 2399 422 1389 253 249 40 22 15 4 5 0 0
90 2945 470 1746 321 307 54 24 15 5 3 0 0
100 3594 532 2230 371 338 67 28 20 3 5 0 0
Regarding potential improvements in the presented pipeline, we focus on two steps:
1. Identifying proper gene sets for inference
Gene set selection can be improved by filtering for genes based on common ex-
pression patterns or gene enrichment properties. Rather than filtering genes by
the fold change ranking, clustering based on expression data to identify common
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expression patterns is an alternative. Additionally, enrichment analysis tools like
GSEA [343] or GO term analysis [98] can be used to create more specific gene sets
e.g. based on shared meta information.
2. Extending GRN reconstruction by prior knowledge integration
Another, very simple way to achieve better results is to make use of the tools func-
tionality to include prior knowledge, as it has been show in a number of studies
like [12, 29, 113, 119, 161, 281, 335, 381]. For instance, sources of prior knowledge
can be databases like those we used for evaluation or ideally specific additional ex-
periments like ChIP-seq to determine potential TF activities and binding partners
[20]. While some of the tested tools (e.g. Banjo, NIR, ARACNE) optional allow,
other tools require the integration of additional prior knowledge (and therefore
have not been considered in this study - see Table 5.3).
We choose to perform the analysis without additional knowledge about known regu-
lators or functional information, as not all tested tools provide this functionality. Some
of the presented tools allow the integration of prior knowledge, as for example, Banjo
or ARACNE can use initial network structures, while others integrate gene information
like “is a transcription factor” to define sets of regulators. To keep evaluation and results
interpretation less complex, we refrained from providing different prior information to
the tools.
We aimed to assess tool performances on “real”, noisy data from aggregated, het-
erogeneous, publicly available experiments. It was clearly shown, that the tools do not
provide high inference quality based on such data for known gene-gene interactions. The
presented study pointed out, that at least a comprehensive gene selection strategy and
prior knowledge is required to increase network inference quality.
For the field of T cell lymphocytes, studies of Ciofani et al. [66] and Äijo et al. [4]
showed the high impact of GRN reconstruction and additional knowledge integration
to investigate regulatory events during T cell activation and T cell fate decision. In
contrast to our work, in both studies time-series data was applied to assess the regulatory
networks. Interestingly, Ciofani et al. reconstructed a Th17 cell specific GRN using time-
series RNA-seq and ChIP-seq data and applied the Inferelator tool (see Table 5.4) to
infer a Th17 cell specific GRN. To show the impact of external information we present
a GRN reconstruction approach for Th2 cell exclusively based on the data integration
from different experiments and database information in Chapter 6.
5.6. Summary
In this chapter, we presented the application of GRN reconstruction algorithms and tools
to a large set of heterogeneous Treg cell specific gene expression data. A collection of
tools and algorithmic approaches from different categories were presented and compared
regarding their advantages and their disadvantages (Table 5.4). We presented a general
GRN inference strategy, compared and tested a selection of reconstruction tools on the
Treg subtype specific meta-expression data set from Chapter 3. The presented strategy
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did not incorporate prior or additional knowledge, therefore the range of available tools
was limited. Other tools were excluded because, no functioning implementation was
available. Each of the finally selected GRN reconstruction tools was applied to ten
gene sets of varying size (number of genes). The gene sets contained those with the
highest fold changes between both Treg subtype in the differential expression analysis of
the meta-expression experiment. The presented test strategy also includes an evaluation
phase, within the inferred networks were compared to information from public interaction
databases, namely STRING-DB and ConsensusPathDB.
In the end, we inferred 110 networks which were compared regarding known inter-
actions. The results do not show high consistency of inferred edges between the tools,
as only small fractions of edges were inferred by multiple tools, furthermore, tools with
overlapping sets are very similar regarding their baseline algorithmic approaches.
Finally we can summarize, that the reconstruction of a GRN from assembled publicly
available gene expression data, that obtains high heterogeneity, does not reveal networks
with high reproducibility using different inference methods. Nevertheless, under the large
amount of unknown interactions, we could infer Treg cell related and experimentally
validated interactions using the majority of tools since the analysis of the top-most often
inferred interactions over all tools shows Treg cell specificity.
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subtype specific regulatory networks
In this chapter we describe the advantages of integrating multiple OMICS data sets
to construct a specific, small-scale, yet high resolution GRN. OMICS refers to data
from different kind of biological experiments, as for example, transcriptomics, genomics,
proteomics. Here, we used publicly available Th2 cell specific data sets. The generated
data was obtained from experiments performed by the group of Ria Baumgrass from
the German Rheumatism Research Center Berlin. The integration strategy in this work
combined gene expression data from microarray, RNA-seq, and DNA-seq data into a
single GRN, centered around Stat6 – the Th2 cell master TF. The work in this chapter
describes a collaboration with the German Rheumatism Research Center (DRFZ) and
the group of Joachim Selbig at the University of Potsdam. It was published in 2016 [168].
The authors contribution to this work was the development of the overall integration
strategy, data source specific analysis workflows for the ChIP-seq analysis, RNA-seq
data analysis of time series data, and microarray data analysis. Furthermore, the author
contributed to the network visualization using Cytoscape [319].
6.1. Motivation
Here, we describe how data integration can help to reconstruct high-resolution GRNs.
The availability of OMICS data from high-throughput experiments keeps increasing
every year (see Figure 3.1, p.24) and provides comprehensive descriptions of nearly
all molecular components and interactions within the cell [174]. We aim to integrate
such information from matching and complementary experiments like time-series RNA
expression, TF-binding and gene knockout studies. Bolouri described the importance of
integrative analysis of large scale datasets for molecular biology and listed key findings
of modeling and analyzing GRN [33]. Two of these findings constitute the imperative
for approaches like ours:
• Current models of the regulation of gene expression are far too simplistic and need
updating.
• Integrative computational analysis of large-scale datasets is becoming a fundamen-
tal component of molecular biology.
An example for data integration is the usage of gene expression experiments like mi-
croarray or RNA-seq, and DNA binding experiments like ChIP-seq to analyze regulatory
mechanisms. Thereby gene expression data is used to extract similarly expressed TFs
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from time-series experiments (during differentiation) and ChIP-seq experiments can indi-
cate, whether co-localized binding sites exist for the co-expressed TFs. Another example
for the benefit of data integration strategy is the combination of expression data and the
verification of derived potential interactions using methods such as RNAi knockdown
applied by Konig et al. to identify useful intervention strategies in infections [193].
In the context of T-cells, Ciofani et al. showed the impact of data integration for im-
proving and verifying interactions in the gene regulatory network of T helper 17 (Th17)
cell master TFs [66]. First, they derived potential TF – target gene interactions using
TFBS detection and motif search based on Th17 cell ChIP-seq data. After establishing
a baseline network, regulatory information for the integrated and additional TFs was
added by integrating RNA-seq expression data from knock-out and wild-type mice and
publicly available microarray expression experiments of other immune cells and con-
ditions. The derived baseline network was enriched by a GRN that was inferred by
analyzing the expression data with the Inferelator tool [36]. GSEA was used to char-
acterize the predicted interactions and top-enriched genes were checked using literature
search. Additionally, Ciofani et al. used GWAS to check associations between genes
covered by the core network and Th17 functions as well as SNP of Th17 cell related
diseases.
Here, we first describe our approach of integrating ChIP-seq, RNA-seq, microarray,
literature and information from databases (Section 6.2). Second, in Section 6.3 we apply
the presented approach to reconstruct a network for Th2 cells around its master TF
Stat6. Aim of our data integration strategy was a better understanding of the T cell
fate decisions of naïve Th cells during differentiation to Th2 cells.
6.2. Integrating ChIP-seq, RNA-seq, Microarrays data
To enable the integration of different experimental data, we developed an integration
pipeline consisting of three parts (see Figure 6.1). After datasets selection (part 1), raw
data must be processed and analyzed (part 2), e.g. differential expression analysis. The
actual integration (part 3) is performed regarding necessary mapping between biological
entities, as far as this has not be considered in previous steps.
Here, we present in detail the applied analysis pipelines and workflows for ChIP-seq,
RNA-seq and microarray experiments. Afterwards, the integrations of the results is
explained.
6.2.1. Processing raw data from ChIP-seq, RNA-seq and microarray
experiments
Prior to the integration of different experimental data and external knowledge, pre-
processing and mapping to a common Id system is required. Pre-processing is individual
to the specific data type, i.e. RNA-seq data analysis differs from microarray analysis.
But, for both an consistent identifier mapping strategy is crucial to ensure that inte-
gration of different data types refers to identical biological instances (e.g. by integrating
94
6.2. Integrating ChIP-seq, RNA-seq, Microarrays data
Figure 6.1.: Integration strategy to create an interaction network around a
master regulator (master TF). This pipeline models the integration of
four different data sources and is divided into three parts, i) data selection
and preparation ii) analysis of each data set using specific workflows. iii) A
mapping schema using a common id system is required to ensure compat-
ibility between the data sets. Entities and links between the data sets are
integrated into a single network based on unambiguous identifier only.
transcriptome, genome data). The next paragraph describes the processing workflows
for the different data types we consider in this study.
ChIP-seq data analysis
For studying the genome-wide DNA-binding ChIP-seq is an appropriate method that
enables the distinct analysis of TF binding and the analysis of the bound sequences and
corresponding genes (see Section 2.4.2). ChIP-seq data analysis was performed based
on the workflow in Figure 2.9 (p.19) and described as follows:
Raw read extraction Sequencing machine output (reads) conversion into fasta format-
ted files (fasta/fastq) using SRAtools software [322]
Quality control Read quality estimation using quality scores provided by the sequencing
machine, statistics of multiple mappings, gc-content calculation and testing for
nucleotide over-representation. FastQC [11] was used for quality control.
Trimming & filtering Read trimming is an essential step of cutting input read ends with
poor quality values, as especially first generation sequencing machines tend to have
a high error rate on read ends [372]. Using Solexa Trimming tool [74] reads were
pre-processed to enable subsequent read mapping.
Read mapping Mapping the raw reads to a matching position in the prior selected
reference genome using Bowtie2 [202] is a prerequisite for subsequent peak calling.
Peak calling After mapping the reads, peak calling is used to identify enriched genomic
regions, i.e. regions with a high number of mapped reads. Next to high number
of mapped reads also the shape of enrichment is accounted by the algorithms and
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used to differentiate between random enrichment (false positives) and enrichment
cause by TF-binding [150].
Peak annotation Associating peaks to genes enables the interpretation of the TF bind-
ing to specific genes. Search for the nearest transcription start side (TSS) of a
gene around the peak is the straight forward way. While the average TFBS is
located about 40bp up- or downstream of the TSS, other cis-regulatory elements
are localized in greater distance to the TSS, e.g. enhancer, silencers, insulators and
tethering elements [331]. We set the maximum allowed distance to 1.5kbp.
After finalizing the ChIP-seq analysis extracted peak annotations provide information
about TF-binding in the promotor region of genes. This association between TF and
genes can be integrated into a GRN as interaction between the TF and the bound genes.
RNA-seq data analysis
RNA-seq experiments are used to measure gene expression for the whole transcriptome.
The advantage of RNA-seq for integration approaches is that RNA-seq enables the com-
parison of gene expression for different cells in different states (time points, treatment)
between each other without restricting the analysis to prior defined regions or transcripts,
as it is the case for microarray gene expression experiments (see next paragraph). To
investigate differentiation processes of cells it is of high importance to acquire the cell
state at different time-points and thus enable the comparison between the initial cell
state (naive T cell) and the differentiation product (T helper cell subtype, like Th1,
Th2).
The applied RNA-seq analysis pipeline is based on the workflow describe in Section
2.4.2 (Figure 2.10, p.20) and described as follows:
Raw read extraction & conversion Raw reads are retrieved and similar to ChIP-seq
experiments files converted into fasta format files.
Quality control Calculating read statistics and checking for outlier is performed during
quality control (see ChIP-seq analysis).
Read mapping We used Bowtie tool to perform the read alignment and TopHat2 tool
for mapping to the selected reference genome [184]).
Transcript assembly We apply Cufflinks [359] to perform the assembly and merge of the
reads to single genes or transcripts in the reference genome. The mapped reads are
assembled and their abundances is estimated to test for differential expression and
regulation in the RNA-Seq samples. Cufflinks estimates the relative abundances of
transcripts based on how many reads support each one, taking library preparation
protocols into account biases.
Differential expression analysis Cuffdiff [359] is used to compare gene/transcript ex-
pressions as well as identify differential expression.
Gene/transcript extraction Finally all raw measures, calculated expressions, fold changes
and p-values are extracted.
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Microarray data analysis
As gene expression data derived from RNA-seq, microarray gene expression data en-
ables the detection of differences on transcriptome level (see workflow in Figure 2.6,
p.16). Since the number of publicly available microarray experiments is still much higher
than RNA-seq measurements such experiments are still very relevant for our integration
approaches. One of the major drawbacks is that expression can be detected only for
chip specific transcripts. After processing, as described in 2.4.1, we perform differential
expression analysis using limma [329].
6.2.2. Data integration procedure
After processing and initial, data set specific analysis, the integration of individual results
is performed (see Figure 6.1). Mapping to a common id system is the most important
step of the integration.
We propose to ensure identifier compatibility already during the data analysis in part
two of the experiment-type specific pipelines. For sequencing data analysis (ChIP-seq,
RNA-seq) it is recommended to use identical reference genomes during read mapping and
peak annotation to avoid ambiguity. For microarray analysis consistent mappings using
a specific reference genome (e.g. the same as used for sequencing data) can be achieved
by genome specific CDF files or mapping services like biomaRt [89]. The integration of
different data sets is achieved by two steps:
1. Creating an adjacency matrix for each data set,
2. Combining adjacency matrices into a single network graph.
Adjacency matrices An adjacency matrix C = N ·N , where N is the number of genes
and each entry in the matrix depicts the relation between two genes. In its simplest
version the matrix is binary, where 1 represents an interaction and 0 no interaction,
respectively. Adjacency matrices can also contain quantitative information, e.g. correla-
tion values or probabilities of interactions. For example, differential expression analysis
of KO and wild-type experiments (as used in Section 6.3 ). The expression change of
genes can be used as quantitative information assigned to the relation of the measured
gene and the knock-out gene. For each experiment an adjacency matrix is created by
specified conditions, like TF binding for ChIP-seq, differential expression (RNA-seq KO
experiments) or co-expression between two genes for microarray experiments are met.
Table 6.1 provides an overview of the applied conditions.
Combining matrices The extracted adjacency matrices are incrementally added to the
final network graph. After all integrated data sets are translated into binary adjacency
matrices, the combination is performed by binary “OR” relation for all interactions. To
conserve the information from particular not binary, adjacency matrices a multi-graph
that enables parallel edges can be constructed. By adding parallel edges the individual
properties and relation information are preserved.
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Table 6.1.: Summary of gene interactions derived from different experiments.
For knock-out (KO) experiments a relation is inferred between the knocked
out gene and affected genes. For time-series or steady state experiments
interactions are defined between co-regulated or co-expressed genes. (WT
stands for wild-type)
Data Sample classes Derived gene-gene interactions, between
ChIP-seq KO KO-gene (TF) and bound genes (peak related)
RNA-seq KO vs. wild-type (WT) KO-gene and differentially expressed genes
time series co-regulated genes
steady state co-expressed genes, co-regulated genes
Mircroarray KO vs. WT KO-gene – differentially expressed genes
time series co-expressed genes
steady state co-expressed genes, co-regulated genes
Alternatively, the final network graph from all experiments can be iteratively con-
structed by adding an edge for each non-zero relation in the respective adjacency. This
is done for each single adjacency matrix, i.e. for each experiment.
6.3. Reconstruction of a Stat6 -centered network for Th2 cells
In this section, we describe in detail the integration strategy of a Stat6 centered regula-
tory network for Th2 cells. The applied integration pipeline using ChIP-seq, RNA-seq,
microarray, literature, and existing databases is illustrated in Figure 6.2. This pipeline
led to a gene regulatory network around the TF STAT6, which fundamentally influences
cell fate decision towards the Th2 cell subtype [390].
6.3.1. Preparation and analysis of publicly available data to reconstruct a
gene regulatory network
We used selected public data sets to reconstruct gene regulatory networks, namely RNA-
seq, microarray and ChIP-seq data sets. The initial network was established based on
a Stat6 KO mice RNA-seq experiment (GSE40463, [365]) and extended by publicly
available RNA-seq and ChIP-seq experiments. In addition, AG Baumgrass (DRFZ)
generated RNA-seq data of Th2 cell differentiation. GEO accession numbers and corre-
sponding references are listed in Table 6.2 for all public data sets. We used published
normalized fragments per kilobase of exon per million fragments mapped (fpkm) values
to identify differentially expressed genes. Differential expression was defined as an abso-
lute log2(fold change) > 1. Low expressed genes were removed (normalized fpkm value
smaller than 1 in all groups).
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Figure 6.2.: Workflow for the construction of the STAT6 network. The used
filter criteria and data sources for each step are shown in the first row and
highlighted in different colors (green for RNA-seq, purple for microarray
data, orange for ChIP-seq). The filter criteria and/or the number of genes
are listed for each integration step and gene group in the second row. Figure
taken from corresponding publication [168].
STAT6 deficient Th2 cells – ChIP-seq processing
We retrieved and integrated STAT6 ChIP-seq raw data of WT and STAT6-deficient
Th2 cells by Wei et al. [379] (GSM550311, GSM550312 part of GSE22105). Reads were
mapped to mouse genome using BWA (Burrows-Wheeler Aligner, [215]). To detect TF
bindings, we applied CisGenome peak detection software to all uniquely mapped reads.
As described by Wei et al., identical ChIP-seq peaks in KO and WT cells were removed
prior to peak annotation. Genes associated to the peaks (by annotation) were integrated
as binding targets respectively interaction partners of Stat6.
T helper cell time-series – RNA-seq data processing
Time-series expression experiment was generated using RNA-seq technology [168]. T
cells were isolated, cultured and finally sequenced in an Ilumina sequencer HiSeq. After
sequencing we performed a quality check and trimmed the sequences using Solexa trim-
ming tool. The trimmed sequence reads where processed in exactly the same way as
retrieved RNA-seq experiments by Hu et al. (GSE22081, [153]). All RNA-seq raw data
was analyzed using the same pipeline to ensure comparability. Subsequently, raw reads
were mapped and indexed using Tophat2 and Samtools. Read mapping was performed
using Ensembl genome assembly mm10. Detected reads per gene (gene counts) were
calculated using HTSeq. Next, differential expression was detected with R package DE-
99
6. Data integration for constructing T cell subtype specific regulatory networks
Table 6.2.: Integrated data sets for Stat6-Th2 cell network reconstruction.
Data source Cell type Description
GEO
accession
number
Reference
RNA-seq Th2 WT & Stat6 KO
naïve CD4+T cells cultured in vitro for 7
days under Th2 condition and restimulated
with plate-bound CD3/28 +IL4 for 2 hrs
GSE40463 [365]
Th1 WT & Stat4 KO
naïve CD4+T cells cultured in vitro for
7 days under Th1 condition and restimulated
with plate-bound CD3/28 +IL12 for 2 hrs
GSE40463 [365]
naive, Th1, Th2,
Th17, iTreg
naïve CD4+T cells cultured in vitro for
4, 8, 12, 24, 48, 72, 168 and 336hrs
under subtype specific conditions
GSE48138 [153]
naive, Th1, Th2, iTreg
naïve CD4+T cells cultured in vitro for
5, 12, 24, 48 hrs) under subtype specific
conditions
DRFZ
un-
published
Microarray Th1, Th2, Th17, iTreg naïve CD4+T cells cultured in vitro for 10 daysunder Th1, Th2, Th17 and iTreg conditions GSE14308 [378]
ChIP-seq Th2 WT & Stat6 KO
naïve CD4+T cells cultured in vitro for 7 days
under Th2 condition and re-stimulated with
plate-bound CD3/28 +IL4 for 2 hrs
GSE22105 [379]
Th2 WT & Stat4 KO
naïve CD4+T cells cultured in vitro for 7 days
under Th2 condition and restimulated with
plate-bound CD3/28 +IL4 for 2 hrs
GSE22105 [379]
Seq. Thresholds for differentially expressed genes were defined by a minimal, absolute
log2 fold change of 1 and a p-value below 0.05. The resulting gene set is suspected to be
highly influenced by Stat6 KO and has been integrated as set of interaction partners of
Stat6 into the adjacency matrix.
Expression analysis of STAT6-regulated genes – microarray data processing
We characterized STAT6-regulated genes using expression levels of the integrated mi-
croarray data set (GSE14308, [378]) of the 10-day-old Th cells (Th2, Th1, Th17 and
iTreg). We calculated the overlap of genes that were STAT6-regulated and significantly
higher expressed after 10-days exclusively in one Th cell subtype compared to all others
and thus we imply a certain Th subtype specificity after the differentiation (10 days, see
Figure 6.5, p.104). For example, a gene expressed at least 1.4 fold higher in Th2 cells
than in Th1, Th17 and iTreg cells indicated Th2 specificity. To illustrate this categories
of T cell subtype-specificity was defined via comparing expression pattern, e.g. if the
expression of a gene higher in Th2 than in Th1 cells (Th2 >Th1), and for the same gene
it is high in Th2 than in Th17 cells (Th2 >Th17), and it is also higher Th2 than in
iTreg cells (Th2 >iTreg). These categories were also used in Figure 6.5. The minimal
thresholds for differential expression was set to log2(fold change) = 0.5 (∼ 1.4 fold).
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6.3.2. Th2 cell specific gene regulatory network assembly
All preprocessed data sets were iteratively integrated into a adjacency matrix represent-
ing the final network. First, we identified STAT6-regulated genes by analyzing RNA-seq
data of 7-day-old in vitro differentiated Th2 cells of WT and Stat6 KO mice (GSE40463,
highlighted in green in Figure 6.2). Gene expression analysis determined 1047 differ-
entially expressed genes. These presumably STAT6-regulated genes were filtered for
TFs, cytokines and cytokine receptors based on a published Th cell microarray data set
(GSE14308, in purple in Figure 6.2) of 782 TFs and 271 cytokines/cytokine receptors in
the context of induction, differentiation and maintenance of Th cell subsets.
From ChIP-seq analysis 4136 genes were considered as STAT6-bound (GSE22105,
highlighted in orange in Figure 6.2). The overlap of the Stat6-bound genes and the set
of TFs and cytokines/cytokine receptors revealed exactly 100 genes that were regulated
also by Stat6 (from RNA-seq analysis). This gene set was further classified into two
categories, either direct or indirect targets of STAT6 (using ChIP-seq binding data of
7-day-old Th2 cells).
Figure 6.3) illustrates the initial definition of the genes forming our basic STAT6
network.
349148  52
408539
767
185
TFs, cytokines and 
cytokine receptors
(functional assignment)
genes regulated by STAT6
(RNA-seq Stat6 KO) genes bound by STAT6
        (STAT6 ChIP-seq)
Figure 6.3.: The Venn-diagram shows the three filtered gene sets forming the
basic network. The intersection (100 genes, highlighted bold) of STAT6-
regulated genes (green) with TFs, cytokines and cytokine receptors (purple)
are dissected into direct and indirect target genes of STAT6 by integrating
the STAT6 ChIP-seq data (orange). Figure adapted from [168].
Next, we integrated both (GSE48138, DRFZ-RNA-seq data) time series expression
data of Th2 cells to check, whether the genes are differentially expressed (compared
to naïve CD4+ T cells) in early phase (0-48 h) and late phase (72-336 h) of Th2 cell
differentiation. The estimation of times of high expression can help to characterize the
specific role of an transcription factor or cytokine during the differentiation process. We
characterized 14 to be early expressed, 14 late expressed, 70 early and late expressed
genes as well as two genes neither differentially expressed early or late. In the next step,
the genes were connected to STAT6 regarding their co-expression in the Th2-RNA-seq
experiments. In the final network visualization (Figure 6.4) edge colors indicate whether
gene expression was increased or decreased in Stat6 KO mice. Furthermore, genes were
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annotated with their expression in other Th cell subtypes based on RNA-seq data and
experiments by Hu et al. (GSE48138, [153]).
The resulting STAT6 network contains the following information: (i) how STAT6
influences the expression of other genes, (ii) whether genes encode for TFs or cy-
tokines/cytokine receptors, (iii) whether genes are directly bound or not by STAT6,
and (iv) whether genes are differentially expressed in early and/or late differentiation of
Th2 cells compared to naïve CD4+ T cells.
6.3.3. Implications from the reconstructed network
The resulting gene regulatory network includes 100 TFs, cytokines and cytokine recep-
tors regulated (48 genes) or directly targeted by STAT6 (52 genes) in Th2 cells (Figure
6.4). Of these, 59 genes are up- and 41 genes are down-regulated. The integration of
expression time series of Th2 cells revealed that 98 of these 100 genes are also differen-
tially expressed in Th2 cells compared to naïve T cells. Most of them are differentially
expressed in early and late phase of differentiation.
The network contains genes known to be active in Th2 cells, such as the master TF
of Th2 cells, Gata3, the Th2 cell specific surface receptors Ccr3, Ccr4, and Ccr8, and
also the cytokines Il4 and Il6, which are known to be positively regulated by STAT6
[35, 78, 390]. Importantly, master TFs for other Th cell subsets are part of the network
but negatively regulated by STAT6, such as Foxp3 for iTreg cells, Tbx21 for Th1 cells,
and Rorg for in Th17 cells [390]. Th2 cell specific TFs are positively regulated by STAT6
and increased in Th2 cells such as Gata3 and Satb1.
Furthermore, we filtered the genes for TFs and performed a literature search regarding
their function in cell differentiation processes. Table 6.3 summarizes the results from
the presented experiments and provides a short functional description and references to
related literature. The total set of 32 TFs is divided into three groups: (i) associated with
differentiation of Th2 cells, (ii) associated with differentiation of other Th cell subtypes
and (iii) so far not reported to be associated with differentiation of Th cells. While
the majority of STAT6-negatively regulated TFs are activators for Th1, Th17 or iTreg
cell differentiation, five out of six Th2 cell specific TFs are up-regulated by STAT6 (see
Tabel 6.3). In summary, STAT6-driven differentiation of Th2 cells is mainly modulated
by activators and not preferentially by repressors.
6.3.4. Evaluation of the network
To validate the Th2 cell specificity of the STAT6 network, we studied gene expres-
sion profiles in Th cells of the 100 STAT6-regulated genes. To confirm the hypothesis
that STAT6-positively regulated genes have a higher expression preference in Th2 cells
compared to STAT6-negatively regulated genes we compared the gene expression levels
for each of the 100 STAT6-regulated genes in 10-day-old in vitro differentiated Th1,
Th2, Th17 and iTreg cells (GSE14308 [379]). There are 64 genes preferentially ex-
pressed in one Th-cell-subtype. We subdivided this group into Th1-, Th2-, Th17- and
iTreg-specifically-expressed genes and discriminated between STAT6-positively- (35) and
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TF
cytokine or cytokine receptor gene bound by STAT6 (STAT6 ChIP-seq)
gene expression increased by STAT6 (RNA-seq of Stat6 KO mice)
gene expression decreased by STAT6 (RNA seq of Stat6 KO mice)
yellow = differentially increased in Th2 cells
blue = differentially decreased in Th2 cells
white/ grey = not differentially expressed in Th2 cells
color of internal node = expression preference in early phase of Th2 
cell differentiation to naive cells (0-48 h)
color of external node = expression preference in late phase of Th2 
cell differentiation to naive cells (72-336 h)
ring structure around STAT6:
(1) only early,
(2) early and late,
(3) only late and
(4) not 
differentially expressed genes in Th2 cells
(RNA-seq, expression time series of Th2 cells)
shape/ node:
color:
line/ edge:
Figure 6.4.: Gene regulatory network of STAT6-regulated genes in Th2 cells.
The network is limited to TFs (square node), cytokines or cytokine receptors
(oval node) and shows indirect (48 genes) and direct targets (52 genes) of
STAT6. The network layout is based on four rings around STAT6 in graded
gray tones. Rings from inside to outside contain genes according to their
expression behavior: genes are only early (1), early and late (2), only late (3)
and not (4) differentially expressed in Th2 cells compared to naïve CD4+
T cells. The edge color indicates the effect of Stat6 on gene expression
changes, while the node color indicates the expression changes compared to
naïve CD4+ T cells. Figure adapted from [168].
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STAT6-negatively regulated (29) genes, as shown in the pie charts (Figure 6.5). The ma-
jority of the 35 STAT6-positively regulated genes (22) is preferentially expressed in Th2
cells. Importantly, there are no Th2-subtype-specific genes among the STAT6-negatively
regulated genes validating the Th2 cell specificity of the STAT6 network. Furthermore,
it confirms the observation that Th2-subtype-specific genes are up-regulated by STAT6
and Th1-, Th17- or iTreg-subtype-specific genes are mainly down-regulated by STAT6.
Comparison of gene expression levels:
Th2>Th1 and Th2>Th17 and Th2>iTreg
Th1>Th2 and Th1>Th17 and Th1>iTreg
STAT6-positively regulated genes (35)
63%
3%
8%
26%
27%
28%
45%
STAT6-negatively regulated genes (29)
Th17>Th1 and Th17>Th2 and Th17>iTreg
iTreg>Th1 and iTreg>Th2 and iTreg>Th17
Figure 6.5.: Expression preferences of Th cell subtype-specific and STAT6-
regulated genes. Gene expression levels of 100 STAT6-regulated genes
were compared between the Th cell subtypes Th1, Th2, Th17, and iTreg.
Figure adapted from [168].
6.3.5. Discussion of the presented integration strategy
In contrast to the large-scale network reconstruction approaches based only on expression
data described in Chapter 5, we showed the power of integrating different, specific, and
very homogenous experiments. The obvious advantage of this strategy is that data
set size can be smaller and as a consequence of this, the impact of variability of the
integrated data is smaller, too. Here, homogeneity depicts the experimental conditions
for cell type distinction, culture methods, stimulation for T cell activation and intervals
between measurements. Additionally, an integrated data normalization strategy covering
all experiments at once, is not required because integration is performed at the results
level, rather than on raw data level (in analogy to the meta-analysis strategy class
described in Chapter 3). Also, the step-by-step integration of each single data set allows
for adaption and changes of the analysis pipeline, without side effecting other parts.
Furthermore, the pipeline is flexible towards improvements and extension in any of the
three steps.
6.4. Summary
In summary, we applied comprehensive data integration to better understand Th2 cell
fate decisions and, in particular, to delineate the gene regulatory network of Th2 cells to
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unravel novel important TFs in Th2 cell differentiation. We identified 11 direct target
genes of STAT6 with so far unreported functions in Th cell differentiation. Among
these are eight genes positively (Asb2, Atf5, Creb3l2, Cebpb, Cited2, Rai14, Tanc2, and
Ddit3 ) and three genes negatively regulated (Aff3, Trps1, and Pou2f2 ) by STAT6 (Table
6.3). Interestingly, two of these TFs (AFF3 and POU2F2) have not been yet directly
associated to Th cell differentiation processes.
The eight STAT6-positively regulated and so far unknown TFs in the context of Th2
cell differentiation (Table 6.3) are of particular interest, because these TFs act as acti-
vators in Th2 or suppressors in Th1, Th17 or iTreg cell differentiation, as it was already
shown for the other two groups.
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7.1. Summary
In this thesis we studied how to apply machine learning methods for a better charac-
terization of regulatory T cell subsets. In detail, we presented an improved strategy
for the identification of Treg subtype specific surface markers and for the reconstruc-
tion of gene-regulatory mechanisms for Treg cells using publicly available data only. We
collected hundreds of publicly available murine T cell specific microarray experiments,
filtered and combined a substantial subset to a large microarray data set containing
experiments from two Treg cell subtypes. We developed and evaluated a meta analysis
strategy as baseline for the identification of marker candidates using an ensemble feature
selection approach based on this data set. Furthermore, we used the same data to recon-
struct gene regulatory networks. To this end, we applied a set of existing reconstruction
algorithms and compared the inferred networks.
The meta analysis in Chapter 3 describes a novel approach for aggregation of pub-
licly available Treg cell specific gene expression experiments to form a large meta exper-
iment for further use. After selecting and collecting hundreds of studies from a public
repository, manual curation by a trained immunologist, and filtering was performed to
ensure biological comparability. In the next step, quality checks based on downloaded
raw data led to a final set of 154 microarray experiments. Subsequent meta analysis
was implemented in two steps. First, experiments were normalized study-wisely, i.e.
all experiments belonging to the same study were preprocessed and normalized. In the
second step, quartile normalization was applied to the full set to adjust for inter-study
effects (also called batch- or lab-effects). The final meta expression set consisted of 154
expression values for each of the 12825 extracted genes. 125 nTreg and 29 iTreg cell
experiments built the final data set. For quality control we analyzed expression value
distributions before and after re-normalization as well as by differential expression anal-
ysis. Subsequently we assessed GO annotation enrichment of the set, which showed that
its set-characteristics, e.g. enriched molecular function terms of differentially expressed
genes did not change.
In Chapter 4 we developed a method to identify six Treg cell subtype specific surface
marker candidates from the meta expression set. We compared multiple feature selec-
tion methods and applied an ensemble of two methods to detect cell type specific gene
markers, followed by SVM-based evaluation of extracted candidate genes. We extracted
41 marker gene candidates. These genes and corresponding proteins were curated for
surface marker properties, which led to a final set of six genes. Subsequently, these genes
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were experimentally validated using qRT-PCR to verify gene expression differences be-
tween iTreg and nTreg cells as obtained from the meta expression data. For three of
these, namely, Ctla2b, Emp1 and Tnfrsf13b we could confirm higher expression in iTreg
cells, while for Gabrr2, Cd97 and Cd79b we confirmed the higher expression in nTreg
cells. Additionally, GO term annotation indicated an enrichment of the 41 extracted
genes towards cell cycle-related functions. Secondary biological analysis revealed that
the differences between the compared Treg cell data sets potentially derived from the
substantial differences of the cell culture conditions applied before performing microar-
ray experiments. Nevertheless, at least one of the candidates (Emp1 ) remained valid as
its expression profile was differential in qRT-PCR experiments under identical culture
conditions for both Treg cell subtypes. In summary, the applicability and validity of the
approach could be shown, as we were able to identify substantial differences between two
groups. However, it remains unclear, whether these genes indicate genomic differences
between the distinct Treg cell subtypes, or are artifacts caused by culture condition or
in the end a mixture of both.
Chapter 5 compares GRN reconstruction methods for regulatory T cells. This com-
parison revealed large differences regarding the need for prior knowledge like regulatory
interactions or pre-classification of genes into known regulators, e.g. TFs and targets
of regulation. Another important difference is that some methods require reduction in
data variability by discretization or binning of values to reduce calculation complexity.
Finally, we applied 11 methods to the Treg cell meta expression set. We used two public
interaction databases to evaluate the inferred networks and, hence, tool performances.
We could extract a small set of overlapping edges between the inferred networks. Some
of these edges are relevant for Treg cell specific regulatory mechanism, as they include
highly specific genes like Foxp3 – the master TF of Treg cells. Furthermore, two cy-
tokines, namely Il-2 and Lta, both relevant for Treg cell differentiation, were part of these
subnetworks. However, the poor overal accuracy of all reconstruction performances il-
lustrate the difficulty of the GRN inference problem based on expression data only. Low
numbers of true positive interactions underline the need for improvements in future work.
In contrast to the results from Chapter 5, the data integration strategy presented
in Chapter 6 created a gene interaction network with substantial numbers of T cell
relevant interactions. Here, we reconstructed a network around Stat6 – the master TF
of Th2 cells, that describes regulatory interactions occurring during cell differentiation
from nTreg and iTreg cell experiments. The network was established based on STAT6-
knockout RNA-seq and microarray data combined with STAT6 DNA-binding data from
ChIP-seq experiments. It was based on TFs and cytokines relevant for T cell develop-
ment, which were extracted from literature data. By using , The initial network was
built using the expression pattern of this reduced set of potential interaction partners.
Only those data from specific phases (time points) during the cell differentiation process
from time-series RNA-seq data was used. The subsequent annotation of binding-site
information (from ChIp-seq data) added a physical dimension to a subset of the ex-
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tracted interactions. The derived (star) network contained 100 edges – one interaction
between each gene and Stat6. We identified two groups of interaction partners of Stat6 :
(i) 52 genes which may directly interact with Stat6 via binding of the TF and (ii) 48
genes which probably are only individually regulated during Th2 cell differentiation.
Interestingly, 11 of these genes were so far unknown to be involved in Th2 cell differen-
tiation. Our integrative analysis approach revealed that eight of these 11 TFs are either
activators or suppressors in other T cell subtypes.
7.2. Future directions
7.2.1. Meta-analysis
The bases of all subsequent analyses is the underlying data. In Chapter 3, we described a
strategy for selecting and curating experimental data to ensure biological comparability.
We were faced with variations in the experimental setup and technology (platform) of
some selected studies, that did not match and led to exclusions of the corresponding
experiments. To reduce the impact of technical and processing variations towards later
analysis, more homogeneous data are required, on one hand. While on the other hand
we performed additional experiments to confirm our findings.
A great opportunity for the aggregation of large transcriptome data sets lies in the
integration of high-throughput sequencing data (RNA-seq) to extend the amount of
available experiments and studies. For about 10 years the amount of available biological
sequence data has continuously increased continuously (see Figure 7.1). Dozens of stud-
ies assessed and confirmed the comparability of RNA-seq and microarray experiments
(for a selection see [115, 245, 250, 284]). The main advantage of RNA-seq in contrast to
microarray technology is its superiority in detecting low abundance transcripts, differ-
entiating biologically critical isoforms, and allowing the identification of genetic variants
[404]. Since RNA-seq experiments have certain advantages, we suggest to improve the
presented meta analysis strategy by combining both technologies (microarray and RNA-
seq). The combination of technologies enlarges the amount of available experiments and
consequently the resulting expression set. Still, the challenge of handling study-effects
exists for both technologies. Ma et al. analyzed the effect on RNA-seq data sets and
observed study-effects to be consistent across microarray and RNA-seq data sets [241].
Therefore, the adaption of meta-analysis methods to RNA-seq data [251, 257] is needed.
Also, it would be highly interesting to analyze the performance of the presented two-step
normalization approach for reducing the batch effect. Note that, especially the second
phase is not restricted to a specific platform or technology.
7.2.2. Cell specific surface marker identification
The presented approach of detecting surface marker candidates to enable distinction
between Treg subtypes has not been tested in vivo so far. Consequently, the next step
towards in vivo application is transferring the results from transcriptome to proteome
level. This requires validation of candidates on protein level via immunoblot analysis
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Figure 7.1.: Number of bases uploaded to the Sequence Read Archive (SRA)
[209]. The SRA together with the European Nucleotide Archive (ENA)
[210] and the DNA Database of Japan [189] are the biggest open repository
for sequence data. All three are partners in the International Nucleotide
Sequence Database Collaboration (INSDC), that agreed on sharing all ex-
periments.
(for details of the method see [106]), followed by flow cytometry based cell sorting. So
far, testing of all extracted candidates using this approach was not possible due to a
lack of working antibodies and the discussed shortcomings regarding culture conditions
of the experiments.
Novel antibody panels (described in [118] or on manufacturer website2) covering hun-
dreds of surface marker proteins, allow for the detection of cell type specific marker
protein expression by flow cytometry. Such panels would allow for the parallel testing
of multiple candidates and multiple cell types.
7.2.3. Gene regulatory network reconstruction
In this thesis, we described the reconstruction of Treg cell specific GRNs using a selection
of methods based on steady-state data, which led to unsatisfying results. Quality of
input data strongly influences GRN reconstruction results, similar to surface marker
2online: http://www.biolegend.com/legendscreen, August 1st, 2016
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identification discussed in Chapter 4. As a consequence, we postulate also for GRN
reconstruction more and better input data for future attempts.
We highlighted two other aspects for improving network inference. First, time-series
data and second, more specific and smaller gene sets prior to inference. The benefit of
time-series data has been tested for GRN reconstruction in various studies [27, 112, 315,
373], especially for the reconstruction of dynamic networks that reflect different temporal
aspects of regulatory mechanisms. However, the usage of steady-state data was justified
by the low amounts of publicly available time-series data, that could be applied to meta
analysis and subsequent GRN reconstruction.
Specifying gene subsets is another option to improve GRN reconstruction. Catego-
rization of genes into regulated and regulating genes, as well as sub-grouping of genes
based on expression profiles are two approaches for subset definition. Such could replace
the presented strategy, of selecting the highest differentially expressed genes over all ex-
periments. One approach is to define groups of differentially expressed genes regarding
correlated temporal phases (time points). This extend existing approaches where time-
delays in gene expression are used to determine regulatory mechanisms [135, 148, 410].
Since it is widely accepted that genes can be grouped into regulators and regulated ones,
it may be worth to utilize time-series data to extract the groups from consecutive time-
points. Decomposing the set of input genes regarding their expression profiles reduces
the complexity of the inference task. As matter of fact, the results of the presented
study indicate that GRN reconstruction performs better for small networks/gene sets
(see Figure 5.5, p. 88).
Additionally, the genes to be studied could be more specifically selected regarding
known regulatory functions or functional annotations, like TFs or miRNAs. Such cate-
gorization can also be incorporated as activity list or initial network structure.
Combining data integration and GRN reconstruction
Another approach for improving GRN reconstruction is to integrate prior knowledge
from databases and related experiments into the inference process. The basic idea is to
combine the results from data integration (Chapter 6) as prior knowledge with methods
for GRN reconstruction (Chapter 5).
More precisely, the presented integration approach for Th2 cells revealed 100 genes
that interact with the TF Stat6 and, thus, form a network with 101 interactions. These
interactions can be passed to reconstruction tools, like birta, MNI or NCA (for details
see Section 5.5). Such tools require initial TF-networks or so-called activity matrices
encoding known interaction (see Table 5.3, 76) as initializing parameter sets. Bayesian
network approaches like Banjo allow for initial network structures to set mandatory and
“forbidden” edges.
Additionally, the analysis of differentially expressed genes from time-series RNA-seq
data, helps to identify simultaneously regulated genes. Such co-regulated genes are more
likely to share regulatory mechanisms and could be used to define subsets for inference for
specific time-points or phase of cell differentiation as well as for treatment or phenotype
studies. Another open question is to evaluate how GRN reconstruction methods like MNI
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(an ODE-based method) can benefit from comparative studies revealing specific gene
sets of interest, for example revealed by gene-knockout experiments or drug-treatment
studies. The major advantage of specific (and often smaller) gene sets is, that the number
of potential nodes in a network is reduced by magnitudes.
In summary, applying the integration strategy to retrieve a baseline set of gene-
regulatory interactions is one future challenge for improving GRN reconstruction. How-
ever, uncovering regulatory mechanisms and even single interactions can help to elucidate
the regulatory program behind T helper cell differentiation.
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A.1. References to microarray experiments integrated into
meta-analysis
The appendix provides detailed information about the microarray gene expression exper-
iments used to create the meta-expression set in Chapter 3. Table A.1 lists all microar-
rays included in the meta-analysis. The table provides detailed information on Treg cell
subtype, cell origin (mouse strain), literature references to corresponding publications
as well as all available GEO accessions (GDS, GSE, GSM). Table A.2 extends Table A.1
by details on referenced literature for each listed microarray experiments.
Table A.1.: Listing of the Treg cell specific microarray experiments included
in the meta expression set (see Chapter 3). Categorization for Treg
subtype was performed by biologist for each single microarray. All infor-
mation were retrieved from NCBI’s GEO Platform http://www.ncbi.nlm.
nih.gov/geo. Full literature references are listed in Table A.2 using PMIDs
as key. Table is adapted from [198, in preparation].
Treg
cell
sub-
type
Mouse strain Title GEO Ex-
periment
Accession
No.
GEO Mi-
croarray
Accession
No.
GEO
Platform
Accession
No.
PMID
iTreg TCR-HA-transgenicmice dtg CD25+ TR_1 GSE12506 GSM314229 GPL339 18056346
iTreg TCR-HA-transgenicmice dtg CD25+ TR_2 GSE12506 GSM314230 GPL339 18056346
iTreg TCR-HA-transgenicmice dtg CD25+ TR_3 GSE12506 GSM314231 GPL339 18056346
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP mesenteric
lymph node Treg,
biological rep 1
GSE41229 GSM1011464 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP mesenteric
lymph node CD4+
non-Treg, biological rep 1
GSE41229 GSM1011465 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP small
intestine Treg, biological
rep 1
GSE41229 GSM1011466 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP small
intestine Treg, biological
rep 2
GSE41229 GSM1011467 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP spleen Treg,
biological rep 1
GSE41229 GSM1011480 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP mesenteric
lymph node Treg,
bilogical rep 2
GSE41229 GSM1011481 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP mesenteric
lymph node Treg,
bilogical rep 3
GSE41229 GSM1011493 GPL6246 24574339
nTreg C57BL/6-Foxp3/GFP Foxp3-GFP small
intestine Treg, biological
rep 3
GSE41229 GSM1011499 GPL6246 24574339
iTreg C57BL/6J Nr1+ GSE41492 GSM1018194 GPL1261 23226238
iTreg C57BL/6J Nr2+ GSE41492 GSM1018195 GPL1261 23226238
iTreg C57BL/6J Nr3- GSE41492 GSM1018196 GPL1261 23226238
iTreg C57BL/6J Nr4- GSE41492 GSM1018197 GPL1261 23226238
nTreg Balbc 13_PTr GSE42021 GSM1030709 GPL1261 23420886
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Treg
cell
sub-
type
Mouse strain Title GEO Ex-
periment
Accession
No.
GEO Mi-
croarray
Accession
No.
GEO
Platform
Accession
No.
PMID
nTreg Balbc 14_PTr GSE42021 GSM1030718 GPL1261 23420886
nTreg Balbc 15_PTr GSE42021 GSM1030727 GPL1261 23420886
nTreg C57BL/6-Foxp3/GFP TR.0hr#3 GSE42276 GSM1036805 GPL6246 23277554
nTreg C57BL/6-Foxp3/GFP TR.0hr#4 GSE42276 GSM1036806 GPL6246 23277554
nTreg C57BL/6-Foxp3/GFP TR.0hr#5 GSE42276 GSM1036807 GPL6246 23277554
nTreg C57BL/6-Foxp3/GFP Foxp3+ ex
vivo_Cytoplasmic
RNA_1
GSE45401 GSM1103573 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ ex
vivo_Polysome-
associated
RNA_2
GSE45401 GSM1103574 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ ex
vivo_Cytoplasmic
RNA_5
GSE45401 GSM1103577 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ ex
vivo_Polysome-
associated
RNA_6
GSE45401 GSM1103578 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ activated in
vitro_Cytoplasmic
RNA_13
GSE45401 GSM1103585 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ activated in
vitro_Polysome-
associated
RNA_14
GSE45401 GSM1103586 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ activated in
vitro_Cytoplasmic
RNA_15
GSE45401 GSM1103587 GPL7546 23658533
nTreg C57BL/6-Foxp3/GFP Foxp3+ activated in
vitro_Polysome-
associated
RNA_16
GSE45401 GSM1103588 GPL7546 23658533
nTreg C57BL/6J Treg_WT_replicate_1 GSE46693 GSM1134630 GPL11180 23812589
nTreg C57BL/6J Treg_WT_replicate_2 GSE46693 GSM1134631 GPL11180 23812589
nTreg C57BL/6J Treg_WT_replicate_3 GSE46693 GSM1134634 GPL11180 23812589
nTreg C57BL/6J Treg_WT_replicate_4 GSE46693 GSM1134636 GPL11180 23812589
nTreg NOD TR.VIVO.0hr#1 GSE48210 GSM1172803 GPL6246 23986534
nTreg NOD TR.VIVO.0hr#2 GSE48210 GSM1172814 GPL6246 23986534
nTreg NOD TR.VITRO.0hr#1 GSE48210 GSM1172825 GPL6246 23986534
nTreg NOD TR.VITRO.0hr#2 GSE48210 GSM1172835 GPL6246 23986534
nTreg C57BL/6J CD4+CD25+ Treg,
B6.H2g7, rep1
GSE6813 GSM155637 GPL1261 19073938
nTreg C57BL/6J CD4+CD25+ Treg,
B6.H2g7, rep2
GSE6813 GSM155638 GPL1261 19073938
nTreg C57BL/6J CD4+CD25+ Treg,
B6.H2g7, rep3
GSE6813 GSM155639 GPL1261 19073938
nTreg NOD CD4+CD25+ Treg, NOD,
rep1
GSE6813 GSM155640 GPL1261 19073938
nTreg NOD CD4+CD25+ Treg, NOD,
rep2
GSE6813 GSM155641 GPL1261 19073938
nTreg NOD CD4+CD25+ Treg, NOD,
rep3
GSE6813 GSM155642 GPL1261 19073938
nTreg C57BL/6-Foxp3/GFP 76091_CD4+,
FoxP3(EGFP+) mouse
cells
GSE6875 GSM158520 GPL1261 17273171
nTreg C57BL/6-Foxp3/GFP 82428_CD4+,
FoxP3(EGFP+) mouse
cells.txt
GSE6875 GSM158523 GPL1261 17273171
nTreg C57BL/6-Foxp3/GFP 85382_CD4+,
FoxP3(EGFP+) mouse
cells
GSE6875 GSM158527 GPL1261 17273171
iTreg NOD ActTreg, rep1 GSE7460 GSM176764 GPL1261 18024188
iTreg NOD ActTregTGF, rep1 GSE7460 GSM176765 GPL1261 18024188
iTreg NOD ActTreg, rep2 GSE7460 GSM177375 GPL1261 18024188
iTreg NOD ActTreg, rep3 GSE7460 GSM177376 GPL1261 18024188
iTreg NOD ActTregTGF, rep2 GSE7460 GSM177377 GPL1261 18024188
iTreg NOD ActTregTGF, rep3 GSE7460 GSM177378 GPL1261 18024188
nTreg C57BL/6J Foxp3 sufficient Treg
CD4+ T cells from
healthy B6 mice_1
GSE11775 GSM298104 GPL1261 19710455,
21642545
nTreg C57BL/6J Foxp3 sufficient Treg
CD4+ T cells from
healthy B6 mice_2
GSE11775 GSM298105 GPL1261 19710455,
21642545
nTreg C57BL/6J Foxp3 sufficient Treg
CD4+ T cells from
healthy B6 mice_3
GSE11775 GSM298106 GPL1261 19710455,
21642545
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Treg
cell
sub-
type
Mouse strain Title GEO Ex-
periment
Accession
No.
GEO Mi-
croarray
Accession
No.
GEO
Platform
Accession
No.
PMID
nTreg TCR-HA-transgenicmice stg TR_1 GSE12506 GSM314235 GPL339 18056346
nTreg TCR-HA-transgenicmice stg TR_2 GSE12506 GSM314236 GPL339 18056346
nTreg TCR-HA-transgenicmice stg TR_3 GSE12506 GSM314237 GPL339 18056346
nTreg Balb/c WT TR_1 GSE12506 GSM314238 GPL339 18056346
nTreg Balb/c WT TR_2 GSE12506 GSM314239 GPL339 18056346
nTreg Balb/c WT TR_3 GSE12506 GSM314240 GPL339 18056346
iTreg TCR-HA-transgenicmice stg 3d TA_1 GSE12506 GSM314241 GPL339 18056346
iTreg TCR-HA-transgenicmice stg 3d TA_2 GSE12506 GSM314242 GPL339 18056346
iTreg TCR-HA-transgenicmice stg 3d TA_3 GSE12506 GSM314243 GPL339 18056346
iTreg C57BL/6J iTreg-1 GSE14308 GSM357849 GPL1261 19144320
iTreg C57BL/6J iTreg-2 GSE14308 GSM357850 GPL1261 19144320
nTreg C57BL/6J nTreg-1 GSE14308 GSM357852 GPL1261 19144320
nTreg C57BL/6J nTreg-2 GSE14308 GSM357853 GPL1261 19144320
nTreg C57BL/6J C57BL/6 CD4+ CD25+
Treg cells #1
GSE14350 GSM358746 GPL1261 19185518
nTreg C57BL/6J C57BL/6 CD4+ CD25+
Treg cells #2
GSE14350 GSM358748 GPL1261 19185518
nTreg C57BL/6J C57BL/6 CD4+ CD25+
Treg cells #3
GSE14350 GSM358749 GPL1261 19185518
iTreg Balbc/Foxp3EGFP Induced regulatory T
cells 1
GSE14415 GSM360147 GPL1261 19265124
iTreg Balbc/Foxp3EGFP Induced regulatory T
cells 2
GSE14415 GSM360148 GPL1261 19265124
iTreg Balbc/Foxp3EGFP Induced regulatory T
cells 3
GSE14415 GSM360149 GPL1261 19265124
iTreg Balbc/Foxp3EGFP Induced regulatory T
cells 4
GSE14415 GSM360150 GPL1261 19265124
iTreg Balbc/Foxp3EGFP Induced regulatory T
cells 5
GSE14415 GSM360151 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Activated natural
regulatory T cells 1
GSE14415 GSM360162 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Activated natural
regulatory T cells 2
GSE14415 GSM360163 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Activated natural
regulatory T cells 3
GSE14415 GSM360164 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Native (not activated)
natural regulatory T cells
1
GSE14415 GSM360165 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Native (not activated)
natural regulatory T cells
2
GSE14415 GSM360166 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Native (not activated)
natural regulatory T cells
3
GSE14415 GSM360167 GPL1261 19265124
nTreg Balbc/Foxp3EGFP Native (not activated)
natural regulatory T cells
4
GSE14415 GSM360168 GPL1261 19265124
iTreg Balbc/Foxp3EGFP IL-2-cultured induced
regulatory T cells 1
GSE14415 GSM360174 GPL1261 19265124
iTreg Balbc/Foxp3EGFP IL-2-cultured induced
regulatory T cells 2
GSE14415 GSM360175 GPL1261 19265124
nTreg 129/SvJ/Foxp3-IRES-GFP NaïveTreg_biological_rep4
GSE16210 GSM407042 GPL1261 Bioproject
PR-
JNA117149
nTreg 129/SvJ/Foxp3-IRES-GFP NaïveTreg_biological_rep5
GSE16210 GSM407043 GPL1261 Bioproject
PR-
JNA117149
nTreg 129/SvJ/Foxp3-IRES-GFP NaïveTreg_biological_rep6
GSE16210 GSM407044 GPL1261 Bioproject
PR-
JNA117149
nTreg C57BL/6J Control Treg_rep1 GSE18148 GSM453647 GPL1261 19800266
nTreg C57BL/6J Control Treg_rep2 GSE18148 GSM453648 GPL1261 19800266
nTreg C57BL/6J Control Treg_rep3 GSE18148 GSM453649 GPL1261 19800266
nTreg DEREG CD4+GFP+FoxP3+ GSE18387 GSM458592 GPL1261 19966212
nTreg C57BL/6-Foxp3/GFP TregLPno1 GSE20366 GSM510238 GPL1261 20231436
nTreg C57BL/6-Foxp3/GFP TregLPno2 GSE20366 GSM510239 GPL1261 20231436
nTreg C57BL/6-Foxp3/GFP TregCD103+Klrg1+no1 GSE20366 GSM510252 GPL1261 20231436
nTreg C57BL/6-Foxp3/GFP TregCD103+Klrg1+no2 GSE20366 GSM510253 GPL1261 20231436
nTreg C57BL/6-Foxp3/GFP T reg resting replicate 1 GSE24210 GSM595507 GPL1261 20953201
nTreg C57BL/6-Foxp3/GFP T reg resting replicate 2 GSE24210 GSM595508 GPL1261 20953201
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Treg
cell
sub-
type
Mouse strain Title GEO Ex-
periment
Accession
No.
GEO Mi-
croarray
Accession
No.
GEO
Platform
Accession
No.
PMID
nTreg C57BL/6-Foxp3/GFP T reg resting replicate 3 GSE24210 GSM595509 GPL1261 20953201
nTreg C57BL/6J WT_1 GSE26425 GSM648480 GPL8321 21199917,
22715468
nTreg C57BL/6J WT_2 GSE26425 GSM648481 GPL8321 21199917,
22715468
nTreg C57BL/6J WT_3 GSE26425 GSM648482 GPL8321 21199917,
22715468
nTreg C57BL/6J WT 1 GSE27434 GSM678219 GPL8321 23444399
nTreg C57BL/6J WT 2 GSE27434 GSM678220 GPL8321 23444399
nTreg C57BL/6J WT 3 GSE27434 GSM678221 GPL8321 23444399
nTreg C57BL/6J WT_1 GSE27896 GSM688866 GPL8321 21444725
nTreg C57BL/6J WT_2 GSE27896 GSM688867 GPL8321 21444725
nTreg C57BL/6J WT_3 GSE27896 GSM688868 GPL8321 21444725
nTreg C57BL/6-Foxp3/GFP activated Treg, biological
replica 1
GSE28130 GSM696984 GPL1261 21642545
nTreg C57BL/6-Foxp3/GFP activated Treg, biological
replica 2
GSE28130 GSM696985 GPL1261 21642545
iTreg C57BL/6-Foxp3/GFP induced Treg, biological
replica 1
GSE28130 GSM696986 GPL1261 21642545
iTreg C57BL/6-Foxp3/GFP induced Treg, biological
replica 2
GSE28130 GSM696987 GPL1261 21642545
nTreg C57BL/6J Wild type Treg rep1 GSE29262 GSM723290 GPL1261 22013112
nTreg C57BL/6J Wild type Treg rep2 GSE29262 GSM723294 GPL1261 22013112
nTreg C57BL/6J Wild type Treg rep3 GSE29262 GSM723298 GPL1261 22013112
nTreg NOD CD25+CD49f+ T cells,
biological rep1
GSE30503 GSM756576 GPL1261 Bioproject
PR-
JNA143315
nTreg NOD CD25+CD49f+ T cells,
biological rep2
GSE30503 GSM756577 GPL1261 Bioproject
PR-
JNA143315
nTreg NOD CD25+CD49f+ T cells,
biological rep3
GSE30503 GSM756578 GPL1261 Bioproject
PR-
JNA143315
nTreg NOD CD25+CD49f+ T cells,
biological rep4
GSE30503 GSM756579 GPL1261 Bioproject
PR-
JNA143315
nTreg NOD NOD CRE natural
Treg_MLB 004
GSE35164 GSM862871 GPL11180 22579476
nTreg NOD NOD CRE natural
Treg_MLB 005
GSE35164 GSM862872 GPL11180 22579476
nTreg NOD NOD CRE natural
Treg_MLB 006
GSE35164 GSM862873 GPL11180 22579476
nTreg Balbc Mouse invivo nTreg cells,
replicate pool 1
GSE35543 GSM870351 GPL1261 23125413
nTreg Balbc Mouse invivo nTreg cells,
replicate pool 2
GSE35543 GSM870352 GPL1261 23125413
iTreg Balbc Mouse stable invitro
iTreg cells, replicate pool
1
GSE35543 GSM870353 GPL1261 23125413
iTreg Balbc Mouse stable invitro
iTreg cells, replicate pool
2
GSE35543 GSM870354 GPL1261 23125413
nTreg C57BL/6J Wild type_1 GSE36095 GSM881027 GPL8321 22715468
nTreg C57BL/6J Wild type_2 GSE36095 GSM881028 GPL8321 22715468
nTreg C57BL/6J Wild type_3 GSE36095 GSM881029 GPL8321 22715468
nTreg C57BL/6-Foxp3/RFP FR1 (CD62Lhi CD69-
Klrg1-) biological
replicate 1
GSE36527 GSM896172 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR1 (CD62Lhi CD69-
Klrg1-) biological
replicate 2
GSE36527 GSM896173 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR2 (CD62Llo CD69-
Klrg1-) biological
replicate 1
GSE36527 GSM896174 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR2 (CD62Llo CD69-
Klrg1-) biological
replicate 2
GSE36527 GSM896175 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR3 (CD62Llo CD69+
Klrg1-) biological
replicate 1
GSE36527 GSM896176 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR3 (CD62Llo CD69+
Klrg1-) biological
replicate 2
GSE36527 GSM896177 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR3 (CD62Llo CD69+
Klrg1-) biological
replicate 3
GSE36527 GSM896178 GPL6246 22786769
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nTreg C57BL/6-Foxp3/RFP FR3 (CD62Llo CD69+
Klrg1-) biological
replicate 4
GSE36527 GSM896179 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR3 (CD62Llo CD69+
Klrg1+) biological
replicate 1
GSE36527 GSM896180 GPL6246 22786769
nTreg C57BL/6-Foxp3/RFP FR3 (CD62Lhi CD69-
Klrg1-) biological
replicate 10
GSE36527 GSM896181 GPL6246 22786769
nTreg C57BL/6-Foxp3/GFP TRGFP B6 #1 GSE37605 GSM923131 GPL6246 22579475
nTreg C57BL/6-Foxp3/GFP TRGFP B6 #2 GSE37605 GSM923132 GPL6246 22579475
nTreg NOD/6-Foxp3/GFP TRGFP NOD #1 GSE37605 GSM923133 GPL6246 22579475
nTreg NOD/6-Foxp3/GFP TRGFP NOD #2 GSE37605 GSM923134 GPL6246 22579475
nTreg C57BL/6-Foxp3/IRES-GFP TRIGFP B6 #1 GSE37605 GSM923135 GPL6246 22579475
nTreg C57BL/6-Foxp3/IRES-GFP TRIGFP B6 #2 GSE37605 GSM923136 GPL6246 22579475
nTreg NOD/6-Foxp3/IRES-GFP TRIGFP NOD #1 GSE37605 GSM923137 GPL6246 22579475
nTreg NOD/6-Foxp3/IRES-GFP TRIGFP NOD #2 GSE37605 GSM923138 GPL6246 22579475
nTreg C57BL/6J WT_1 GSE39864 GSM980505 GPL8321 22922362
nTreg C57BL/6J WT_2 GSE39864 GSM980506 GPL8321 22922362
nTreg C57BL/6J WT_3 GSE39864 GSM980507 GPL8321 22922362
nTreg C57BL/6-Foxp3/GFP WT 1 sample A GSE40493 GSM995225 GPL6246 23053511
nTreg C57BL/6-Foxp3/GFP WT 1 sample B GSE40493 GSM995226 GPL6246 23053511
nTreg C57BL/6-Foxp3/GFP WT 2 sample A GSE40493 GSM995227 GPL6246 23053511
nTreg C57BL/6-Foxp3/GFP WT 2 sample B GSE40493 GSM995228 GPL6246 23053511
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Table A.2.: Literature references of PMIDs corresponding to the experiments
used to create the meta-expression set in Chapter 3. The table is
adapted from [198, in preparation].
PMID Reference
17273171 Lin W, Haribhai D, Relland LM, et al.;Regulatory T cell development in the absence
of functional Foxp3; Nat Immunol;2007 Apr;8(4):359-68;Epub 2007.
18024188 Hill JA, Feuerer M, Tash K, et al.; Foxp3 transcription-factor-dependent and -
independent regulation of the regulatory T cell transcriptional signature; Immunity;
2007Nov;27(5):786-800.
18056346 Hansen W, Westendorf AM, Reinwald S,et al.; Chronic antigen stimulation in
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2.1. Development of naïve T (Th0) cells into T helper cell lineages/
subtypes. Process of T cell differentiation is mainly driven by presence
and absence of lineage specific cytokines (written on the arcs) and so
called master TFs (written in the cells). Cytokines at the right side are
those, expressed by the activated cells. . . . . . . . . . . . . . . . . . . . . 10
2.2. Putative mechanisms used by Treg cells. Treg cells have multipe
putative targets as described by Caridade et al. [51]. These include (1)
targeting dendritic cells (DCs) – leading to weak or abrogated signals
to naïve/effector T cells; (2) Metabolic disruption; (3) Competition – for
critical cytokines, such as IL-2, or direct disruption of effector cell engage-
ment with APCs; (4) Cytolysis – direct cytotoxic effect and consequent
apoptosis of effector T cells or APCs; (5) Production of inhibitory cy-
tokines – including IL-10, IL-35, and TGF-ß. Figure adapted from [51]. . 12
2.3. Gene expression of eukaryotic organ is initiated in the cell nu-
cleus. DNA is transcribed into RNA. Next RNA is spliced and trans-
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2.4. TF-binding in promoter region initiates gene transcription. Bind-
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phenomenon that gene regulation is cause by cooperatively acting of TFs,
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2.5. Schema of a microarray experiment from sample purification to
data analysis. The figure illustrates processing steps and their sequential
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2.6. Microarray expression analysis workflow. Various workflow variants
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2.7. The decrease of sequencing costs per human genome over time.
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2.8. Illustration of the processing workflow for ChIP-seq experiments.
ChIP-seq procedure consists of i) the isolation of the target samples (here
immune cells), ii) fragmentation of the isolated DNA, followed by iii) the
chromatin immunoprecipitation with the subsequent RNA purification,
iv) adapter ligation and end repair of the isolated sequences, v) library
preparation and vi) clustering the targeted RNAs following by vii) the
actual sequencing and subsequent analysis of detected reads. The figure
is adapted from Kidder et al. [183]. . . . . . . . . . . . . . . . . . . . . . . 18
2.9. Chromatin Immunoprecipitation sequencing(ChIP-seq) peak call-
ing analysis workflow. Analysis workflow consist of six steps followed
by an additional annotation step (extraction of associated genes). While
step 1-4 are similar to RNA-seq analysis, peak calling and peak annotation
are specific to ChIP-seq analysis. . . . . . . . . . . . . . . . . . . . . . . 19
2.10.RNA sequencing(RNA-seq) expression analysis workflow.The steps
1-4 are similar to the ChIP-seq analysis workflow (Figure 2.8), while step
5-7 are specific to RNA-seq analysis. The general outline of the workflow
is based on the work of Trapnell et al. [359] . . . . . . . . . . . . . . . . . 20
3.1. GEO Gene Omnibus platform growth over the last 15 years.
Plot illustrates the orders of magnitudes of platform, studies and sam-
ples submitted to the GEO database each year since inception. Until
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perform on 15,358 were submitted to the GEO database. (Numbers were
take from the website (https://www.ncbi.nlm.nih.gov/geo/summary/
?type=history, online on 2016/01/10) . . . . . . . . . . . . . . . . . . . . 24
3.2. Schema illustrates the steps of meta-analysis starting from re-
questing online repositories up to assembling the meta expres-
sion matrix. Sections 3.4.1 - 3.4.6 describe the pipeline in detail. . . . . 32
3.3. Fractions of platform types in the final meta expression set. 154
arrays (29 iTreg and 125 nTreg) from 36 GEO series were selected. This
set contained six different Affymetrix GeneChip R⃝technologies. Numbers
below the platform type indicate the corresponding amount of integrated
microarrays. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.4. Different ProbeSet Ids link to the same Ensembl Mouse Gene
Identifier This problem is solved by assigning the expression values of
the ProbeSet with the highest fold change between measured experimental
states,(e.g. stimulation, cell type, treatment or time point) to the gene. . 36
3.5. Hierarchical clustering of assembled meta expression matrix.
Most of the microarrays from the same experiment (GSE) cluster to-
gether, which illustrate the lab-/batch effect, as their expression profile is
more similar among studies than towards other experiments. . . . . . . . 37
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3.6. Upper boxplots show expression distribution of non-adjusted
expression values after meta experiment assembly. Varying ex-
pression values are clearly visible for both cell types (nTreg - red, iTreg
- blue) and for all included studies. Lower boxplots show expression
distribution after applying quantile re-normalization. Mean expression as
well as minimal and maximal expression are adjusted to common levels,
to enable subsequent expression analysis. . . . . . . . . . . . . . . . . . . 38
3.7. QQplots illustrate difference before and after re-normalization.
First row of figures shows qqplots of non-adjusted data, where second
row of figures shows re-normalized data. By comparing upper and lower
figures it becomes clear that expression values became more homogeneous,
which illustrates the reduction of the inter-study effect (the shift onto the
diagonal), at the same time the profile of expression differences between
single genes are widely kept (compressions and stretches in line profiles).
200 randomly selected genes were used to plot four comparisons of ex-
pression profiles from two independent microarrays (origin from different
studies) each time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.8. Genes differentially expressed between iTreg and nTreg cells.
Heatmap shows the mean gene expression extracted from the assembled
and re-normalized meta expression set. Color key indicates expression
values. Upper band of the heatmap represents expression in iTreg cells,
where lower band represents expression in nTreg cells. . . . . . . . . . . . 40
4.1. Support Vector Machines (SVM) aim to find the “best” hyper-
plane (line a) that separates two classes. Blue and yellow dots
represent entities of two classes, that are separated by a line (a), that
maximized decision boundaries (arrow-line d). Two dimension can be
separated by a line, like illustrated here, while for higher-dimensional
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vectors define the decision function. The support vectors line c1 and c2
determine the decision boundaries. Line b is one “not optimal” example
of a separating hyperplane. . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4.2. Data preparation and feature selection pipeline. Green arrows and
braces represent data flows. We performed two data split steps to ensure
that all samples from identical studies were not shared between data sets.
Feature selection depicts the strongest attributes; here the genes that
describe Treg cell subtype class best. GSE is accession number prefix of
GEO series, that identifies a specific study. . . . . . . . . . . . . . . . . . 52
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4.4. First phase of evaluation: Classification of experiments based on
potential marker genes. The complete meta expression set was used
for leave-one-out cross validation, but samples from the same study are
not shared between training and test sets. . . . . . . . . . . . . . . . . . 56
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ance metrics derived for both Treg subtype classes. In contrast to Table
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4.6. a) Relative mRNA expression of candidate genes was analyzed
by qRT-PCR. mRNA was extracted from cultured iTreg and ex vivo
nTreg cells of Foxp3-IRES-GFP mice and normalized to RPS-18 expres-
sion (n=6). The results show high consistency for predicted markers
between meta-analysis and validation experiments; validation and orig-
inal experiments were performed under similar conditions (non-cultivated
nTreg cells). b) Comparison of fold changes for candidates derived
from meta-analysis and qRT-PCR experiments. Rough-hatched
bars show log2 fold changes calculated from meta-analysis. Fine-hatched
bars depict fold changes calculated from qRT-PCR between cultured iTreg
and ex vivo nTreg cell. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.7. Immunoblot analysis of EMP1 and GABRR2. Analysis revealed
stability of differences in protein expression between cell subtypes for both
candidates. Expressions of both proteins where subtracted by background
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4.8. Gene expression log2 fold changes including cultured ex vivo
nTreg cells. Non-hatched bars show fold changes calculated from Bioin-
formatics meta-analysis. Rough-hatched bars depict fold changes calcu-
lated from qRT-PCR between iTreg and not cultured nTreg cell. Fine-
hatched bars depict fold changes from qRT-PCR between iTreg and five
days cultured nTreg cells. . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.9. Number of microarray experiments per study. The majority (72%)
of integrated studies/ study parts are rather small, containing less than
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5.1. Directed GRN with three nodes v1, v2, v3 and two edges e1, e2.
Node v1 is the source of e1and target of e2, v2 is targeted by a regulatory
event initiated by v1. v1 might represent a TF that is target of another
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5.2. A Bayesian network representing conditional probabilities among
variables. The graph illustrates a simple BN, where the v1...v5 repre-
sent genes and the causal relationship amongst them. In this example
the expression of v3 and v4 depends on v1 and v2 respectively, where the
expression of v5 depends on the common expression of v3 and v4. Despite
no direct relation between v1 and v5, it is clear, that v5 depends on the
expression of v1 and this relation is mediated by v3. . . . . . . . . . . . . 69
5.3. The left network GDBN represents the Dynamic Bayesian Net-
work (DBN) over two time points of a time-series. The transitions
v1 → v3 → v5 → v1 represent a circle transition over two time points.
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5.4. Tool testing strategy. The six layers (1-6) illustrate the main steps of
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size. The measures were calculated based on the “combined” evaluation
corpus. The lines for Banjo are plotted before the lines of Genie3 and
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5.6. Boxplots of F-measure and accuracy aggregated for each tool
over all gene sets to illustrate variance. Comparison shows that
no tool is able to outperform all others in terms of F-measure and ac-
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6.1. Integration strategy to create an interaction network around a
master regulator (master TF). This pipeline models the integration of
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6.3. The Venn-diagram shows the three filtered gene sets forming
the basic network. The intersection (100 genes, highlighted bold) of
STAT6-regulated genes (green) with TFs, cytokines and cytokine recep-
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by integrating the STAT6 ChIP-seq data (orange). Figure adapted from
[168]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
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ANN artificial neural network
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